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ABSTRACT 
Trichuriasis, caused by the intestinal nematode Trichuris, is a disease that affects up to a 
billion people worldwide. To date, most of our knowledge of this disease comes from the 
mouse model, Trichuris muris, which has been successfully used to dissect the immune-
mediated effector mechanisms that elicit the expulsion of the nematode.  
 
Numerous studies have shown a temporal association between intestinal nematode 
expulsion and goblet cell hyperplasia; however their precise role in response to nematode 
infection remains elusive. Goblet cells found at mucosal surfaces secrete many constituent 
components of the mucus barrier, including the gel-forming mucins (Muc2 in the 
intestine); mucins are large multifunctional glycoproteins that provide the structural 
framework of the barrier. The studies presented in this thesis demonstrate that the mucosal 
barrier and in particular its mucin components, changes in response to acute and chronic 
T.muris infection.  
 
In animals resistant to chronic T. muris infection, IL-13-mediated increase in Muc2 
production and secretion was observed at the site of infection. Critically, expulsion of the 
nematode was significantly delayed in the absence of Muc2. Further investigation 
subsequently showed that Muc5ac, a mucin normally expressed in non-intestinal mucosa 
was, in fact, expressed in the intestine following nematode infection and was associated 
with nematode expulsion in the resistant mice. Moreover, mice deficient in Muc5ac were 
susceptible to chronic infection, despite a strong underlying TH2-type immune response 
which is essential to eliminate the nematodes, suggesting that Muc5ac acts as a critical 
effector molecule. Several qualitative changes in the mucins were also noted during 
resistance: mucins were more highly charged and more sulphated during nematode 
expulsion. Overall, the changes within the mucus barrier during resistance result in altering 
the rheological properties of the mucus layer making it less porous and mucins were shown 
to directly „damage‟ the nematodes during nematode expulsion as reflected by a significant 
reduction in ATP levels. Chronic infection was accompanied by decreased levels of low 
charged and highly sialylated Muc2. Additionally, we demonstrated that the excretory 
secretory products released by the nematode consist of serine proteases capable of 
depolymerising the Muc2 mucin network, which may be part of the nematodes regime to 
improve its niche and/or aid movement through the mucus layer. Overall, this resulted in a 
porous mucus layer and a favourable environment for the parasite. 
 
Data is presented to show that the intestinal mucus barrier and its constituent mucins are an 
integral part of the co-ordinated expulsion mechanisms that occur in animals resistant to 
T.muris infection and we identify a mechanism whereby the nematode exerts its effects on 
the mucin environment to promote its survival within the host.  
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1.1 The intestinal mucus barrier 
The large intestine is the final part of the digestive system and is responsible for the 
efficient absorption of water, sodium and chloride ions as well as the secretion of 
bicarbonate ions and mucus. The main components of the large intestine are the caecum, a 
pouch like structure, and the colon (Barrett, 2006; Hedrich, 2004), which consist of deep 
crypts that open onto the luminal surface as depicted in Figure 1.1A. The intestinal 
epithelial cell layer is continuously being regenerated by stem cells found at the bottom of 
the crypts (Brittan and Wright, 2004). The epithelial cell layer consists of several different 
cell types: enterocytes are the main cell type which are absorptive cells; these are 
interrupted by specialised secretory cells called goblet cells because of their shape as 
illustrated by Figure 1.1B.  
 
 
The epithelial cell layer is protected by a layer of mucus, which is an essential part 
of the innate immune system, enabling the host to prevent access of pathogens. Mucus 
primarily consists of mucins, water, proteins and inorganic salts. The viscous and gel-like 
properties of the mucus barrier, which enable it to physically protect and lubricate the 
mucous membranes, are conferred mainly by mucins (Thornton and Sheehan, 2004). 
Goblet cells within the crypts of the epithelia synthesise and store mucins within their 
granules (Figure 1.1B), which can then be released via exocytosis in response to specific 
stimuli (Hasnain, 2010; Thornton et al, 2008). Many factors can stimulate secretion of 
mucins and mucus (e.g. cytokines, growth factors, bacterial products and viruses) and, of 
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particular relevance to this project, parasitic Excretory Secretory Products (ESPs) (Matsuo 
et al, 1997).  
 
1.1.1 Mucins  
Mucins are large heavily glycosylated proteins and typically have a molecular mass 
in excess of 10
6 
Da. These large proteins are densely substituted with short glycan chains 
which have many important functional roles (Thornton et al, 2008). For example, it is well 
known that glycans have fundamental roles in many biological processes such as cell 
interaction, cell growth, cell signalling, cell adhesion and immune defence (Singh and 
Hollingsworth, 2006). Furthermore, glycan chains are also thought to modulate the 
structural and functional activity of proteins, which is discussed in detail below. 
 
1.1.1.1    Glycosylation  
There are two main types of glycosylation in mucins: N-glycosylation and O-
glycosylation. Synthesis and transfer of N-glycans, which are important in intracellular 
processes (e.g. protein trafficking), occurs within the rough endoplasmic reticulum, where 
they are attached to asparagines (Asn) in the protein sequence Asn-X-Serine/Threonine 
(where X can be any amino acid except proline) through N-acetylglucosamine (GlcNAc) 
(Taylor and Drickamer, 2003). Mucins, however, are predominantly decorated with O-
glycan sugars, which accounts for up to 80% of their molecular weight. The O-glycan 
sugars attach through N-acetlygalactosamine (GalNAc) to a serine or threonine residue in 
the serine-threonine-proline (STP) rich tandem repeats in the protein core (Taylor and 
Drickamer, 2003). Glycosylation of the mucin tandem repeat depends on several factors 
such as the presence of proline adjacent to serine/threonine, steric hindrance by 
neighbouring glycans and the availability of glycosyltransferases (Thornton et al, 2008). 
This results in diverse site-specific and mucin-specific glycosylation patterns which 
influence the properties of the mucin and therefore the mucus gel (Robbe et al, 2004). This 
extensive O-glycosylation occurs in the Golgi complex and is essential to the extracellular 
function of the protein. It is involved in the hydration, extension and expansion of the 
protein in solution which results in a reduction in the flexibility of the protein 
(Hollingsworth and Swanson, 2004). The dense O-glycan substitution of mucins shields 
the underlying polypeptide from degradation by proteases. Furthermore, these glycans can 
act as decoy extracellular receptors for viruses, bacteria and parasites, consequently 
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removing the pathogens and limiting the potential danger of infection (Hollingsworth and 
Swanson, 2004). The changes in glycosylation and its potential role of glycosylation in 
intestinal disease will be discussed later (refer to section 1.3).  
  
 At least 20 genes that encode for mucins have been identified and coined, MUC 
genes; nomenclature is presented as MUC/Muc for human/mice respectively. Mucins have 
been classified into two major groups: cell surface mucins and secreted mucins (Thornton 
and Sheehan, 2004).  
 
 
1.1.1.2    Cell surface mucins 
Cell surface mucins are intercalated in the plasma membrane through a 
transmembrane domain. The large extracellular mucin domain which contains the STP-rich 
region, is extensively O-glycosylated (Figure 1.2). The cytoplasmic domain is thought to 
play a role as a molecular sensor and is involved in signal transduction pathways. In mice, 
Muc1, Muc4, Muc12, Muc13, Muc15, Muc16, Muc17 (orthologue of human MUC3) and 
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Muc20 are all classed as cell surface mucins (Linden et al, 2008a; Singh and 
Hollingsworth, 2006). In the intestine, Muc1, Muc4, Muc13 and Muc17 have been shown 
to be expressed at high levels (Figure 1.2) (Linden et al, 2008a). Although membrane 
bound, the cell surface mucins can be released as they are susceptible to post-translational 
proteolytic cleavage at the conserved SEA domain (Figure 1.2). It is thought (but not 
proven) that the cell surface mucins also directly contribute to the physical properties of 
the mucus layer (Singh and Hollingsworth, 2006).  
 
 
1.1.1.3    Secreted mucins 
Epithelial surfaces are covered with a mucus gel layer which provides protection, and 
lubrication. The viscoelastic and barrier properties of mucus are mainly due to the 
polymeric secreted mucins. Of the secreted mucins, MUC2/Muc2, MUC5AC/Muc5ac, 
MUC5B/Muc5b, MUC6/Muc6 and MUC19/Muc19 are classed as polymeric (gel-forming) 
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mucins (Escande et al, 2004; Thornton et al, 2008; Thornton and Sheehan, 2004), whereas, 
MUC7 and MUC8 are non-polymeric mucins (Figure 1.3). Gel-forming mucins share a 
common evolutionary ancestor and, with the exception of MUC19/Muc19, are located on 
chromosome 11p15.5 in humans and on chromosome 7 in mice (Escande et al, 2004; 
Pigny et al, 1996). It is predominantly Muc2/MUC2 that is expressed in the normal adult 
intestine, however, Muc5ac/MUC5AC which is predominantly a gastric/respiratory mucin, 
has been shown to be produced in the intestine during foetal development (Buisine et al, 
1998).  
 
1.2 Assembly of mucins  
The assembly of the secreted polymeric mucins is thought to be very similar to that 
of another O-glycosylated polymeric protein, von Willebrand factor (vWF) (Sheehan et al, 
1996). Although the whole pathway has not yet been elucidated, vWF has been shown to 
form 20MDa polymers through disulphide bond linkage of 250kDa subunits (Sadler, 
1998). Similar to vWF, N-glycosylation of mucin monomers occurs on the polypeptide 
chain in the endoplasmic reticulum (ER), this is followed by each linear mucin monomer 
(500nm) forming disulphide bonds with other monomers, which is mediated by the 
cysteine residues in the C-terminus (cysteine knot domain) (Figure 1.4) (Sheehan et al, 
1995; Sheehan et al, 1996). The dimers are then translocated to the Golgi where the 
tandem repeat domains are O-glycosylated. Polymers, which can extend up to 10µm in 
length, are subsequently formed by disulphide bonds between the D-domains
1
 present at 
the N-terminus. Once secreted, interactions between the mucin polymers form a network of 
large entangled structures (2-100MDa) (Hollingsworth and Swanson, 2004; Perez-Vilar 
and Hill, 1999; Sheehan et al, 1995).  
Glycosylation, polymerisation and entanglement are all important factors in 
determining the gel-forming properties of the mucins, and hence the properties of the 
mucus gel. However, it is not yet clear whether these are the only essential factors. It is 
possible that carbohydrate-carbohydrate, mucin-carbohydrate, mucin-mucin or mucin-
protein interactions contribute towards the gel-forming properties. Electron microscopy 
studies on airway mucus have shown unreduced mucins to form extensively entangled 
networks (Sheehan et al, 1996; Thornton and Sheehan, 2004). However, whether there are 
                                                 
1
 D-domains are very similar to and have been named after the D (dimerisation) domains from von 
Willebrand factor (vWF). 
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specific „cross-links‟, or whether this occurs due to the sheer size and volume occupancy 
of the mucins is undetermined. It is important to acknowledge that, in the intestine, the 
mechanism of mucin assembly appears to differ from that observed in other mucus gels 
(Herrmann et al, 1999).  
 
Intestinal polymeric mucins are assembled via non-reducible linkages as well as 
disulphide bonds (Asker et al, 1995). Axelsson et al. hypothesise that the non-reducible 
„extra‟ linkage is either between amino acids in the primary mucin sequence or possibly 
between smaller linking proteins (Axelsson et al, 1998); the details of the nature of this 
bond have not yet been elucidated. However, it was recently demonstrated that Fc-gamma 
binding protein is covalently bound to the N-terminus of MUC2/Muc2 (Johansson et al, 
2009) and may act as a mucin cross-linker. In the intestine, the mucins are proposed to 
form a heterogeneous mucus barrier which is comprised of two distinct layers (Johansson 
et al, 2008): a „loose‟ outer layer that the commensal flora can penetrate and an adherent 
inner layer that excludes the commensal flora from direct contact with the underlying 
epithelia (Figure 1.5). The adherent layer is densely packed with mucins and, upon 
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proteolytic cleavage, forms the loose outer layer hence the components within the layers 
are similar (Johansson et al, 2008). The different nature of the assembly of the mucins in 
tissues may reflect the different functional requirements at the sites: for instance, in the 
airways a transportable gel is required for clearance, whereas in the intestine, a non-
transportable gel provides mechanical protection and lubrication.                      
 
 
1.3 Role of mucins in disease 
Changes in the mucus layer underlie many common human disorders. For instance in 
respiratory diseases, such as asthma, cystic fibrosis (CF) and Chronic Obstructive 
Pulmonary Disease (COPD) an overproduction of thick viscous mucus impairs airway 
clearance (Thornton et al, 2008; Thornton and Sheehan, 2004). Since mucins are the main 
determinants of the properties of the mucus layer, changes in these complex glycoproteins 
are a feature of such disorders. The major gel-forming mucins in normal airway secretions 
are MUC5AC and MUC5B which exists in two different glycosylated forms (Thornton and 
Sheehan, 2004). In airway disease, an increase in mucin content and a change in mucin 
composition is observed: which imparts different charge to the molecule. Interestingly, the 
ratio of MUC5B charge form is altered and the low charge form predominates in disease 
conditions (Kirkham et al, 2002). Overall, these changes can lead to inflammation and 
increased coincidence of secondary bacterial infections (Thornton et al, 2008). Therefore, 
this suggested that the changes in mucin production could be associated with the 
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inflammation in infection and the alteration in mucins may lead to changes in mucus 
properties and, in turn, an inability to effectively clear pathogens. 
As this project is concerned with the intestinal mucus barrier, a short review of what 
is known about changes in mucin expression, mucin production and mucin structure in 
intestinal diseases and parasitic infections is discussed below. 
 
1.3.1 Inflammatory bowel disease 
Inflammatory bowel disease (IBD) is a combined term used to describe a group of 
inflammatory conditions of the intestine, including ulcerative colitis and Crohn‟s disease. 
In contrast to mucin overproduction seen in airway disease, it is a decrease in mucin 
production, specifically of Muc2/MUC2, that is observed in intestinal diseases (McGuckin 
et al, 2009). Evidence from human and animal model studies (Table 1.1) has revealed that 
a diminished intestinal mucus barrier in the intestine can lead to direct bacterial contact 
with the epithelial cell layer, resulting in colitis-like inflammation (Heazlewood et al, 
2008; Johansson et al, 2008). Aberrant expression of the respiratory/gastric mucin 
MUC5AC within the intestine has also been reported from studies on patients with 
ulcerative colitis (Forgue-Lafitte et al, 2007). Furthermore, qualitative changes in the 
glycosylation of mucins, in particular a loss in sulphation of mucins (Corfield et al, 1996), 
is associated with IBD and are thought to play a role in intestinal disease (An et al, 2007; 
Dawson et al, 2009; Tobisawa et al, 2010). 
  
1.3.2 Colonic adenocarcinomas 
A role for Muc2 has been suggested in the suppression of colorectal carcinoma: 
several murine models with alterations in intestinal secreted mucins result in developing 
invasive adenocarcinomas (Table 1.1). In particular, Muc2-deficient mice support this 
hypothesis, as these mice spontaneously develop adenomas which develop into invasive 
adenocarcinomas (Velcich et al, 2002). Furthermore, gastric and colonic tumours result in 
a loss of glycosylation on mucins, which could lead to altering the protective properties of 
the mucus barrier (Lidell et al, 2008). Similar to the changes in IBD, de novo expression of 
MUC5AC correlates with colon tumour progression and is used as a early marker for 
colonic carcinogenesis (Forgue-Lafitte et al, 2007).      
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Murine Model Description Phenotype Reference 
Muc2-deficient  In the absence of Muc2, goblet cells lose 
their goblet-like morphology, however the 
goblet cell lineage remains unaltered. 
Mice spontaneously develop adenomas 
that progress to invasive 
adenocarcinomas. Mice also 
spontaneously develop colitis, are more 
susceptible to DSS-induced colitis and 
bacterial infections. 
 
Van der Sluis et al 2006 
Velcich et al 2002 
Bergstorm et al 2010 
Winnie/Eeyore Missense mutations in the Muc2 gene results 
in aberrant Muc2 polymerisation, leading to 
ER stress. 
Mice spontaneously develop colitis and 
intestinal permeability increases which 
results in high inflammation. Increased 
susceptibility to DSS-induced colitis.  
 
Heazlewood et al 2008 
Agr2-deficient  Mice deficient in Agr2, the disulphide 
isomerase secreted with Muc2, which results 
in abrogating Muc2 biosynthesis.  
 
Spontaneous severe intestinal 
inflammation and goblet cell apoptosis.  
Park et al 2009 
Zhao et al 2010 
C3GnT transferase-
deficient 
Loss of the core 3-derived O-glycans on 
Muc2, which results in decreased production 
of Muc2.  
Mice have a diminished mucus barrier, 
increased permeability, are susceptible to 
DSS-induced colitis and developed 
colorectal tumours. 
  
An et al 2007 
GlcNAc6ST2-
deficient  
Mice deficient in N-acetyl glucosamine-6O-
sulphotransferase, which catalyses the 
transfer of sulphates on mucins.  
 
Reduced mucin sulphation, susceptibility 
to DSS-induced colitis and increased 
leukocyte inflammation. 
 
Tobisawa et al 2010 
NAS1-deficient  Mice deficient in Na
+
 sulphate transporter 1 
which is involved in sulphate homeostasis. 
Reduced mucin sulphation, increased 
susceptibility to colitis. Mice are more 
susceptible to systemic infection with 
Campylobacter jejuni.  
Dawson et al 2009 
Table 1.1: Murine models of alterations in intestinal secreted mucins. 
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1.3.3 Protozoan infection  
Entamoeba histolytica, a protozoan parasite that traverses the intestinal epithelium to 
reach the blood stream, expresses at least four cysteine proteases. These proteases have 
been shown to degrade MUC2 polymers in vitro (using CHO-K1 and LS174T cell lines), 
subsequently disrupting the gel-forming ability of the mucins and hence the protective 
nature of the mucus gel. The cleavage sites have also been identified in the C terminal 
domain which lies between two threonines in the sequence Arg/Lys-Thr-Thr (Lidell et al, 
2006; Moncada et al, 2003; Moncada et al, 2000).   
 
1.3.4 Bacterial and Fungal infections  
Streptococcus pneumoniae (S. pneumoniae) is a gram-negative bacterium that resides 
in the middle ear, where Muc2 is the major mucin expressed: infection induces acute otitis 
and hyperplasia of goblet cells (Lin et al, 2002). The level of the gel-forming mucin Muc2 
was more prominent in S. pneumoniae infected rats. Moreover, aberrant expression of 
Muc5ac was also observed post infection, which remained elevated until day 14 of the 
infection (Lin et al, 2002).  
Lipopolysaccharide (LPS), a gram-negative bacterial product, can induce mucus 
hypersecretion. In vitro stimulation of murine-derived biliary epithelial cells with LPS 
induced a significant increase in Muc2 and Muc5ac expression (Zen et al, 2002). 
Importantly, Muc2 has been shown to directly bind to Citrobacter rodentium and clear 
infection (Linden et al, 2008a). Furthermore, recently, it was demonstrated that the absence 
of Muc2 results in enhanced colonisation of C. rodentium (Bergstrom et al, 2010). 
Campylobacter jejuni, which is the main cause of gastroenteritis, can more readily cause 
systemic infections in mice with reduced mucin (Muc2) sulphation (Dawson et al, 2009) 
and in the absence of Muc2 (Bergstrom et al, 2010).  
Helicobacter pylori is a gram-negative bacterium present in the stomach. Infection is 
usually asymptomatic, however it can cause peptic ulcers and stomach cancer. H. pylori is 
thought to degrade mucins through proteases, which leads to a reduction in the 
viscoelasticity of the mucus gel and hence allowing H. pylori to enter the mucus gel (Celli 
et al, 2009). Furthermore, sialyl and sulphate groups on gastric mucins play an important 
role in adhesion of the bacterium (Linden et al, 2004; Linden et al, 2002; Sutton, 2001). In 
addition, H. pylori has been found to reduce mucus secretion by directly impairing the 
function of goblet cells. Normally MUC5AC and MUC6 are the secreted mucins present in 
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the stomach and MUC2 expression is non-detectable. However, studies have shown that in 
MUC5AC and MUC6 expression decrease and MUC2 expression increases as the disease 
progresses (Byrd and Bresalier, 2000; Byrd et al, 1997; Byrd et al, 2000). MUC6 has been 
found to exhibit anti-bacterial activity, therefore the bacterium could possibly down-
regulate its expression to make its own survival possible. Importantly, the properties of the 
mucus layer return to normal when the bacterium is eradicated.  
Haemophilus influenzae was used in an in vitro model to study the signalling 
pathways involved in MUC2 and MUC5AC expression. Transforming Growth Factor- 
(TGF-) receptor II and Toll-like receptor-2 (TLR-2) are utilised by the virus for the 
induction of MUC2 and MUC5AC expression through different pathways. TGF- signals 
through the Smad binding proteins, which translocate into the nucleus and act as 
transcription factors to mediate NF-B dependent (initiated by TLR-2) induction of MUC2 
(Jono et al, 2002; Jono et al, 2003). In contrast to MUC2, MUC5AC is negatively regulated 
by TGF--Smad signalling through p38 MAPK. The role of TGF- in influenza infection 
as an immune response mediator has not been investigated apart from its role in 
macrophage activation. Induction in the levels of TGF- and MUC2 has also been shown 
to correlate with resistance in the infection of Candida albicans (Jono et al, 2003), 
highlighting a protective function of MUC2.    
 
1.3.5 Helminth infection  
The most convincing data for the importance of mucus and mucins in nematode 
rejection comes from studies on the Trichinella spiralis (T. spiralis) and Nippostrongylus 
brasiliensis (N. brasiliensis). The nematodes T. spiralis and N. brasiliensis were shown to 
be enveloped in mucus just before their rejection, which lead to the „mucus-trap‟ 
hypothesis (Bell et al, 1984; Carlisle et al, 1990; Miller et al, 1981).  
Primary infection with the intestinal nematode T. spiralis results in goblet cell 
hyperplasia by day 8 of infection, enhancement of mucus secretion and glycocalyx
2
 
thickness. Another study showed that the mRNA expression of the mucins present in the 
small intestine, Muc2 and Muc17, increases significantly in T. spiralis infected mice 
compared to the uninfected mice (Shekels et al, 2001). A reduction in glycosylation is 
observed in the T. spiralis infected mice, which may be due to the release of partially 
                                                 
2
 Glycocalyx is a “carbohydrate rich zone” found at the surface of the cell consisting of glycoproteins 
(including cell-surface mucins that project from the apical surface of the cells).  
Introduction | 28 
 
synthesised mucins or possibly due to the glycosidases activity exhibited by the parasite. 
Overall, this suggests that mucin expression and the mucin phenotype is different in 
different life cycle stages of the nematode and is regulated in a specific way, perhaps by 
the nematode or by the immune response (Khan, 2008).  
Detailed studies by Yamauchi et al. have observed an increase in α-2-3-
sialyltransferase IV and Muc2 expression on day 2-3 after T. spiralis infection (Kawai et 
al, 2007; Yamauchi et al, 2006). Maturity of the T. spiralis helminth results in a marked 
increase in Muc17 and 3-0 sulphotransferase-1 expression in the intestine, which remains 
high until the rejection of the parasite from the intestine on day 14, after which the levels 
start to decrease and return to normal by day 18. The up-regulation of sialomucins 
observed in T. spiralis infection has been found to be under the regulation of thymus 
derived T cells (Kawai et al, 2007). The alterations in mucin O-glycans (sulphate and sialyl 
groups) are thought to play an important role in the establishment of the nematodes, 
however, their exact role is unknown. One study illustrated that inducing sulphation in vivo 
leads to a reduction in the establishment of the intestinal nematode Strongyloides 
venezuelensis but not N. brasiliensis (Ishikawa et al, 1995). However, sulphotransferases 
up-regulated just before the rejection of the N. brasiliensis parasites are thought to play a 
protective role in worm expulsion.  
 
1.4 Trichuriasis   
 The Trichuris nematode, which belongs to the phylum Trichuridae, is near 
ubiquitous as there have been about 90 to 95 species identified in different vertebrate host 
species worldwide (Lee, 2002); a few examples of these are shown in Table 1.2. These 
nematodes, coined whipworms because of their characteristic morphology, are unlike any 
other helminth as they do not undergo any tissue migration and are found only in the large 
intestine (Bethony et al, 2006; Lee, 2002). The distinctive bipolar eggs of Trichuris spp. 
can remain dormant but potentially infective for long periods. Once ingested through 
contaminated food or soil, the embryonated Trichuris eggs accumulate within the caecum 
(Bethony et al, 2006). After hatching the L1 Trichuris larvae embed into the epithelium of 
intestinal crypts and develop into cylindrical adult nematodes after moulting four times. 
The posterior end of the nematode protrudes in the lumen, where adults mate and a single 
female can lay up to 20,000 eggs per day that are shed in the faeces (Bethony et al, 2006). 
The anterior ends of the nematodes have a buccal cavity that is believed to secrete 
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digestive enzymes enabling the worm to burrow into the intestinal mucosa by forming a 
syncytial tunnel.  
 
Species Infects 
Trichuris tenuis Camel 
Trichuris parvispicularis Cane rat 
Trichuris bovis Cattle 
Trichuris campanula Cat 
Trichuris vulpis Dog 
Trichuris giraffae Giraffe 
Trichuris globulosa Goat 
Trichuris muris Mouse 
Trichuris dediphis Opossum 
Trichuris suis Pig 
Trichuris trichiura Primate 
Trichuris leporis Rabbit 
Trichuris ovis Sheep 
Trichuris discolor Zebra 
 
 
1.4.1 Response to Trichuris trichiura  
 Trichuris trichiura affects up to a billion people worldwide; heavy infections can 
lead to chronic diarrhoea, intermittent stomach pain and weight loss. In heavily infected 
individuals, the trauma of the whipworm burrowing into the intestinal epithelium can cause 
a chronic haemorrhage that may result in anaemia (Bundy et al, 1987b). T. trichiura 
infection can last for up to 4 years and can also lead to secondary bacterial infections, 
which coupled with allergic responses, can result in colitis, proctitis, rectal prolapse, 
insomnia and malnutrition (Bundy and Cooper, 1989). The spectrum of differences 
observed in disease pathology in humans in terms of the intensity of infection are thought 
to be due to differences in age, genetic background, physiology and nutrition. Although 
infections are usually low level and asymptomatic, heavy infections correlate with 
impaired cognitive and physical development in children (Cooper and Bundy, 1988). 
These insidious Trichuris nematodes are extremely successful within the host, because 
Table 1.2: Species of Trichuris affecting their corresponding vertebrate hosts 
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they not only have the ability to evade an immune attack but are thought to actively subvert 
the immune responses generated by the host (which will be discussed later on).  
 Trichuriasis is a disease still largely neglected by the medical and international 
community, despite its impact on economy, education and public health. This may be due 
to the geographical distribution of T. trichiura infection and possibly because infection 
does not cause sudden onset of serious debilitating symptoms. New strategies are at present 
being introduced to control transmission and develop vaccines as part of a multi-disease 
programme. Currently, treatment with multiple courses of benzimidole is common practice 
in the affected areas (Bethony et al, 2006). However, re-infections to the same level can 
easily occur as individuals remain in endemic areas and continuous intervention can lead to 
resistance to anti-helmintics (Turner et al, 2002). The chronic immune-activated state in 
nematode infections has been hypothesised to render the host susceptible to infections such 
as HIV and tuberculosis by impairing its ability to generate protective immunity (Borkow 
and Bentwich, 2000). Studies have demonstrated that nematode infections can modify 
responses to other vaccinations required in affected areas (Cooper et al, 1999; Duff et al, 
1999). Other studies have shown that repetitive anti-helmintics treatment can lead to an 
increase in allergic reactions (van den Biggelaar et al, 2004). Therefore, infections with 
nematodes are not only debilitating themselves, but also have a profound effect on 
subsequent infections and treatment of other diseases. Nematode infections are generally 
associated with a TH2-type immune response that down-regulates a TH1-type immune 
response. Analysis of whole blood culture from a range of age groups (4-36 years) in 
Cameroon revealed that only 17% of that group produced IL-4, IL-9 and IL-13, in response 
to Trichuris infection. However, the majority of the group produced high levels of parasitic 
specific IL-10, TNF-α and IFN-γ (Jackson et al, 2004; Turner et al, 2002). A study by 
Turner et. al. illustrated that children infected with T.trichiura secrete more 
immunoregulatory cytokines, such as IL-10 and TGF-β (Turner et al, 2002). Other field 
studies have shown that chronic infection by T. trichiura in children is characterized by 
high concentrations of IgE, degranulating mast cells and the release of histamine. 
Furthermore, an age-dependent relationship was observed with infection intensity as 
antibody levels rise with the acquisition of infection (Bundy et al, 1987a; Bundy et al, 
1988). The intensity of infection declines in adulthood which lead to the suggestion that 
continued exposure could potentially result in acquired immunity.  
 The data from field studies is limited and the interpretations of these correlations 
are subject to several variables, especially due to concurrent infections that occur in the 
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affected areas. Overall, the protective immune response to T. trichiura in humans remains 
largely unresolved. Most of our understanding about Trichuriasis is derived from the 
studies in animal model systems of this disease; mainly with the Trichuris muris (T. muris) 
model in mice and some with the Trichuris suis (T. suis) model in pigs. 
   
1.4.2 Lessons from animal models  
 According to Wessler „a living organism with an inherited, naturally acquired or 
induced pathological process that in one or more respects resembles the same phenomenon 
in man‟ will serve as a model system for studying a human disease (Wessler, 1976). 
T.muris infection occurs naturally in wild mice and using defined inbred mouse strains is 
utilised as a well-established laboratory model. T. muris is closely related to the human 
T.trichiura whipworm at a morphological and antigenic level (Cliffe and Grencis, 2004). 
Studies on the T. muris mouse model have shown that once ingested, the eggs accumulate 
in the caecum and predominantly at this site hatch. The L1 larvae establish infection within 
the epithelium at the base of the crypts of Lierberkϋhn. By day 35 the larvae develop into 
1.5cm long cylindrical adult worms in the large intestine after moulting 4 times at days 9-
11, day 21, day 24-28 and day 32-34 (Lee, 2002) (Figure 1.6).  
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 The infection variability (susceptibility or resistance to chronic infection) seen in 
the human population can be replicated using different inbred strains of mice or by varying 
the dose of infection (Cliffe and Grencis, 2004; Else and deSchoolmeester, 2003). The 
T.muris model not only provides a manipulable system that can be used to investigate the 
host-parasite interactions, but it can be used to examine the immune mechanisms operating 
during acute and chronic infection.  
 
1.4.3 Immunological basis of infection  
 Antigens from extracellular pathogens, such as Trichuris living in the intestinal 
crypts, are shed. These can be degraded and presented on major histocompatibility 
complex (MHC) Class II molecules by antigen presenting cells, such as dendritic cells and 
macrophages, to CD4 T cells. This subsequently stimulates their proliferation and 
differentiation into effector T helper (TH) cells (Else and Grencis, 1991).  
 CD4 T cells have been shown to be extremely important in resistance to T. muris as 
neutralisation leads to the failure to expel the nematode (Koyama et al, 1995). On the basis 
of the differing cytokine secretion patterns, CD4 T cells have been characterised as TH1 
and TH2 cells. More recently other subsets of CD4 T helper cells, TH17 and regulatory T 
cells (TREG), are also being investigated in this setting (D'Elia et al, 2009a). Several studies 
have focussed on the immune response that develops and, the cytokines and chemokines 
involved as a result of exposure to Trichuris (Artis and Grencis, 2008; Grencis, 2001). 
What initiates and promotes either a TH1 or TH2-type immune response is still largely 
undetermined. It is however, well-established that animal models resistant to chronic 
infection predominantly exhibit a TH2 response, whilst the strains that are susceptible to 
chronic infection exhibit a TH1 response (Figure 1.7).  
 
1.4.3.1 TH1 vs. TH2 immune response  
 TH2 responses, associated with resistance, are characterized by the production of 
IL-4, IL-5, IL-9 and IL-13 by CD4 T cells where both IL-4 and IL-13 operate through a 
STAT6 dependent pathway (Bancroft et al, 1998; Else et al, 1994; Faulkner et al, 1998). 
Therefore, it was concluded that IL-4 and IL-13 were important in mediating resistance as 
their production correlated with expulsion. Else et al. demonstrated this by the obstruction 
of the IL-4 receptor (IL-4R) in normally resistant mice which resulted in the animals 
mounting an appropriate TH1 response and subsequent survival of the T. muris nematode. 
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Administration of the IL-4 cytokine complex into a susceptible model early on in infection 
resulted in worm expulsion (Else et al, 1994; Else et al, 1992). Furthermore, although the 
IL-13-deficient mice were shown to be able to mount a TH2 response (characterised by the 
production of IL-4 and IL-9), they were unable to expel the parasites, demonstrating the 
importance of the IL-13 cytokine. Additionally, IL-13 can also mediate Trichuris 
expulsion in IL-4-deficient mice as IL-13 administration leads to expulsion (Bancroft et al, 
2000; Bancroft et al, 1998). Additionally, a gender based difference with regards to 
susceptibility to chronic infection were observed in the IL-4/IL-4R-deficient mice 
(discussed later in detail) (Hepworth et al, 2009). IL-4 and IL-13 production can be 
enhanced by the release of chemotactic chemokines such as IL-5 (Bancroft et al, 1994), 
CCL2 (deSchoolmeester et al, 2003), CCL3 (Cruickshank et al, 2009) and CCL7 
(deSchoolmeester et al, 2003); in fact, CCL2-deficient mice are susceptible to chronic T. 
muris infection. In contrast, the CCL11 chemokine involved in recruiting eosinophils 
acting in synergy with IL-5 has been shown not to be critical for T. muris worm expulsion 
(Dixon et al, 2006).  
 Neutralisation of IL-9, another TH2-type cytokine, rendered resistant mice 
susceptible to T. muris infection, reduced colonic muscle contractility and goblet cell 
hyperplasia which accompany worm expulsion and will be discussed in detail later 
(Faulkner et al, 1998; Khan et al, 2003). It was demonstrated that IL-1 signalling is 
essential for CD4
+
 TH2-mediated protective immunity (Humphreys and Grencis, 2009). 
Furthermore, the IL-1-deficient mice were unable to expel the T. muris nematode. Another 
IL-1 superfamily member, IL-33 was shown to be up-regulated early during infection and 
skew the immune response towards TH2-type immunity by inducing the release of IL-4, 
IL-13 and IL-9 (Humphreys et al, 2008). The recent addition to the IL-17 cytokine gene 
family, IL-25, is also critical in worm expulsion, as it promotes TH2 cytokine-dependent 
immunity and limits heightened expression of TH1-type cytokines, IFN-γ and IL-17 
(Owyang et al, 2006). The IL-7-like cytokine, thymic stromal lymphopoietin (TSLP), 
known to promote TH2-type immune responses by influencing DC responses in allergic 
models, has recently been shown to be essential to T. muris expulsion (Massacand et al, 
2009; Taylor et al, 2009).   
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 The TH1 immune response is mediated through the predominant production of IFN-
γ, IL-18 and IL-12. IL-12 is mainly produced by macrophages and dendritic cells in 
response to bacterial products such as LPS via signal transducer and activator of 
transcription factors; STAT3 and STAT4. Indeed, the introduction of IL-12 into the 
resistant T. muris model was shown to result in susceptibility providing evidence that the 
TH1 cytokine environment promotes T. muris chronicity (Bancroft et al, 1997). IL-18 gene 
deletion results in resistance in the susceptible mouse strains as it usually down regulates 
TH2-type cytokine (IL-4 and IL-13) production (Helmby et al, 2001). The transcription 
factor, T-bet, which directs TH1 lineage commitment is up-regulated by the cytokine IL-27. 
Moreover, IL-27R-deficiency in mice resulted in a strong TH2-type immune response 
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which enables these mice to clear T. muris infection (Bancroft et al, 2004; Hunter et al, 
2004).   
 Significant levels of IL-10 have been observed in chronic T. muris models; 
although IL-10-deficient mice suffer severe pathology and do not survive, suggesting IL-
10 is critical in regulating both TH1 and TH2 responses. The role of IL-10, however, seems 
to be dependent on IL-12 as the IL-10/IL-12-deficient mice were resistant to T. muris 
infection (Schopf et al, 2002). Moreover, administration of broad spectrum antibiotics in 
the IL-10-deficient mice resulted in improving survival rates (Schopf et al, 2002). This 
suggests that secondary bacterial infections were contributing to the morbidity and 
mortality observed with T. muris infection.  
 
1.4.3.2 TH17 and TREG immune reponse 
 Recently, a focus of attention has been the T helper subset TH17 cells (which were 
discovered in autoimmune murine models) and TREG cells. TH17 cells have been shown to 
be essential for the clearance of extracellular bacteria such as Citrobacter rodentium 
(Mangan et al, 2006). IL-17, produced by TH17 cells, is significantly up-regulated in vivo 
if challenged by Borrelia burgdorferi and blocking IL-17 results in abolishing the arthritis-
like symptoms caused by this parasite (Weaver et al, 2006). Moreover, DC-derived TGF-β 
can direct a TH1 cell to a TH17 cell and IL-23 has been shown to induce differentiation of 
CD4 T cells into TH17 in the absence of IFN- γ (IFN-γ-deficient mice) (Tato et al, 2006); 
however, their role in T. muris remains to be defined.  
 TREG cells act as suppressors to control the immune response and interestingly, a 
correlation has been observed between T. muris infection and elevation in TREG immune 
cells. They have been shown to protect the host from pathology induced by nematodes, 
however further studies are underway exploring this arm of the immune response (D'Elia et 
al, 2009a).  
 
1.5 Host-mediated Immunomodulation 
1.5.1 Immune effector cells 
1.5.1.1 Antibodies: Infection with Trichuris has been shown to correlate with high levels 
of serum antibodies. There is some suggestion that FcγRI and FcγRII mediate the 
internalisation of IgG1, IgG2a, IgG2b and IgE. Therefore FcγR-deficient mice were used 
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to explore the role of antibodies in host protection. However, the FcγR-deficient mice were 
able to clear infection similarly to the wild-type mice (Betts and Else, 1999). In contrast, 
studies using B-cell-deficient μMT mice, showed that these mice were unable to expel the 
T. muris nematode. This study illustrated the importance of B cells in conditioning and 
maintaining a TH2-type immune response (Blackwell and Else, 2001). Interestingly, a more 
recent study showed that antibodies in the T. muris setting may play a role in vaccination 
mediated immunity as opposed to natural immunity (Dixon et al, 2008).  
 
1.5.1.2 Eosinophils: Moderate eosinophilia in the caecum accompanies Trichuris infection 
(Dixon et al, 2006). Coupled with this, eosinophils are generated by the TH2 type cytokine 
IL-5 and hence were proposed to play an important role in resistance. As discussed 
previously, mice deficient in CCL11 (which acts synergistically with IL-5) to recruit 
eosinophils did not alter the worm expulsion kinetics (Dixon et al, 2006). Furthermore, the 
ablation of eosinophil production by blocking IL-5 in resistant mice still resulted in 
expulsion, confirming that eosinophils are not essential for protection (Betts and Else, 
1999).    
 
1.5.1.3 Mast cells: Local mastocytosis is also a feature of Trichuris infections. Mast cells 
too were considered to be significant as they are controlled by TH2 type cytokines (IL-3, 
IL-4, IL-9 and IL-10) and in related systems such as T. spiralis infection mastocytosis is 
known to play a protective role (Grencis et al, 1993). In vivo administration of a 
monoclonal antibody against stem cell factor receptor (c-kit) was used to reduce the mast 
cell numbers in T. muris infected mice; however, this had no effect on the expulsion of the 
parasite (Betts and Else, 1999).  
 
1.5.1.4 Dendritic cells and Basophils: Dendritic cell (DC) infiltration to the caecum has 
been shown to correlate with resistance in the T. muris model (Cruickshank et al, 2009). 
Cruickshank et al demonstrated that the elevation in DC markers occurs faster in resistant 
mice as compared to susceptible mice. This subsequently leads to differences in the 
chemokine pattern between resistance and susceptibility (Cruickshank et al, 2009). A 
recent study by Artis and colleagues have demonstrated that mice with restricted Cd11c 
expression on MHC class II presenting cells (classically defined as DC) were unable to 
induce a TH2-type immune response, goblet cell hyperplasia and mice are subsequently 
unable to clear T. muris infection (Perrigoue et al, 2009). However, this study highlighted 
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that after nematode infection, basophils act as potential antigen presenting cells that 
express MHC class II and are able to drive and maintain a TH2-type immune response.   
 
1.5.1.5 Macrophages: Recent focus has been on the role of macrophages in a TH2 setting, 
although macrophages do not usually initiate an immune response, they can amplify and 
possibly influence it by releasing several factors and acting as antigen presenting cells. It 
has been well documented that exposure to TH1 (IFN-γ or LPS) or TH2 (IL-4/IL-13) 
stimuli results in „classically‟ (CAMØ) or „alternatively‟ (AAMØ) activated macrophages 
respectively (Reyes and Terrazas, 2007). AAMØ in a TH2 setting have been linked to roles 
in wound repair, anti-inflammation, and expulsion of parasite. Studies by Allen et al. have 
shown that AAMØ are crucial in killing the nematode, Brugia malayi (B. malayi) (Falcone 
et al, 2001). In infection with Heligmosomoides bakeri/polygyrus AAMØs produce 
arginase which is involved in clearing infection (reviewed in detail by(Reyes and Terrazas, 
2007)).  
 Recent reports, however, suggest that AAMØs have an anti-inflammatory role and 
are induced to dampen down the immune response, as seen in B. malayi (Loke et al, 2000; 
MacDonald et al, 1998) and Schistosoma mansoni (Smith et al, 2004) infections. 
Furthermore, AAMØs produce IL-6, TGF-β (implicated to have fibrogenic properties) and 
CC chemokines, CCL6 and CCL9/10 associated with the polarisation towards a TH2 
immune response (Gordon, 2003). Immune effector molecules such as IL-1, IL-12, and 
nitric oxide, possibly secreted by macrophages, have also been associated with distorting 
the immune response to become predominantly TH1; however, further studies are still 
needed to confirm these observations.  
 
1.5.1.6 Natural Killer cells: Natural killer (NK) cells can produce high levels of IL-13 and 
therefore were proposed to play an important role in resistance to Trichuris. In the 
T.spiralis mouse model, IL-13 produced by NK cells had been shown to responsible for the 
disease pathology and changes in intestinal architecture (McDermott et al, 2005). 
However, no major differences in Trichuris worm expulsion kinetics were observed in the 
NK1.1-deficient mice (Cliffe and Grencis, 2004; Koyama, 2002). Recently, however using 
anti-asialo GM1 antibody which abolishes NK cell activity, a slight delay in T. muris worm 
expulsion was observed (Hepworth and Grencis, 2009). This suggested that NK cells may 
indeed play an active role in worm expulsion but are not essential for worm expulsion.   
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1.6 Intestinal effector mechanisms  
1.6.1 Epithelial cells 
 Intestinal cell turnover plays an important role in modulating the fine balance that 
can cause resistance or susceptibility. Pulse chase experiments with bromodeoxyuridine 
(BrdU), which is incorporated into the DNA of proliferating cells, have shown that 
intestinal epithelial cell turnover is higher in resistant mice (BALB/c) compared to 
susceptible mice (AKR) (Cliffe et al, 2005). IFN-γ induces the production of the 
chemokine CXCL10, which reduces the rate of epithelial cell turnover resulting in the 
survival of the T. muris parasite in susceptible mouse models (Cliffe et al, 2005). 
Increasing the rate of epithelial cell turnover, by blocking CXCL10 in SCID (severe 
combined immunodeficient) mice, was sufficient for the expulsion of parasite. 
Furthermore, the CXCL10 receptor (CXCR3) was only expressed in susceptible mice 
(Cliffe et al, 2005).  
 As previously described, the intestinal epithelial cell-derived cytokine, TSLP, was 
also shown to be important in immunity to Trichuris. Recent studies illustrated that 
deletion/neutralisation of TSLP disrupts the TH2 immune response (potentially by 
disrupting basophilia) and impairs resistance to T. muris (Massacand et al, 2009; Perrigoue 
et al, 2009; Taylor et al, 2009).  
 
1.6.2 Enteroendocrine and Enterochromaffin cells 
 5-hydroxytryptamine (5-HT), mainly produced by enterochromaffin cells in the 
gut, is known to alter gut physiology, namely motility and secretory function, in 
gastrointestinal disorders (reviewed in detail by Akiho et al, 2007). Expression is induced 
by CD4
+ 
T cells and an increase in expression is observed in a resistant environment (TH2-
type immune response) (Wang et al, 2007), although its exact role in Trichuris infection is 
unknown.  
 As previously described, gender biased differences have been observed between 
acute and chronic T. muris infection. Recently, Hepworth et al demonstrated that IL-18 
influences the expression of androgenic hormones (probably secreted by enteroendocrine 
cells), which are shown to be important in determining the balance between a TH1 or a 
TH2-type immune response (Hepworth et al, 2009). In this study, female-associated 
hormones induced and male-associated hormones suppressed TH2 cytokine production, 
resulting in resistance and susceptibility to T. muris, respectively.  
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1.6.3 Smooth muscle 
 In other helminth models such as T. spiralis, a significant increase in intestinal 
motility and muscle contractility is associated with worm expulsion. At a cellular level, 
increases in actin and myosin are also observed in T. spiralis infection, which is thought to 
aid the expulsion of the parasite and are regulated through TH2-type cytokines (for details 
refer to the review by Khan and Collins, 2006). In the Nippostrongylus brasiliensis 
infection model, using IL-4αR-smooth muscle specific conditional transgenic mice it was 
shown that administration of IL-12 using an adenovirus vector expressing the TH1 cytokine 
resulted in delayed worm expulsion and significantly decreased hypercontractility (Khan 
and Collins, 2006; Zhao et al, 2003). Studies by the same group demonstrated that IL-9 
directly influenced intestinal muscle function and interestingly, an increase in contractility 
was associated with accelerated T. muris clearance (Khan and Collins, 2006; Khan et al, 
2003).  
 
1.6.4 Mucus barrier 
 The Trichuris worm shares a very intimate relationship with the mucus barrier as it 
lives potentially within the layer of mucus that blankets the epithelial surface (Figure 1.8). 
In the T. muris model, goblet cell hyperplasia is associated with worm expulsion in several 
resistant settings (Artis and Grencis, 2008). Nuclear factor kappa B (NF-κB) transcription 
factor is thought to play a direct role in regulating goblet cell hyperplasia through the 
induction of IL-4 and IL-13 (Artis, 2006). Several studies have proposed bioactive goblet 
cell factors, secreted into the mucus barrier, act as potential candidates involved in 
resistance to T.muris; these are discussed below.     
 
1.6.4.1 Gel-forming mucins: As introduced previously, the large polymeric mucin 
glycoproteins are the major product of goblet cells and determine gel-like properties of the 
mucus barrier. However, the role of mucins in T. muris remains largely unexplored.  
 
1.6.4.2 Relm-β: Gene expression of Relm-β (resistin-like molecule-β), a goblet cell protein 
specifically expressed in the caecum and distal colon, was found to be highly induced in 
the TH2 environment. It was suggested that Relm-β impairs survival of T. muris by 
affecting their chemosensory apparatus and hence impairing chemotaxis (Artis et al, 2004). 
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A recent study, however, revealed that Relm-β-deficient mice still have the ability to expel 
T. muris  (Artis and Grencis, 2008).  
 
1.6.4.3 Tff3: Intestinal goblet cells release another small protease-resistant cysteine-rich 
protein called intestinal trefoil factor (Tff3). Tff3 has been found to be important in goblet 
cell differentiation and proliferation and it has been shown to enhance mucus viscosity in 
mixtures with mucin glycoproteins (Thim et al, 2002). The expression of Tff3 usually 
correlates with the increase in goblet cell numbers and therefore was thought to be released 
as a selective effector molecule to protect the damaged mucosa by increasing mucus 
production and altering the mucus gel properties. It is possible that Tff3 is up-regulated in 
response to the damage caused by the nematode as it is known to be involved in mucosal 
repair (Podolsky et al, 2009).     
 
1.6.4.4 Intelectin: Microarray analysis revealed that an anti-parasitic protein, intelectin, 
produced by goblet cells in the epithelium cell compartment, was up-regulated in the 
resistant (BALB/c) T. muris model (D'Elia et al, 2009b). Although supplementary studies 
are needed to define the precise role of intelectin in a TH2 setting, there was no increase in 
intelectin expression in a susceptible environment (D'Elia et al, 2009b). 
 
1.6.4.5 Angiogenin-4: Else et al proposed Angiogenin-4 (Ang-4) as a potential effector 
molecule as it was up-regulated in resistant mice (D'Elia et al, 2009b). Ang-4 has been 
known to be secreted into the intestinal lumen and exert its bactericidal activity against 
intestinal microbes (Ganz, 2003). Further immunohistochemical analysis identified goblet 
cells as a novel cellular source of Ang-4; however its role in resistance to Trichuris 
remains unknown.   
 
1.6.5 Commensal Flora 
 An impressive number of commensal flora (1014) resides in the niche of the T.muris 
nematode (Guarner and Malagelada, 2003). The adherent mucus layer in the intestine 
protects the epithelial cells from direct contact by bacteria (Johansson et al, 2008). A 
recent study has demonstrated an essential role for the commensal gut flora during T. muris 
infection (Hayes et al, 2010). This study shows that commensal flora, such as Escherichia 
coli bind to the opercula at the poles of the Trichuris egg to induce hatching. Moreover, it 
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was demonstrated that in vivo treatment of immunocompetent and immunodeficient mice 
with antibiotics significantly reduced the establishment of T. muris infection, therefore, 
highlighting the essential role of the microflora in the intestine during nematode infection.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.7 Nematode-mediated Immunomodulation 
 Even though a considerable amount is known about the immune response and the 
effector mechanisms that may mediate worm expulsion, how the nematode itself modulates 
the immune response to promote chronic infection is still elusive. Interestingly, more than 
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one isolate of T. muris exists: Edinburgh (E), Japan (J) and the Sobreda (S) isolates (Else, 
2005). The S isolate influences infection to chronicity more readily than other strain and 
although the exact mechanism by which it evades the immune response is unknown, it 
provides evidence for nematode-mediated immunodulation (D'Elia et al, 2009a).  
 The excretory secretory products (ESPs) released from Trichuris spp. are thought to 
be very well-conserved and similar in terms of antigenicity (Roach et al, 1988). 
Interestingly, the major product from T. muris ESPs has homology to the TH1-type 
cytokine IFN-γ, therefore it may be secreted to mimic and hence manipulate the host‟s 
immune response (Grencis and Entwistle, 1997). As discussed previously the T. trichiura 
nematode forms a syncytical tunnel and embeds itself into the caecal epithelium. Drake et 
al have shown that the major protein secreted by the Trichuris nematode has the ability to 
induce ion-conducting pores in a lipid bilayer, which in turn may aid nematode invasion 
(Drake et al, 1994). Other studies have attributed tunnel formation to the protease activity 
(zinc metalloprotease, thiol protease and phenol oxidase) detected in Trichuris ESPs (Hill 
and Sakanari, 1997). T. suis ESPs have been shown to contribute to epithelial cell damage 
within the niche and have anti-bacterial activity against Campylobacter jejuni (Abner et al, 
2002). Although several studies have shown that the ESPs released through the course of 
infection are highly immunogenic (Drake et al, 1994), their function in vivo remains 
largely unknown.   
 
1.7.1 Therapeutic uses of Trichuris 
 The fact that Trichuris induces a strong TH2-type immune response while 
dampening the TH1-type immune response has been exploited to treat disease. Recent data 
suggests that an immunoregulatory response (TREG) is also generated in response to 
nematode infection. Therefore, diseases like inflammatory bowel disease, Crohn‟s disease 
and even allergies, where an imbalance in the immune response leads to pathology can be 
manipulated by utilising nematodes themselves or their ESPs. Most clinical studies have 
utilised the T. suis whipworm as it can transiently infect humans but cannot permanently 
colonise within the caecum.     
 Several clinical studies by Weinstock et al have shown that T. suis, can be 
successfully used in Crohn‟s disease to reduce mucosal inflammation (Summers et al, 
2003; Summers et al, 2005a; Summers et al, 2005b; Summers et al, 2006). Furthermore, 
studies with T. suis ESPs in mice have been shown to prevent the onset of airway 
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hyperactivity observed in asthma (Hepworth et al, 2010). It was also reported that IgE 
levels in allergic rhinitis were dampened with treatment (Summers et al, 2010) however, 
contradicting data has also been reported (Bager et al, 2010). Although, the treatment with 
T. suis seems to be well tolerated in humans and safe at therapeutic doses, its long term 
effects are unknown.  
 
1.8 Conclusion 
 The Trichuris nematode has co-evolved with its host and is finely tuned to its 
specific niche, where it minimises damage to prolong its survival. Animal models of 
trichuriasis provide a foundation of knowledge that defines the immunological basis of 
resistance and susceptibility to chronic infection. Overall, it is thought that, at least in mice, 
an amalgamation of mechanisms (under the TH2 immunological control) result in worm 
expulsion (Figure 1.8). Although much is known about the immune regulation and 
potential effector mechanisms in mice, as discussed, important pieces of the puzzle remain 
unknown.  
 
1.9 Aims of the project 
        Our knowledge concerning the role of the mucus barrier is limited when it comes to 
nematode infections. This project utilises both glycobiology and immunology approaches 
to explore the relationship of mucus barrier and the nematode, T. muris. Therefore, the 
major aims of the thesis are: 
 To investigate the changes in the mucus barrier during the different life stages of 
the T. muris nematode by utilising models resistant or susceptible to chronic 
infection.  
 To determine whether mucins, the major macromolecular component of the 
mucus barrier, play a role in the rejection of the T. muris nematode.  
 To gain insight into the qualitative changes in mucins, specifically glycosylation, 
during infection.  
 To investigate how the changes above are regulated by the host immune response 
and whether these changes have an impact on the physical properties of the 
mucus gel.  
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 To assess whether the nematodes can exert any effects on the mucus gel and 
whether the changes in the mucus barrier have an effect on the nematode itself.  
 
1.10 Outline of this thesis  
Changes in the mucosal barrier during acute and chronic T. muris infection (Chapter 
2)  
 The glycoconjugate components of the intestinal epithelium provide physical 
protection and, by sequestering host defence factors provide a „chemical‟ barrier (Thornton 
et al, 2008). The dynamic mucus barrier is the first line of defence, underneath this barrier 
is the „glycocalyx‟ which consists of the cell-surface mucins intercalated into the apical 
surface of the epithelial cell layer (Linden et al, 2008b). The epithelial cell layer itself is an 
intrinsic barrier, consisting of goblet cells and enterocytes that secrete „bioactive‟ factors. 
In this study we comprehensively characterise the changes within the mucosal barrier 
components in response to infection during acute and chronic T. muris infection (Hasnain 
et al, 2010a). Mucosal thickening, altered goblet cell differentiation resulting in depleted 
goblet cell numbers and glycoprotein secretion, were noted in the mice susceptible to 
chronic infection (Hasnain et al, 2010a). In contrast, a prominent feature during acute T. 
muris infection was a localised response of goblet cell hyperplasia (induced by the TH2-
type cytokine, IL-13).  In addition to the synthesis of glycoproteins within the goblet cells 
of the caecum (the niche of the parasite), an increase in the secretion of glycoproteins into 
the mucus barrier, mediated by the gamma amino-butyric acid receptor-α3 (GABA-α3) 
was observed during nematode rejection.  
 
Role of secreted gel-forming mucins during T. muris infection (Chapter 3 and 4) 
 Goblet cell hyperplasia and hypersecretion correlated with worm expulsion; 
however, the role of the major product of the intestinal goblet cells, Muc2 mucin, had not 
been addressed previously. Muc2 is a polymeric glycoprotein which forms a network 
within the mucus barrier and is responsible for its gel-like and viscous properties.  Along 
with the increase in goblet cell number, the expression of Muc2 was also up-regulated 
during worm expulsion (Hasnain et al, 2010b). In resistance, the changes in the mucin 
network affect the physical nature of the mucus barrier and affect the vitality of the worm, 
thus aid worm expulsion. To address the protective capacity of Muc2 during T. muris 
worm expulsion, mice deficient in Muc2 were infected with a high dose of T. muris eggs. 
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A functional role for Muc2 was uncovered, as the absence of Muc2 significantly delayed 
worm expulsion despite a TH2-type immune response against T. muris. Surprisingly, the de 
novo expression of Muc5ac was observed in the caecum of the Muc2-deficient mice and 
mice resistant to chronic infection, prior to worm expulsion (Chapter 3).  
 We subsequently addressed the importance of the IL-13 induced Muc5ac in the 
caecum during T. muris expulsion, by challenging Muc5ac-deficient mice with a high dose 
of T. muris eggs. Muc5ac-deficient mice still displayed an induction in TH2-type cytokines 
leading to goblet cell hyperplasia, increased levels of Muc2 and an increase in epithelial 
cell turnover during T. muris infection. Importantly, however, the absence of Muc5ac 
rendered the mice susceptible to chronic T. muris infection. This study uncovers a novel 
role for Muc5ac, not just as a macromolecular component of the intestinal mucus barrier, 
but also as a crucial effector molecule acting independently of the underlying immune 
response to facilitate worm expulsion (Chapter 4).  
 
Changes in mucin glycosylation during T. muris infection (Chapter 5) 
 The heavily glycosylated mucin proteins were shown to be critical to T. muris 
worm expulsion, as discussed above. The degree of sulphation on mucins in the niche of 
the parasite, i.e. the caecum, is higher than in any other site in the body. Therefore, in order 
to further dissect the mechanisms by which mucins may confer protection we characterised 
the changes in mucin glycosylation, in particular sulphation, during T. muris infection. 
Histological analysis revealed increased mucin sulphation during resistance; in contrast, 
mucins were highly sialylated during chronic T. muris infection. In light of these findings 
we hypothesised that mucin sulphation may affect the kinetics of worm 
establishment/expulsion. Therefore, to this end we infected mice deficient in the sulphate 
transporter NaS1, which have disturbed sulphate homeostasis and hence depleted intestinal 
mucin sulphation, with a high dose of T.muris eggs. Depleted levels of mucin sulphation 
did not affect worm establishment. However, as the demand of cellular sulphate increases 
after infection, mucin sulphation recovered in the NaS1-deficient mice by up-regulating the 
sulphate anion transporter1 (Sat1). This study indicated that increased sulphomucin levels 
are a physiological response against intestinal parasitic infection.  
 
Effects of nematode Excretory Secretory Products (ESPs) on the mucus gel (Chapter 6)  
 In order for the nematode to successfully survive within the host, it releases ESPs 
to actively exert its immunomodulatory functions. As the Trichuris nematode lives under a 
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blanket of mucus during chronic infection, we speculated that the adult nematode may 
directly affect the mucus gel to promote its own survival within the host. Using 
biochemical techniques we demonstrate that the ESPs released by the nematode have the 
ability to alter the mucins within the mucus gel. Moreover, the changes in the mucus 
barrier in resistance prevented the ESPs from degrading the mucins; however, mucins 
extracted from susceptible mice post infection were more prone to degradation. Overall, 
our experiments illustrate that ESPs contain a serine protease that not only had the ability 
to depolymerise the mucin network but may also potentially affect the „non-reducible‟ 
linkage specific to the Muc2 protein. Therefore, the T. muris nematode may secrete ESPs 
to degrade the mucus gel as part of its regime to aid its movement and promote its own 
survival within the host, during chronic infection.  
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ABSTRACT 
The intestinal mucosal barrier, part of the innate immune defence, is responsive to the 
external environment and changes in response to infection. There is disparate evidence for 
the epithelial and goblet cell products within the intrinsic barrier being part of a response to 
resolve infection. We comprehensively analysed the changes of mucosal glycoconjugates 
during acute and chronic infection by utilising the Trichuris muris (T. muris) model. 
Transcription factors, atonal homolog 1 (Math-1) and SAM pointed domain containing 
ETS transcription factor (Spdef) were activated during acute infection, which promoted 
stem cell fate towards a secretory cell phenotype. The thickness of the intermediate barrier, 
the carbohydrate-rich glycocalyx, composed of cell surface mucins increased with 
exposure to T. muris, with an increase in Muc4, Muc13 and Muc17. Overall, 
hypersecretion of glycoproteins into the extrinsic barrier (mediated by IL-13) correlated 
with an induction in gamma amino-butyric acid-α3 receptor (GABA-α3) during acute 
infection. Furthermore, altered glycosylation was observed during acute and chronic 
infection; mucins were more highly charged during acute infection than during chronic 
infection. This study readdresses the changes within the mucosal barrier, in particular in 
the cell surface and secreted mucins during acute and chronic nematode infection.  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
ABBREVIATIONS 
DBA, Dolichos biflorus; GABA-α3, gamma amino-butyric acid α-3; PAS, Periodic-Acid 
Schiff‟s; pi., post infection; Spdef, SAM pointed domain containing ETS transcription 
factor; TH, T Helper; T. muris, Trichuris muris.   
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INTRODUCTION 
 The intestinal mucosa forms a dynamic defensive barrier that is responsive to the 
external environment (Thornton and Sheehan, 2004). The barrier has two major 
components: the intrinsic barrier which consists of the continuous epithelial cell lining and 
the extrinsic barrier which is the combination of the secretions from the goblet cells within 
the epithelium composing the mucus barrier (Linden et al, 2008b; Thornton and Sheehan, 
2004). Moreover, cell surface mucins intercalated into the apical surface of the epithelium 
with their extracellular domain protruding out, are a dominant glycoconjugate component 
of the glycocalyx which forms an intermediate layer of defence between the extrinsic and 
intrinsic barriers (Linden et al, 2008b). Different components of the mucosal epithelium 
have been extensively studied in relation to parasitic infections, particularly intestinal 
dwelling nematodes (Hogan et al, 2006; Linden et al, 2008a). It is clear that innate and 
adaptive immune systems play a key role in resistance and susceptibility to chronic 
nematode infections (Artis and Grencis, 2008). Recent studies conducted on the nematode 
models have been focused on changes in non-mucin goblet cell products, such as resistin-
like molecule-β and intelectin, in response to infection (Artis, 2006; Artis et al, 2004; Nair 
et al, 2008). Few studies, however, have fully characterised the prevalent glucoconjugate 
components of the goblet cells and the protective intestinal glycocalyx in response to 
nematode infection. In light of the recent data demonstrating a clear role for Muc2, the 
major goblet cell product, during resistance to the mouse whipworm Trichuris muris 
(T.muris) (Hasnain et al, 2010), the present work has comprehensively characterised this 
goblet cell and glucoconjugate axis in relation to resistance or susceptibility to chronic 
infection.     
 The Trichuris muris (T. muris) nematode survives in the host by eliciting a TH1-
type immune response; however, resistance is dependent on a TH2-type immune response 
(Cliffe and Grencis, 2004). In BALB/c mice, a high dose infection (>150 eggs) results in 
the TH2-mediated expulsion of the nematode; whereas, a low dose infection (<15 eggs) 
results in a TH1-dominant immune response and consequently a chronic infection (Bancroft 
et al, 2001).  Therefore, the nematode T. muris in mouse provides a manipulable system 
that can be used to investigate the changes in mucosal barrier operating during acute and 
chronic infection within a single system (Bethony et al, 2006; Cliffe and Grencis, 2004). It 
is thought that multiple effectors under immunological (TH2) control orchestrate the 
responses involved in the expulsion of the nematode (Cliffe et al, 2005; Hasnain et al, 
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2010; Khan and Collins, 2004). The intestinal epithelium, the niche of the parasite, consists 
of four distinct cells types; enterocytes, paneth cells, enteroendocrine cells and goblet cells 
(Zaph et al, 2007). Stem cells at the bottom of the intestinal crypts can differentiate into 
absorptive cells (enterocytes) or secretory cells (paneth, enteroendocrine or goblet cells) 
(Noah et al, 2009). Absorptive cell differentiation is dependent on the transcription factor 
Hes-1 (hairy and enhancer of split 1), whereas differentiation towards secretory cell 
lineage is dependent on Math-1 (atonal homolog 1) (Shroyer et al, 2005). The recently 
discovered transcription factor, Spdef (SAM pointed domain containing ETS transcription 
factor), was shown to facilitate the terminal differentiation of secretory cells into goblet 
cells (Noah et al, 2009). During T. muris infection, within the niche of the parasite, 
hyperproliferation of cells in the intestinal crypts has been reported. Goblet cell 
hyperplasia has been described in models that are able to reject T. muris (Else, 2005; 
Hasnain et al, 2010), whereas hyperplasia of enterocytes is observed during chronic 
infection (Artis et al, 1999). Goblet cell hyperplasia is thought to be largely under the 
control of TH2-type cytokines (Khan et al, 2001; McKenzie et al, 1998), although some 
studies have suggested that IL-4/IL-13 independent goblet cell hyperplasia can occur 
(Marillier et al, 2008).  
 In this study, we aimed to conduct a comprehensive analysis of the changes in the 
components of the mucosal barrier: the epithelial cell layer, cell surface mucins and the 
extrinsic mucus barrier during acute and chronic T. muris infection. We reconfirmed that 
goblet cell hyperplasia is a prominent feature of acute infection as an activation of 
transcription factors involved in goblet cell differentiation was observed. Expression of cell 
surface mucins, Muc4, Muc13 and Muc17 was elevated with the exposure to T. muris 
infection, resulting in an increase in the thickness of the apical glycocalyx. Interestingly, 
along with the increase in the storage and synthesis of glycoproteins within the goblet 
cells, which has been previously reported, an increase in secretion of these glycoproteins 
was observed during worm expulsion. The hypersecretion of glycoproteins was mediated 
by the gamma amino-butyric acid-α3 (GABA- α3) receptor under the control of the TH2-
type cytokine, IL-13. Furthermore, we demonstrate for the first time that along with the 
depleted mucin production, there is a general alteration of glycosylation on the mucins in 
chronic infection.  
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MATERIALS AND METHODS 
Animals 
Male BALB/c mice were purchased from Harlan Olac. Female wild-type BALB/c mice, 
IL-4-deficient (BALB/c-background) and IL-4R-deficient (BALB/c-background) mice, 
originally obtained from Dr. McKenzie (McKenzie et al, 1998), were maintained in the 
Biological Services Unit at The University of Manchester. The protocols employed were in 
accordance with guidelines by the Home Office Scientific Procedures Act (1986). All mice 
(6-12wk old) were kept in sterilized, filter-topped cages, and fed autoclaved food in the 
animal facilities.  
 
Parasitological technique 
The techniques used for T. muris maintenance and infection were described previously 
(Wakelin, 1967). Mice were orally infected
 
with approximately 150 eggs for a high dose 
infection and <15 eggs for a low dose infection. Worm burdens were assessed by counting 
the number of worms present in the caecum. 
 
Histology, Immunohistochemistry and Immunofluorescence microscopy 
The whole caecum (rolled) was fixed in 95% ethanol and processed by using standard
 
histological techniques. Sections were treated with 0.1M potassium hydroxide for 30 
minutes prior to staining with
 
periodic acid Schiff (PAS). Slides were counterstained with 
1% fast-green. Standard immunohistochemical and immunofluorescent staining methods 
(Linden et al, 2008a; McGuckin and Thornton, 2000) were used to determine the levels of 
SAM pointed domain containing ETS transcription factor (Spdef) using the mspdef 
antibody (Abcam) and lectins (Heazlewood et al, 2008). Biotinylated lectins (Sambucus 
nigra, Mackia amuresis, Peanut agglutinin, Maclura pomifera, Dolichos biflorus, Triticum 
vulgaris and Ulex europeaus) were used for the detection of glycans. 
 
Mucus extraction and agarose gel electrophoresis  
The caecum was gently flushed with PBS and subsequently flushed 5 times with 3M Urea 
to obtain the secreted mucus; the tissue was fixed for histology before and after treatment 
to ensure only the secreted mucus within the intestinal lumen was isolated without caecal 
crypt disruption (data not shown). The mucus was solubilised in 8M guanidium chloride, 
reduced using 50mM dithiothreitol (DTT) and carboxylmethylated using 0.125M 
iodoacetamide prior to electrophoresis on a 1% (w/v) agarose gel. Mucins were detected 
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after western blotting using PAS-staining (Thornton et al, 1989). Subsequently, the 
staining intensity of the positive-bands was determined using the GS-800 BioRad 
Densitometer (Thornton et al, 1994; Thornton et al, 1989).  
 
Anion-Exchange Chromatography  
Crude mucus samples were reduced, carboxymethylated and treated with DNAse before 
being subjected to anion exchange chromatography as described previously (Linden et al, 
2002; Thornton et al, 1996), using a Resource
TM
 Q column. Samples were eluted with the 
starting buffer (10mM piperazine at pH 5 in 6M Urea containing 0.02% 3-
[(chloamidopropyl) dimethylammonio]-1-propanosulphonate) for 15 minutes (0.5ml/min), 
followed by a linear gradient (60 mins) up to 0.4M Lithium perchlorate-10mM piperazine 
at pH 5 in 6M Urea containing 0.02% 3-[(chloamidopropyl) dimethylammonio]-1-
propanosulphonate (Linden et al, 2002; Thornton et al, 1996). Fractions were blotted onto 
nitrocellulose membrane using a 72-well slot blot manifold (Schleicher & Schuell, Dassel, 
Germany) attached to a vacuum pump. Membranes were then assayed for glycoprotein 
using PAS reagent, as described previously (Thornton et al, 1989). Staining intensity was 
measured using a Bio-Rad GS-800 Calibrated densitometer.  
 
Real Time PCR (RT-PCR) 
Total RNA from epithelial cells was isolated using the previously described method (Cliffe 
et al, 2005). cDNA was generated using an IMPROM-RT kit (Promega) and Absolute 
QPCR SYBR Green (ABgene) was used for quantitative PCR. Primer efficiencies was 
determined using cDNA dilutions and genes of interest were normalised against the 
housekeeping gene, β-actin and expressed as a fold difference to uninfected naïve mRNA 
levels. mRNA expression was investigated using the primer pairs shown in 
Supplementary Table 2.1. Melting curves were analysed and products were directly 
sequenced to verify the identity of the amplified genes. In brief, products were digested 
with Exonuclease I and Calf Intestinal Phosphatase and subsequently sequenced using the 
ABIPRISM Big-Dye Terminator cycle sequencing reaction at the Sequencing Facility in 
The University of Manchester. The data was analysed using Chromas Pro v1.34 and the 
sequences obtained were compared against the GenBank database; 
http://www.ncbi.nlm.nih.gov/BLAST.  
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Quantification of histological staining  
The number of goblet cells were counted in 100 longitudinally sectioned crypt units 
(expressed per crypt). The number of epithelial cells were counted in 20 longitudinal crypts 
and expressed as per crypt. 5 randomly selected fields of view were analysed to determine the 
levels of positive lectin staining; indicated as 90-100% (++++), 60-80% (+++), 10-50% (++) 
and 0-10% (+). 
 
Statistical analysis 
All results are expressed as the mean  SEM. Statistical analysis was performed using 
SPSS version 16.0. Statistical significance of different groups was assessed by using 
parametric tests; ONE-way Analysis of variance with post-test following statistical 
standards or paired student t test. P<0.05 was considered statistically significant.  
 
RESULTS 
Up-regulation of secretory cell lineage transcription factors during acute T. muris 
infection 
 It is well established that a TH1-type immune response (characterised by IFN-γ) 
leads to a chronic T. muris infection, whereas a TH2-type immune response (characterised 
by IL-4 and IL-13) leads to the expulsion of the nematodes (Cliffe and Grencis, 2004). 
Chronic infection leads to changing the gross morphology of the niche of the parasite 
(caecum). Furthermore, no changes were observed in the number of goblet cell and, an 
increase in epithelial cell numbers is associated with chronicity (Supplementary Figure 
2.1).  Stem cells located at the bottom of the intestinal crypts mature and differentiate into 
absorptive cells or secretory cells as migrate to the luminal surface (Noah et al, 2009). 
Therefore, to investigate whether there was a change in differentiation of stem cells that in 
turn promotes differentiation towards a certain cell lineage during acute or chronic 
infection, the expression of transcription factors involved in the differentiation of the 
intestinal progenitor stem cell into absorptive cells or secretory cells was determined using 
RT-PCR (Figure 2.1).  
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 The enterocyte differentiation transcription factor Hes-1 (hairy and enhancer of 
split 1), the transcription factor for differentiation towards absorptive cell lineage Math-1 
(atonal homolog 1) (Shroyer et al, 2005) and Spdef (SAM pointed domain containing ETS 
transcription factor), the transcription factor involved in the terminal differentiation of 
goblet cells (Noah et al, 2009) were chosen as markers of cell lineage. Levels of Hes-1 
were significantly increased on day 21 pi., explaining the increase in epithelial cell 
numbers (Supplementary Figure 2.1G), in chronic infection compared to acute infection 
and uninfected controls (Figure 2.1A). In contrast, Math-1 and Spdef were only 
significantly up-regulated on day 14 and 21 pi. of acute infection (Figure 2.1B & C) when 
an increase in goblet cell numbers was also observed (Supplementary Figure 2.1H). 
Furthermore, immunofluorescence microscopy with the mSpdef antibody showed that 
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Spdef was up-regulated at the bottom of the intestinal crypts of mice with acute infection 
(Figure 2.1D; on day 21pi.).  
 
The increase in glycocalyx thickness with exposure to T. muris infection 
 Glycocalyx is the “carbohydrate rich zone” found at the surface of cells, consisting 
of glycoproteins including cell surface mucins that project from the apical surface of the 
cells (Linden et al, 2008b). Using immunofluorescent microscopy with the Dolichol 
Biflorus (DBA) lectin, which recognises the D-GalNAc glycan, revealed that with 
exposure to T. muris infection there was an increase in the thickness of the glycocalyx 
layer, as compared to the uninfected naïve mice (Figure 2.2A & B). However, the 
glycocalyx was significantly thicker in mice during acute infection (day 21 pi.) as 
compared to during chronic infection.  
 To comprehensively characterise the changes in the composition of the glycocalyx 
during acute and chronic T. muris infection, the levels of cell surface mucins were 
determined using RT-PCR (Figure 2.2). In the intestine, Muc1, Muc4, Muc13, Muc15, 
Muc17 and Muc20 have previously been shown to be expressed (Singh and Hollingsworth, 
2006). No major changes were observed in Muc1, Muc15 and Muc20 levels during chronic 
or acute infection when compared to uninfected control mice (day 21 pi. shown here; 
Figure 2.2). However, a marked increase in Muc4, Muc13 and Muc17 levels were 
observed in response to T. muris infection (Figure 2.2). As expected with the increased 
thickness of glycocalyx layer, the levels of Muc4 and Muc13 were significantly higher in 
the mice during acute infection. However, the increase in Muc17 was more prominent in 
the mice during chronic infection. Similar trends in the levels of these cell surface mucins 
were observed on day 14 and 35 pi. (Supplementary Table 2.2).  
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Hypersecretion of glycoproteins mediated by GABA-α3 receptor during worm rejection  
 An elevation in transcription factors that determine the secretory cell lineage was 
observed during acute infection, furthermore there was an increase in the number of goblet 
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cells within the caecal crypts (Figure 2.1). Therefore, to determine whether there was also 
an increase in the secretion of glycoproteins during acute infection, the mucus secreted into 
the intestinal lumen was isolated and subjected to agarose gel electrophoresis (Figure 2.3A 
& B). On day 14 pi., an increase in the secretion of glycoproteins was observed in both 
acute and chronic models. Interestingly, during acute infection, as well as an increase in 
the amount of glycoproteins stored within goblet cells (refer to Supplementary Figure 
2.1H), higher amounts of glycoproteins were secreted into the mucus barrier (Figure 2.3A 
& B).  
 Studies have shown that GABA-α receptors mediate the hypersecretion of 
glycoproteins into the mucus barrier, under the control of IL-13 in asthma models (Xiang 
et al, 2007). Several studies have described GABA receptors, α-subunit 1-3 and β-subunit 
1-3, to be expressed in the intestine (Nakajima et al, 1996; Zeiter et al, 1996). By utilising 
RT-PCR we investigated the basal expression of these GABA receptors in the uninfected 
BALB/c mice; all GABA subunits, with the exception of GABA-α2 and GABA-β3, were 
expressed at high levels in the caecum (Figure 2.3C). Interestingly, in response to 
infection only the expression of GABA-α3 was altered (Figure 2.3D); an increase in levels 
of GABA-α3 was observed during acute infection (day 21 pi.), and this correlated with the 
increase in glycoprotein secretion. The expression of all the other α and β isoforms 
remained unaltered when challenged with T. muris infection (data not shown). To dissect 
the role of the immune response in the up-regulation GABA-α3 receptor and mucus 
hypersecretion, we utilised the IL-4-deficient and IL-4R-deficient mice. The IL-4-deficient 
mice do not contain any active IL-4 but are able to expel the nematodes due to IL-13 
mediated effector mechanisms (Supplementary Figure 2.2; (Bancroft et al, 1998)). In 
contrast, the IL-4Rα1 chain is missing in the IL-4R-deficient mice and as both chains in 
the heterodimeric receptor are required to initiate intracellular signalling (Ramalingam et 
al, 2008), IL-4 and IL-13 cannot act in the IL-4R-deficient mice, which are therefore 
susceptible to chronic infection ((Bancroft et al, 1998) Supplementary Figure 2.2).  
 Interestingly, the levels of GABA-α3 remained unaltered in the IL-4R-deficient 
mice (Figure 2.3E), where goblet cell depletion was also observed (Supplementary 
Figure 2.2). In the IL-4-deficient mice, however, along with the hyperplastic goblet cell 
response against T. muris, a 10-fold increase in levels of GABA-α3 was also observed post 
infection (Figure 2.3E). 
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Altered glycosylation on goblet cell mucins during chronic T. muris infection  
 Interestingly, a slight difference in the electrophoretic migration of mucins, when 
subjected to agarose gel electrophoretic analysis (Figure 2.3A), was noted during acute 
infection which suggested a change in glycosylation. Therefore, to evaluate the variation in 
mucin glycoconjugates in response to acute and chronic T. muris infection, dual 
immunofluorescence labeling for Muc2 (Muc2 antibody, red) and glycans (lectin, green) 
was performed (Figure 2.4A) and the relative lectin-staining was quantified (Figure 2.4B). 
The most striking differences were observed in the staining with the DBA lectin, which 
recognises the D-GalNAc glycan (Figure 2.4). Most of the goblet cells within the caecal 
epithelium stained positive with the DBA lectin on day 21 pi. of acute infection, when the 
nematodes are rejected. In contrast, in the chronic infection only a few goblet cells stained 
with the DBA lectin. In fact, during chronic infection (day 21 pi.) less staining was 
observed with all lectins employed (Figure 2.4A & Supplementary Figure 2.3). Low 
levels of staining were observed using the Sambucus nigra lectin which detects the α-2,6-
sialic acid compared to the Mackia amuresis lectin which detects the α -2,3-sialic acid. 
This suggested that mucins within the caecum contained mucins majorly containing the α-
2,6-sialic acid.  
 Overall, lectin histochemistry analysis suggested that the mucins produced during 
acute infection are altered in their glycosylation compared to those produced by 
chronically infected mice. To assess whether the charge density of the mucins was also 
altered, the secreted mucus was isolated from the caecum of the two groups of mice on day 
21 pi., reduced and carboxymethylated and analysed by anion exchange chromatography 
(Figure 2.4C). PAS-staining of fractions collected from the anion exchange 
chromatography showed that mucins isolated from the chronically infected mice (on day 
21 pi.) eluted before the mucins from mice with acute infection (Figure 2.4C). This 
suggested that the mucins in the caecum of the chronically infected mice were less charged 
as compared to the mucins from the mice with acute infection. 
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DISCUSSION 
 The T. muris nematode survives within its host by eliciting a TH1-type immune 
response in mice susceptible to chronic infection, whereas in an acute infection a TH2-type 
immune response results in nematode expulsion (Cliffe and Grencis, 2004). The intestinal 
mucosa, the niche of the nematode, forms a dynamic barrier that is responsive to the 
external environment and changes in response to infection due to the inflammatory 
response. It has already been demonstrated that TH2-type cytokine mediated regulation of 
epithelial cell turnover (Cliffe et al, 2005), smooth muscle contractility (Khan et al, 2003) 
and the mucus barrier (Hasnain et al, 2010) can contribute to efficient worm expulsion 
(Artis and Grencis, 2008).  Recently, we have demonstrated a significant role for the 
intestinal mucin Muc2 (Hasnain et al, 2010), which is the major intestinal goblet cells 
product, during the expulsion of the T. muris nematode. In the present study we aimed to 
characterise the changes within the mucosal barrier, in particular in its glyconconjugate 
components that may play a role in parasite rejection, by using the acute and chronic 
mouse models of T. muris infection. 
 Surprisingly, the glycocalyx which forms a layer of defence underneath the mucus 
barrier on apical surface of epithelial cells has not been investigated in this setting 
previously. Cell surface mucins, which are anchored to the apical cell surface, are a major 
component of this glycocalyx layer and extend further than most other cell surface 
structures (Linden et al, 2008a; McAuley et al, 2007; Packer et al, 2004; Renes et al, 2002; 
Singh and Hollingsworth, 2006; Tu et al, 2008). Cell surface mucins provide both a 
physical barrier and are also involved in intracellular signalling events; their expression has 
been shown to be both infection promoting and infection limiting with regard to 
pathogenic bacteria (Linden et al, 2008a; Linden et al, 2008b). We observed a striking 
difference in the thickness of the glycocalyx in response to T. muris infection, with the 
increase being more prominent during acute infection. Analysis of the cell surface mucin 
components, of the glycocalyx during acute and chronic infection, revealed an increase in 
the levels of Muc4, Muc13 and Muc17, which most likely explains the increase in the 
thickness of the glycocalyx. Although the up-regulation of cell surface mucins was not 
exclusive to acute infection, they may contribute to worm expulsion. Whether this is 
because cell surface mucins directly influence the physicochemical properties of the 
glycocalyx or whether they are shed into the mucus affecting its barrier properties or have 
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a role that is associated with the increased epithelial cell extrusion shown to be critical to 
worm expulsion (Cliffe et al, 2005), requires further attention.   
 The rejection of the whipworm was accompanied by increased differentiation of 
stem cells within the basal caecal crypts into goblet cells. Math-1 is involved in the 
differentiation of a progenitor stem cell into a secretory cell type and Spdef subsequently 
regulates its terminal differentiation into a goblet cell (Noah et al, 2009; Shroyer et al, 
2005). Both these transcription factors were up-regulated during acute T. muris infection, 
around the time of worm expulsion. In contrast, Hes-1, which is involved in the 
differentiation towards an enterocyte fate, was only up-regulated in the mice susceptible to 
chronic infection. This agrees with previously published data, where an increase in 
epithelial cell proliferation is observed during chronic infection (Artis et al, 1999; Cliffe et 
al, 2005). Overall, this clearly demonstrated that there is a bias towards goblet cell 
differentiation during acute infection which is not observed during chronic infection. The 
extrinsic mucosal barrier is composed of a mixture of products secreted by the goblet cells 
within the epithelial cell layer (Thornton et al, 2008). Therefore, during acute infection, 
along with the increased differentiation towards the goblet cell lineage, and hence the 
increased levels of glycoproteins within the goblet cells, we also observed an increase in 
the amount of glycoproteins in the mucus barrier. The intestinal mucus barrier forms a 
bilayer: a „loose‟ outer layer containing the commensal flora and the inner adherent layer 
which is devoid of commensal flora (Johansson et al, 2008). It has been proposed that a 
diminished mucus barrier can result in inflammation in several mouse models 
(Heazlewood et al, 2008; Johansson et al, 2009; Park et al, 2009), due to the direct contact 
of the commensal flora with the epithelial cell surface. We show here that there is a 
diminished glycoprotein content within the mucus barrier during chronic infection. 
Therefore, during chronicity to T. muris the diminished mucus barrier could result in the 
commensal flora coming into contact with the epithelial cell layer which may result in 
exacerbation of epithelial inflammation.  
 Previously published data has described goblet cell hyperplasia to be under the 
control of a TH2-type immune response. Although one study has shown goblet cell 
hyperplasia to be independent of IL-4/IL-13 (Marillier et al, 2008), our data supported the 
hypothesis of TH2 cytokines controlling goblet cell hyperplasia post T. muris infection 
(Hayes et al, 2007; McKenzie et al, 1998; Woodruff et al, 2009). Studies have shown that 
GABA receptors expressed in the mucosal epithelium can mediate this hypersecretion of 
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mucus in asthma (Xiang et al, 2007). Our data demonstrated that within the caecum, 
GABA-α3 receptor expression is elevated in response to the increased IL-13 levels, which 
may mediate the secretion of glycoproteins into the mucus barrier. It is important to 
highlight that differences were observed in the expression of the GABA receptors between 
the caecum and the colon. This corroborates our previous findings, where we observed 
goblet cell hyperplasia in response to T. muris only in the caecum (the niche of the 
parasite) (Hasnain et al, 2010). If in fact, the GABA-α3 receptor is up-regulated to mediate 
glycoprotein hypersecretion during worm expulsion, it could provide a novel therapeutic 
target which could be manipulated to induce secretion of glycoproteins during chronic 
nematode infections to increase the thickness of the mucus barrier and potentially lessen 
inflammation. 
 Interestingly, lectin histochemistry has identified an alteration in glycosylation of 
mucins within the caecal niche of the parasite. Moreover, the mucins within the mucus 
barrier were less charged during chronic infection as compared to mice with acute 
infection. The presence of more highly charged mucins with an altered glycosylation 
pattern in acute infection may affect the physicochemical properties of the mucus barrier 
and contribute to worm rejection. For instance, mucin glycosylation may play an important 
role in the hydration of the mucus gel (Singh and Hollingsworth, 2006) and hence barrier 
properties of the mucus gel. Furthermore, mucin glycans are thought to provide a 
framework within the mucus gel which allows the sequestration and presentation of 
essential host defence molecules (Thornton et al, 2008).  
 In conclusion, in this study we have characterised the changes within the dynamic 
mucosal barrier during acute and chronic nematode infection. The glycocalyx that coats the 
apical surface of the intestinal lumen was thickened in response to infection, with an 
increase in the cell surface mucins, Muc4, Muc13 and Muc17. Moreover, we have clearly 
demonstrated that along with goblet cell hyperplasia observed during worm expulsion, 
there was an increase in the secretion of more highly charged mucins into the mucus 
barrier. Furthermore, during chronicity the decrease in goblet cell numbers results in a 
depleted mucus barrier, containing predominantly lowly charged mucins. Taken together, 
this study highlights dynamic changes within the glycoconjugate components of the 
extrinsic and intrinsic mucosal barrier and, emphasises that the quality and the quantity of 
these components may be important during worm expulsion.       
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ABSTRACT 
Background & Aims: Hyperplasia of mucin-secreting intestinal goblet cells accompanies 
a number of enteric infections including infections by nematode parasites. Nevertheless, 
the precise role of mucins in host defence in nematode infection is not known. We 
investigated the role of the mucin (Muc2) in worm expulsion and host immunity in a 
model of nematode infection.  
Methods: Resistant (BALB/c, C57BL/6), susceptible (AKR), and Muc2-deficient mouse 
strains were infected with the nematode, Trichuris muris and worm expulsion, energy 
status of the whipworms, changes in mucus/mucins, and inflammatory and immune 
responses were investigated following infection.  
Results: The increase in Muc2 production, observed exclusively in resistant mice, 
correlated with worm expulsion. Moreover, expulsion of the worms from the intestine was 
significantly delayed in the Muc2-deficient mice. Although a marked impairment in the 
development of PAS-stained intestinal goblet cells was observed in Muc2-deficient mice, 
as infection progressed a significant increase in the number of PAS-positive goblet cells 
was observed in these mice. Surprisingly, an increase in Muc5ac, a mucin normally 
expressed in the airways and stomach, was observed following infection of only the 
resistant animals. Overall, the mucus barrier in the resistant mice was less permeable than 
that of susceptible mice. Furthermore, the worms isolated from the resistant mice had a 
lower energy-status.  
Conclusions: Mucins are an important component of innate defence in enteric infection; 
this is the first demonstration of the important functional contribution of mucins to host 
protection from nematode infection. 
 
 
 
 
 
 
 
 
 
ABBREVIATIONS  
ND, Not detectable; PAS, Periodic-Acid Schiff‟s; pi., Post infection; Relm, Resistin-like 
molecule; Tff, Trefoil factor; TH, T Helper; T. muris, Trichuris muris; WT: Wild-type  
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INTRODUCTION 
  The mucus barrier is an essential part of the innate immune system which 
hydrates and protects the underlying epithelia. The gel-like properties of the barrier are 
mainly due to the polymeric mucins which are the major secretory products of epithelial 
goblet cells (Artis et al, 2004; Sheehan and Thornton, 2000; Thornton and Sheehan, 2004). 
The colonic epithelium expresses mainly MUC2/Muc2 in large amounts which is stored in 
bulky apical granules of the goblet cells and is the most important factor determining the 
goblet cell morphology (Chang et al, 1994; Tytgat et al, 1994; Van der Sluis et al, 2006). 
Muc2 forms a heterogeneous mucus barrier that is proposed to comprise of two distinct 
layers; a „loose‟ outer layer that bacteria can penetrate and an adherent inner layer that 
excludes bacteria from direct contact with the underlying epithelia (Johansson et al, 2008).  
  Alterations or absence of MUC2 production can lead to many common human 
disorders such as colon carcinoma (Boland et al, 1982), ulcerative colitis (Buisine et al, 
1999), and celiac disease (Crabtree et al, 1989). A role for Muc2 in the suppression of 
colorectal carcinoma has also been suggested as Muc2-deficient mice spontaneously 
develop colitis and adenomas that progress to invasive adenocarcinoma (Velcich et al, 
2002), suggesting an important function for this mucin in colonic protection (Van der Sluis 
et al, 2006). Furthermore, missense mutations in the Muc2 gene results in aberrant Muc2 
oligomerisation leading to endoplasmic reticulum stress and subsequently increased 
susceptibility to colitis (Heazlewood et al, 2008). 
   Hyperplasia of mucin producing goblet cells has been described in a number of 
parasitic infections including Nippostrongylus brasiliensis, Hymenolepsis diminuta, 
Trichinella spiralis and Trichuris muris (Else and Finkelman, 1998; Khan et al, 2001; 
Miller and Nawa, 1979; Shekels et al, 2001; Webb et al, 2007). Putative mechanisms 
underlying the protective role of mucins against infectious agents include the 
demonstration of trapping of Hymenolepsis diminuta (Webb et al, 2007) and Trichinella 
spiralis (Carlisle et al, 1991) in the mucus and inhibition of parasite motility and feeding 
capacity (Carlisle et al, 1991; Ishiwata and Watanabe, 2007; Miller, 1987). Goblet cell 
response, in all four of these nematode models, is thought to be under the control of a T 
helper (TH) 2-type immune response and is considered as a potential effector mechanism 
(Cliffe and Grencis, 2004; Deschoolmeester and Else, 2002; Else, 2005). Recently a 
number of goblet cell bioactive factors such as resistin-like molecule-β (Relm-β), intelectin 
and calcium-activated chloride channel-3 (ClCa3) have been suggested to play an 
important role in nematode infection (Artis and Grencis, 2008; Hogan et al, 2006). 
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However, a definitive and precise role of mucins, the major secreted product of goblet 
cells, in host defence in intestinal nematode infection remains to be elucidated.  
 The nematode T. muris inhabits the caecum of mice and is closely related at the 
morphological, physiological and antigenic levels to Trichuris trichiura, the causative 
agent of chronic trichuriasis in humans (Else and Grencis, 1991). In this parasitic infection, 
strains resistant to chronic infection (BALB/c, C57BL/6) expel the parasites through the 
generation of a TH2-type immune response whereas susceptible strains (AKR), that do not 
expel the worms, develop a TH1-type immune response (Cliffe and Grencis, 2004; Cliffe et 
al, 2007). In this study, we demonstrated that the increase in Muc2, the major determinant 
of mucus barrier properties, correlates with worm expulsion. In the absence of Muc2 there 
is a delay in worm expulsion, but interestingly Muc5ac is up-regulated in the Muc2-
deficient mice prior to expulsion. Moreover, Muc5ac is up-regulated in the wild-type mice 
that are resistant to infection, but not in those unable to expel. The physical properties of 
the mucus barrier are also altered during infection, resulting in a less porous network, with 
overall changes having a direct effect on the viability of the whipworm. Collectively, these 
data demonstrate for the first time a protective role for mucins in nematode infection. 
 
MATERIALS AND METHODS 
Animals 
Breeding
 
pairs of Muc2-deficient mice originally produced by gene mutation (Velcich et 
al, 2002) and their wild-type (C57BL/6) littermates (Albert Einstein Medical College,
 
USA) were kept at the animal facilities of McMaster University, Hamilton, Ontario,
 
Canada. AKR, BALB/c (Harlan Olac) and SCID mice were maintained in the Biological 
Services Unit at Manchester University. The protocols employed were in accordance with 
guidelines by the McMaster University Animal Care Committee, Canadian Council on the 
Use of Laboratory Animals and the Home Office Scientific Procedures Act (1986). All 
mice were kept in sterilized, filter-topped cages, and fed autoclaved food in the animal 
facilities. Only 6-10wk old male mice were used. 
 
Parasitological techniques 
The techniques used for T. muris maintenance and infection were described previously 
(Wakelin, 1967). Mice were orally infected
 
with approximately 100-300 eggs for a high 
dose infection and <15 eggs for a low dose infection. Worm burdens were assessed by 
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counting the number of worms present in the caecum as described previously (Wakelin, 
1967).  
 
Histology, immunohistochemistry and immunofluorescence 
A 1cm segment or the whole caecum (rolled) was fixed in 10%
 
neutral buffered formalin 
or 95% ethanol and processed by using standard
 
histological techniques. Sections were 
treated with 0.1M KOH for 30 minutes prior to staining with
 Periodic Acid Schiff‟s (PAS) 
reaction (Linden et al, 2008). Slides were counterstained with either haematoxylin and 
eosin or 1% fast-green. Standard immunohistochemical and immunofluorescent staining 
methods (Kirkham et al, 2008; Linden et al, 2008) were used to determine the levels of 
Muc2, Muc5ac, Relm-β and Tff3.  
 
Antibodies 
Immunodetection was carried out using a polyclonal antibody raised against a murine 
Muc2 (mMuc2) (Heazlewood et al, 2008). Commercially available 45M1 antibody was 
used for the detection of mouse Muc5ac (Lidell et al, 2008). The mouse Muc5b-specific 
antibody (Zhu et al, 2008) was a kind gift from Dr. Camille Ehre (University of North 
Carolina, Chapel Hill). Commercially available mRelm-β (Abcam, Cambridge, United 
Kingdom) and mITF (Santa Cruz Biotechnology Inc., CA, USA) antibodies were used to 
detect Relm-β and Tff3, respectively. Detection of BrdU incorporated into nuclei was 
carried out using a monoclonal anti-BrdU antibody (AbD Serotec,Oxford, United 
Kingdom) (Potten et al, 2002).  
 
Mucus extraction and agarose gel electrophoresis  
The caecum was gently flushed with PBS, scraped and mucus solubilised in 8M guanidium 
chloride. Subsequently, extracted mucus samples were reduced using 50mM dithiothreitol 
(DTT) and carboxylmethylated using 0.125M iodoacetamide prior to electrophoresis on a 
1% (w/v) agarose gel. Mucins were detected after western blotting with mucin specific 
antisera (Thornton et al, 1996).  
 
Analysis of mucus network properties 
Caecal tissue isolated from BALB/c and AKR mice was cut longitudinally, washed with 
PBS and kept hydrated in a 6 well plate. 0.1μm blue fluorescently labelled polymer 
microspheres (Dukes Scientific, UK) were placed on top of the luminal surface of the 
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caecum (set as a reference) and their position analysed using the Nikon C1 Upright 
confocal microscope. 3D optical stacks were taken every 5μm and combined to obtain a Z-
stack at the time points stated.       
 
Worm isolation for ATP analysis 
The caecum was longitudinally cut and segmented before incubation with 0.1M NaCl for 2 
hours at 37°C with frequent shaking. Worms were counted after separation from debris and 
epithelial cells using a 0.7μm filter and kept in RPMI-1640 supplemented with 10% FCS. 
Live worms were subsequently homogenised using the FastPrep
®
 homogeniser (MP 
Biomedicals, Inc.).  
 
Energy status of worms 
The CellTiter-Glo
®
 luminescent cell viability assay was carried out according to 
manufacturer‟s instructions (Promega Corp., USA). Relative light units (RLUs) were 
calculated per worm: RLU = (sample light units − blank light units)/number of worms. 
Substrate only was used as a blank control whereas, worms were boiled before 
homogenisation for negative controls. To determine recovery of energy status, worms 
recovered on D19 pi. were washed extensively in DMEM, added to 6 well plates with 
LS174T cells (maintained as previously described by Hayes et al.(Hayes et al, 2007)) for 
24 hours prior to measuring ATP levels.   
 
RT-PCR 
Total RNA from epithelial cells was isolated using the previously described method (Cliffe 
et al, 2005). cDNA was generated using an IMPROM-RT kit (Promega) and Absolute 
QPCR SYBR Green (ABgene) was used for quantitative PCR. Primer efficiencies was 
determined using cDNA dilutions and genes of interest were normalised against 
housekeeping gene, β-actin and expressed as a fold difference to uninfected naïve message 
levels. mRNA expression was investigated using primers 5‟-
GTGGGCCGCTCTAGGCACCAA-3‟ and 5‟-CTCTTTGATGTCACGCACGATTTC-3‟ 
for β-actin; 5‟-GTCCAGGGTCTGGATCACA- 3‟ and 5‟-
CAGATGGCAGTGAGCTGAGC-3‟ for Muc2; 5‟-GTGATGCACCCAT 
GATCTATTTTG-3‟ and 5‟-ACTCGGAGCTATAACAGGTCATGTC-3‟ for Muc5ac; 
GGTTGCTTTGGCTATCGTCTATTT and AAAGATGTCCAGCTGCCCATA for Muc1; 
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CCACCTCCTCGACCCTTACT and CTCCGACTTCAGACCCGTAG for Muc4; 5‟-
GTGGGACGGGCTCAAATG-3‟ and 5‟-CTC TACGCTCTCCACCAGTTCCT-3‟ for 
Muc17;  5‟-TTGCTGGGTCCTCTGGGATA-3‟ and 5‟-GCCGGCACCATA CATTGG-3 
for Tff3 and 5‟-GCTCTTCCCTTTCCTTCTCCAA-3‟ and 5‟-
ACCACAGTGTAGGCTTCATGCTGTA-3‟ for Relm-β.  RT-PCR products were directly 
sequenced to verify the identity of the amplified genes. In brief, products were digested 
with Exonuclease I and Calf Intestinal Phosphatase and subsequently sequenced using the 
ABIPRISM Big-Dye Terminator cycle sequencing reaction at the Sequencing Facility in 
the University of Manchester. The data was analysed using Chromas Pro v1.34 and the 
sequences obtained were compared against the GenBank database; 
http://www.ncbi.nlm.nih.gov/BLAST.     
 
Rate of epithelial cell turnover 
The rate of intestinal epithelial cell turnover was assessed by visualising BrdU 
incorporated into nuclei after mice were injected with 10mg of BrdU 16hrs before 
sacrifice, as described previously (Cliffe et al, 2005).  
 
Evaluation of in-vitro cytokines production from splenocytes  
Single-cell suspensions of spleen were prepared in RPMI 1640 containing 10% FCS, 5mM 
L-glutamine, 100U/ml penicillin, 100g/ml streptomycin, 25mM Hepes, 0.05mM 2-ME 
(all Gibco-BRL).  Cells (10
7
) were incubated in the presence of 5g/ml Concavalin A (Con 
A). IL-4 and IL-13 levels in the supernatant were measured by enzyme immunoassay using 
a commercially available kit (R & D Systems; Minneapolis, MN).  
 
Investigation of intestinal tissue cytokines levels  
Frozen intestinal tissues were homogenized in lysis buffer containing
 
protease inhibitor 
cocktail. The homogenates were freeze-thawed
 
three times and centrifuged, and then 
supernatant was collected
 
and stored at -20°C until analyzed.
 
IFN-γ, IL-4 and IL-13 level in 
the supernatant was measured by enzyme immunoassay
 
technique using a commercially 
available kit purchased from
 
R&D Systems. Concentration of protein in the intestinal
 
tissue 
was determined by a commercially available DC Protein
 
Assay kit (Bio-Rad), and the 
amount of cytokines in the tissues was
 
expressed per milligram of tissue protein.
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Quantification of histological staining  
The numbers of goblet cells expressed per crypt were counted in 50 longitudinally 
sectioned crypt units. The area stained (pixel/mm
2
) per 100 crypts was determined by using 
the ImageJ software version 1.39a.  
 
Statistical analysis 
All results are expressed as the mean  SEM. Statistical analysis was performed using 
SPSS version 16.0. Statistical significance of different groups was assessed by using 
parametric tests (ONE-way Analysis of variance with post-test following statistical 
standards or paired Student t test). P<0.05 was considered statistically significant.  
 
RESULTS 
Increased Muc2 production correlates with worm expulsion  
 It has been well documented that susceptible (AKR) mice harbour the T. muris 
worms until patency (D35 post infection; Figure 3.1A). Whereas, the resistant (BALB/c) 
mice start expelling worms by D14 post infection (pi.) and expulsion is achieved by D21 
pi. (Bancroft and Grencis, 1998; Cliffe and Grencis, 2004) (Figure 3.1A). Changes in the 
production of Muc2, the major gel-forming constituent of intestinal mucus, were explored 
within the caecum of AKR or BALB/c mice exposed to a high dose T. muris infection. 
Immunohistochemical staining and RT-PCR analysis for Muc2 (Figure 3.1B & C) showed 
that significantly higher amounts of Muc2 were expressed within the caecal crypts of the 
resistant mice on D21 pi. compared to naïve and susceptible mice; a similar staining 
pattern was observed with the PAS reagent (Supplementary Figure 3.1).This increase in 
goblet cell number and Muc2 levels was restricted to the niche of the parasite, was not 
observed in the colon (Supplementary Figure 3.1) and correlated with worm expulsion. 
Therefore, to further understand the role of Muc2 in T. muris infection we performed a 
high dose infection in Muc2-deficient mice on the resistant C57BL/6-background.  
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Muc2 deficiency delayed T. muris worm expulsion from infected mice 
 A high dose T. muris infection established in both wild-type and Muc2-deficient 
mice; showed no marked difference in the number of worms at D13 pi. (Figure 3.2). 
However, as infection progressed, there was a significant decrease in worm burden in the 
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wild-type mice; evident by D15 pi. (46% reduction) and with a 84% decrease over 
establishment levels by D20 pi. In contrast, in the Muc2-deficient mice there was no 
decrease in worm burdens until after D20 pi. although mice did eventually expel their 
parasites.   
 
 
Muc2 deficiency had no significant effect on TH2-type immune response elicited by T. 
muris infection 
 We next sought to determine whether the delay in worm expulsion in the Muc2-
deficient mice was due to an alteration to the adaptive immune response to T. muris 
infection. IL-4 and IFN- levels in intestinal tissue were not detectable in the naïve wild-
type and Muc2-deficient mice.  Furthermore, there was no significant difference in IL-4 or 
IFN- levels in intestinal tissues between both strains on D20 pi. (Figure 3.3A and B). 
Consistent with the local immune response, there was no significant difference in IL-4 and 
IL-13 production from in vitro ConA stimulated spleen cells (Figure 3.3C and D). Thus, in 
spite of the delay in worm expulsion Muc2 deficiency had no significant effect on 
generation of the TH2-type immune response in T. muris infection. The crypt architecture, 
an indicator of inflammation, changed during infection; there was an increase in crypt 
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length on D15 pi. in wild-type and Muc2-deficient mice which was more pronounced in 
the Muc2-deficient mice (Figure 3.3E).   
 
 
 Using the highest position of BrdU-positive cells in the crypts as a measure of rate 
of epithelial cell turnover (Potten et al, 2002), it was clear that  cell turnover was higher in 
the naïve Muc2-deficient mice compared to wild-type mice. However, there was no 
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significant difference in epithelial cell turnover between the Muc2-deficient and wild-type 
mice on D20 pi. (Figure 3.3F), indicating that the delay in worm expulsion in Muc2-
deficient mice was not associated with an alteration of the “epithelial escalator” (Cliffe et 
al, 2005).  
 
 
T. muris infection induced expression of PAS-positive goblet cells in Muc2-deficient 
mice 
 In spite of the similar number of goblet cells (as defined by Relm-β and Tff3; 
Supplementary Figure 3.2) in the infected and non-infected Muc2-deficient and wild-
type mice, there was a significant difference between the number of PAS-positive goblet 
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cells (Figure 3.4). As with the resistant BALB/c mice, there was a significant increase in 
the numbers of PAS-positive goblet cells in wild-type mice post infection. Although there 
was significant impairment in the development of hyperplastic goblet cells in the Muc2-
deficient mice, unexpectedly by D15 pi. there was an increase in PAS-positive goblet cells, 
with significant elevation by D30 pi. (Figure 3.4 & Supplementary Figure 3.3).  
 
T. muris infection triggers Muc5ac mucin production  
 Following exposure to T. muris the levels of Muc2 were significantly elevated in 
the wild-type mice (Supplementary Figure 3.3). As expected, no Muc2 positive goblet 
cells were seen in the Muc2-deficient mice. Similarly, higher amounts of Muc2 (assessed 
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by western blotting after agarose gel electrophoresis) were present in the content of mucus 
collected in the wild-type mice post infection (Figure 3.4). 
 Although, there was little evidence of mature, glycosylated Muc2 in the Muc2-
deficient mice, interestingly, on D21 pi. there was a faint band consistent with the 
electrophorectic migration of Muc2 in these mice (red box; Figure 3.4B). This along with 
the PAS-positive goblet cells suggested the presence of another polymeric mucin post 
infection. To identify this mucin, the mucus (pooled from 5 Muc2-deficient mice) was 
analysed by western blotting after agarose gel electrophoresis. The mouse Muc5b-
antiserum did not reveal any bands (data not shown). In contrast, a Muc5ac monoclonal 
antibody (Bara et al, 1991; Lidell et al, 2008), identified bands in the mucus samples from 
infected mice (Figure 3.5A). Immunofluorescence microscopy (Figure 3.5C), RT-PCR 
(Figure 3.5D) and tandem mass spectrometry (data not shown) confirmed the de novo 
expression of Muc5ac post infection in the Muc2-deficient mice. Furthermore, the PAS-
stained material after agarose gel electrophoresis showed coincidence with the Muc5ac 
reactive band (Figure 3.5B; arrow), suggesting Muc5ac is a significant component of the 
mucus in the Muc2-deficient animals. No marked changes were observed in the expression 
of the cell surface mucins, Muc1, Muc4 and Muc17, which are thought to contribute to 
mucosal protection (Supplementary Figure 3.2).  
 
Muc5ac is up-regulated as part of the ‘normal’ response to worm expulsion  
 Unexpectedly, Muc5ac expression was also significantly up-regulated in the wild-
type mice on D14 and 21 pi (Figure 3.6).  In contrast to the Muc2-deficient mice, western 
blotting revealed that Muc5ac mucin was not the major component in the mucus, since the 
major PAS-bands migrated further than the broad, Muc5ac-reactive band (Figure 3.6A and 
B; arrow) and was coincident with Muc2 staining bands (data not shown). However, the de 
novo expression of Muc5ac was only observed in the resistant mouse models (high dose in 
C57BL/6 and BALB/c mice) and not in the susceptible models (low dose in BALB/c, high 
dose in AKR and SCID mice) (Figure 3.6D). Immunofluorescence microscopy and 
immunohistochemistry confirmed the expression of Muc5ac post infection (D15 and 21pi.) 
in the caecal crypts of the resistant models (Figure 3.6C). No reactivity was observed in 
the susceptible models (data not shown).  
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Susceptibility is associated with altered mucus porosity  
 Fluorescently labelled beads were used to investigate mucus permeability post 
infection (D19) in BALB/c and AKR mice (Figure 3.7A). The beads travelled to a depth 
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of ~100μm over a 60 second period in both strains. Thereafter, there was a reduction in 
diffusion rate of the beads in the resistant (BALB/c) mice. However, the beads travelled 
significantly further in the mucus of susceptible (AKR) mice over a 20 minute period.  
 
 
Worms in a resistant environment have a reduced energy status 
 ATP measurements were carried out to determine the energy status of worms in 
resistant and susceptible mice as a measure of worm vitality. As infection progressed (D21 
pi.) in the AKR mice, there was a significant increase in the ATP production of the worms 
(Figure 3.7B). In contrast, there was a marked reduction in ATP production in the worms 
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isolated from the BALB/c mice. However, these worms were not irreversibly damaged as 
they recovered their ATP production when transferred to in vitro culture with the colonic 
LS174T cell line for 24 hours (Supplementary Figure 3.4A).  Importantly, worms taken 
from Muc2-deficient mice showed a comparable drop in energy status during worm 
expulsion (Supplementary Figure 3.4B).   
 
DISCUSSION 
 It is well-established that T. muris survives by eliciting a TH1 response in mice 
susceptible to chronic infection in the absence of a TH2 response. In common with all other 
studies of intestinal helminth immunity, multiple effectors under immunological (TH2) 
control are likely to be operating during worm expulsion. Whilst we already know that IL-
13 mediated regulation of epithelial cell turnover and smooth muscle contractility can 
contribute to worm expulsion, little detail is known regarding the protective role of the 
secreted barrier i.e. mucus (Artis and Grencis, 2008; Cliffe and Grencis, 2004; Else and 
deSchoolmeester, 2003). Previously we have shown that the TH2-type immune response in 
resistance plays an important role in the development of goblet cell hyperplasia (Khan et 
al, 2001; Khan et al, 2003). Some reports have also suggested mucus produced from goblet 
cells have an important role in trapping and removing nematodes from the intestine 
(Carlisle et al, 1991; Miller, 1987; Webb et al, 2007). The polymeric mucins are 
responsible for the physical properties of the mucus barrier (Sheehan et al, 1995; Thornton 
et al, 2008) and changes in mucins are associated with pathophysiology of a number of 
gastrointestinal disorders (Heazlewood et al, 2008; Van der Sluis et al, 2006). Recently it 
has also been shown that deficiency in the major component of the intestinal mucus 
barrier, Muc2, leads to an abnormal morphology of the colon and contributes to the onset 
and perpetuation of DSS-induced experimental colitis (Van der Sluis et al, 2006; Velcich 
et al, 2002). 
 In this study we demonstrated, using the T. muris model that Muc2 increased in 
resistance (restricted to the caecum; the niche of the parasite) which correlated with worm 
expulsion. However, this was not the case for the mice susceptible (AKR) to T. muris 
infection supporting the hypothesis that Muc2 contributed to host protection in nematode 
infection. A distinct functional role for Muc2 in host protective immunity in T. muris 
infection was demonstrated in the Muc2-deficient mice. These animals exhibited a 
significant delay in worm expulsion even though the adaptive immune response was 
unaltered; similar TH2-type immune responses were shown in Muc2-deficient and wild-
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type control mice following infection. Unexpectedly, de novo expression of Muc5ac was 
observed just before worm expulsion in the Muc2-deficient mice and resistant mouse 
models, but not in the susceptible models.  
 Overall, the network properties of the intestinal mucus barrier are different between 
resistance and susceptibility and the changes in the parasitic niche can have damaging 
effects on the vitality of the parasite. To our knowledge this is the first direct 
demonstration for a functionally protective role of gel-forming mucins in nematode 
infection. Analysis of caecal mucus from Muc2-deficient mice revealed that Muc5ac was 
the only polymeric mucin present in the mucus post infection. Moreover in wild-type mice, 
though not the major mucin (which is Muc2), for the first time in a nematode infection we 
show the up-regulation of Muc5ac post intestinal infection. 
 Several studies have elucidated that TH2-type cytokines such as IL-13 have the 
ability to up-regulate MUC5AC/Muc5ac expression levels (Fujisawa et al, 2008; Kondo et 
al, 2006). Therefore, the up-regulation in Muc5ac expression observed post infection, in 
both wild-type and Muc2-deficient mice may be as a result of IL-13 production. 
Interestingly, this de novo expression of Muc5ac was observed in all the resistant models 
(TH2-type response) but in none of the susceptible models (TH1-type response) of T. muris 
infection. While this mucin is predominantly found in airway and stomach mucus (Ho et 
al, 1993; Thornton et al, 2008), studies on patients with ulcerative colitis and 
adenocarcinomas have shown MUC5AC expression in the intestine along with MUC2 
(Forgue-Lafitte et al, 2007; Lidell et al, 2008). However, this is the first time that Muc5ac 
expression has been implicated in response to an enteric parasitic infection.  
 We observed no discernable PAS-positive goblet cells throughout the caecum of 
Muc2-deficient mice without infection. However, this was not due to the absence of goblet 
cell lineage as the expression of Tff3 and Relm-β was observed in the caecum of both 
infected and non-infected wild-type and Muc2-deficient mice. This observation 
corroborates with the findings of Van der Sluis et al where the expression of Tff3 was 
observed, despite the lack of PAS-positive goblet cells (Van der Sluis et al, 2006). Muc2 
seems to be the major phenotypic determinant of goblet cells and in the absence of Muc2, 
goblet cells lose their characteristic goblet-like shape and specific staining but the goblet 
cell lineage is still present (Van der Sluis et al, 2006; Velcich et al, 2002). Interestingly, 
post infection there was an increase in PAS-positive goblet cells in the Muc2-deficient 
mice. Although, the size of the goblet cells in Muc2-deficient mice was smaller compared 
to those in wild-type mice, their emergence correlated with worm expulsion. 
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 We have shown a functional role for the mucus barrier in host protective immunity 
to T. muris infection since in the absence of Muc2 worm expulsion is significantly delayed. 
Moreover, the physical properties of the mucus barrier are changed after infection; 
although the details of how these changes contribute to protection remains to be fully 
elucidated. However, one possibility is that in the susceptible mice, the lower levels of a 
Muc2 result in a network that may compromise defence due to inappropriate presentation 
or concentration of other host defence proteins in the environment of the worms. Whereas, 
in the resistant mice, these other proteins (such as Relm-β, Tff3 and angiogenins) may be 
retained and effectively concentrated at the sites of worm infection by specific interactions 
with Muc2 or with the infected induced Muc5ac, or by the physical constraints imposed by 
the mucin network; thus rendering the host interface unsuitable for worm reproduction 
and/or survival which results in expulsion (Ishiwata and Watanabe, 2007). Indeed, changes 
in the niche of the parasite do have a detrimental effect on the parasite, as worms extracted 
from mice during worm expulsion clearly have a reduced energy status as compared to 
those extracted from the susceptible mice. This reduction in the worm vitality is reversible 
if worms are transferred to a „favourable‟ environment, supporting the notion that 
expulsion reflects damaged, but not killed parasites.      
 Another explanation supported by our finding, which is by no means mutually 
exclusive, is that the physical nature of the mucus barrier is changed in such a way as to 
facilitate worm expulsion. We have shown that around the time of worm expulsion the 
mucus barrier is less porous in the resistant mice as compared to the susceptible mice and 
this alteration in physical properties of the barrier post infection may directly impact on the 
niche of the worms. The intestinal mucus barrier is proposed to comprise of a „loose‟ outer 
layer and a less porous, adherent inner layer (Johansson et al, 2008). The results from the 
bead penetration assay revealed that after 60 seconds the beads travelled to a ~100μm 
depth in the mucus from the susceptible and resistant mice, suggesting the properties of the 
„loose‟ layer are similar in both. However, the beads travelled at different rates thereafter, 
suggesting that the differences in network properties observed between the resistant and 
susceptible mice is mainly in the inner adherent layer of the barrier. This alteration may 
physically constrain the worms thus affecting the niche. 
 What might be the role of the infection-induced mucin Muc5ac in protection 
against the worms? Muc5ac is assembled in a different manner to Muc2 and does not 
possess the disulphide-resistant cross-links present in Muc2 (Carlstedt et al, 1995; 
Herrmann et al, 1999; Sheehan et al, 2000; Sheehan et al, 1991), thus it may result in a 
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mucus gel with different rheological properties. Indeed, Muc5ac is a major component of 
airways mucus and unlike the intestinal barrier which is normally an adherent Muc2-rich 
gel, a specific functional requirement in the airways makes a transportable mucus gel. Thus 
Muc5ac may change the rheological nature of the mucus gel, and in conjunction with the 
intestinal muscle hypercontractility (controlled via TH2 response (Khan et al, 2001; Khan 
et al, 2003)), could physically aid worm expulsion. This is consistent with the observations 
of mucus trapping in N. brasiliensis and T. spiralis infection, in which globules of mucus 
trap worms, which are then transported out of the intestine (Carlisle et al, 1991; Miller, 
1987). Another interesting possibility raised by the data is that expulsion occurs in two 
phases: an early phase influenced by Muc2 and a final, clearance phase that occurs 
independently of Muc2, possibly involving Muc5ac.  
 In conclusion, this study clearly demonstrates that the mucus barrier is a significant 
component of a well co-ordinated response in the gut to worm expulsion. Even though 
T.muris has an intracellular niche within the gut epithelium, in resistance as the „epithelial 
escalator‟ displaces worms, it may be that the overall changes in barrier have a subsequent 
significant detrimental effect on the worm itself and the additional changes in the physical 
properties of mucus contribute to the efficient elimination of the worms from the intestinal 
lumen. Moreover, it further highlights the functionally dynamic and highly regulated 
nature of the mucus barrier during immunologically mediated intestinal disease.  
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ABSTRACT 
De novo expression of Muc5ac, which is a mucin not normally expressed in the intestinal 
tract, is observed in the caecum of mice resistant to Trichuris muris infection. Therefore, in 
this study we investigated the role of Muc5ac, which is detected just before worm 
expulsion and associated with the development of interleukin-13 (IL-13) resistance to this 
nematode. We show that Muc5ac-deficient mice were incapable of expelling T. muris from 
the intestine and developed long term chronic infections, despite developing strong TH2 
responses.  Muc5ac-deficient mice had elevated levels of IL-13; however, an increase in 
the TH1-cytokine IFN-γ was also observed, which is thought to favour chronic nematode 
infection. Therefore, to determine whether IFN-γ was promoting susceptibility, IFN-γ was 
neutralized in vivo.  In the absence of IFN-γ, Muc5ac-deficient mice developed even 
stronger TH2-type immune responses, characterised by increased levels of IL-4, IL-9 and 
IL-13 and significant production of goblet cell bioactive molecules (Resistin-like 
molecule-) Relm- and (intestinal trefoil factor) Tff3. Nevertheless, despite developing 
even stronger TH2 effector responses, the Muc5ac-deficient mice remained highly 
susceptible to chronic T. muris infection. Importantly, human MUC5AC had a direct 
detrimental effect on the nematode‟s vitality. Thus, for the first time we identify a single 
mucin, Muc5ac, as a direct and critical mediator of resistance during chronic intestinal 
nematode infection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABBREVIATIONS  
PAS, Periodic-Acid Schiff‟s; pi., Post infection; TH, T Helper; T. muris, Trichuris muris; 
WT, Wild-type. 
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INTRODUCTION 
 The intestinal epithelium is covered by a thick layer of mucus that enables the host 
to inhibit the access of pathogens to the underlying mucosa (Deplancke and Gaskins, 
2001). Specialised secretory cells termed „goblet cells‟ secrete gel-forming mucins, the 
major macromolecular components of the mucus barrier that are responsible for its 
viscoelastic properties (Thornton et al, 2008). In the adult intestine, MUC2/Muc2 is the 
major gel-forming mucin stored within the granules of goblet cells (Allen et al, 1998). 
Aberrant expression of MUC2 underlies many human gastrointestinal diseases, such as 
ulcerative colitis (Longman et al, 2006), colorectal carcinomas (Andrianifahanana et al, 
2001) and parasitic infections (Lidell et al, 2006). MUC5AC, a mucin normally expressed 
in non-intestinal mucosa, has been reported to be expressed in the intestine along with 
MUC2, during inflammation in diseases such as ulcerative colitis and adenocarcinoma 
(Forgue-Lafitte et al, 2007). A host protective role for this mucin in the intestine following 
infection has not been demonstrated.  
 Trichuriasis, caused by the nematode Trichuris trichiura, is one of the most 
prevalent nematode infections causing significant morbidity and mortality in humans (Artis 
and Grencis, 2008). The nematode Trichuris muris (T. muris) is closely related to T. 
trichiura at a morphological and antigenic level and is thus used as a well-established 
mouse model of human Trichuriasis (Cliffe and Grencis, 2004). It is well-established that 
the expulsion of the T. muris nematode is critically dependent on TH2-associated cytokines, 
whereas, a TH1-type immune response is beneficial for the nematode, resulting in a chronic 
infection. Our recent studies have highlighted that the mucus barrier is a significant 
component of the well-coordinated response initiated against the nematode, influenced by 
the TH2-type cytokines (Hasnain et al, 2010a; Hasnain et al, 2010b) and, we have recently 
demonstrated that in the absence of the major intestinal mucin, Muc2, a significant delay in 
worm expulsion occurs (Hasnain et al, 2010b). Interestingly, MUC5AC/Muc5ac a mucin 
predominantly expressed in the adult airway, stomach and occular epithelia (Bara et al, 
2003; Buisine et al, 1998; Inatomi et al, 1996) was expressed in the caecum of resistant 
mice and associated with worm expulsion. We hypothesise that Muc5ac may function as a 
pharmacological regulator to damage the nematodes directly or indirectly via associated 
“protective” molecules. In addition, the incorporation of Muc5ac within the mucus layer 
may influence the biochemical properties of the mucus gel and thus facilitate worm 
expulsion (Hasnain et al, 2010b). To investigate the role of Muc5ac in enteric parasitic 
Role of Muc5ac during nematode infection | 117 
 
infection, we examined the etiology of T. muris infection in the targeted Muc5ac-deficient 
mice and the interaction of MUC5AC with T. muris in vitro.  
  In this study we demonstrate, for the first time, that Muc5ac induced by IL-13 is 
critical for worm expulsion. Loss of Muc5ac resulted in susceptibility to chronic T. muris 
infection, compared to wild-type mice which expelled their worm burden. These findings 
are particularly important, as previously described effector mechanisms were activated, 
including a TH2-type immune response (Grencis, 1993), goblet cell hyperplasia , up-
regulation of Muc2  (Hasnain et al, 2010b) and the activation of the epithelial cell escalator 
(Cliffe et al, 2005) without parasite expulsion. Together, these results identify a unique 
functional role for the Muc5ac mucin during intestinal infection.  
 
RESULTS and DISCUSSION 
 Our recent studies have shown that Muc5ac was up-regulated during T. muris 
expulsion in a strong TH2-type environment and therefore may be a critical component of 
the immune regulated response (Hasnain et al, 2010b). Muc5ac levels were measured in 
IL-4 and IL-4R deficient mice during T. muris infection to determine whether the induction 
of Muc5ac was regulated by IL-4 and IL-4/IL-13 pathways, respectively. The IL-4 
deficient mice had a delay in worm expulsion and were able to mount a goblet cell 
response, whereas the IL-4R deficient mice (which have defective IL-4 and IL-13 
signalling) were susceptible to chronic infection and did not exhibit goblet cell hyperplasia 
(Hasnain et al, 2010a). Expression of Muc5ac was assessed using immunofluorescence 
microscopy. De novo Muc5ac expression was observed in IL-4 deficient mice, on days 18 
and 35 post infection (pi.), correlating with worm expulsion. However, Muc5ac was 
undetectable in caecal crypts during infection in IL-4R deficient mice, which manifest 
defects in both IL-4 and IL-13 signalling (Figure 4.1), indicating that Muc5ac in the 
caecum was regulated by IL-13 (Rose et al, 2000) and to a lesser extent IL-4.     
  
Role of Muc5ac during nematode infection | 118 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  As Muc5ac expression correlated with worm expulsion in resistant mice even in 
the absence of Muc2 (Hasnain et al, 2010b), we investigated the role of Muc5ac during 
nematode expulsion. Muc5ac-deficient mice on the resistant C57BL/6-background were 
infected with a high dose of T. muris eggs. Infection became established similarly in the 
wild-type and Muc5ac-deficient mice as seen on day 14 pi. (Figure 4.2). As expected, 
wild-type (WT) mice cleared 70% of their worms by day 23 pi. and were essentially 
parasite free by day 45 pi. (Figure 4.2). However, there was no significant reduction in 
worm burdens in the Muc5ac-deficient mice at any time point (day 14, 23 and 45 pi.) 
demonstrating that these mice were susceptible to chronic infection (Figure 4.2). 
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Therefore, the inability of mice to express Muc5ac rendered them susceptible to chronic 
infection.  
 
 
 The „epithelial cell escalator‟ (Cliffe et al, 2005) and goblet cell hyperplasia 
(Hasnain et al, 2010b) are immune-mediated effector mechanisms which contribute to 
worm expulsion. The rate of epithelial cell (EC) turnover was determined by measuring 
BrdU incorporation into ECs and measuring the length of longitudinal caecal crypts during 
infection (Cliffe et al, 2005). On day 23 pi., a marked increase in EC turnover was 
observed in Muc5ac-deficient mice compared to uninfected controls (Figure 4.3A). 
Furthermore, this was accompanied by an increase in caecal crypt length indicative of 
increased proliferation of ECs at the base of the crypt unit (Figure 4.3B). Despite the 
increase in epithelial cell turnover, the worms were not expelled from the intestine.   
 PAS staining and immunofluorescence microscopy with mMuc2 antibody were 
used to determine changes in the number of goblet cells in the caecal tissue of the Muc5ac-
deficient mice during T. muris infection. The absence of Muc5ac in naïve and infected 
Muc5ac-deficient mice was confirmed with immunofluorescence microscopy with 45M1 
(MUC5AC/Muc5ac) antibody (Supplementary Figure 4.2). During infection, an increase 
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in goblet cell numbers was apparent in Muc5ac-deficient mice infected with T. muris (day 
23 and 45 pi.) compared to naïve mice (Figure  4.4A-C). However, the total number of 
PAS-positive goblet cells was ~20% lower in the Muc5ac-deficient mice compared to 
infected wild-type mice (Figure 4.4A, B); this was attributed primarily to the absence of 
Muc5ac, as similar amounts of Muc2 were present in both groups of mice (Figure 4.4A, 
C).  
 
 
 
 
 
 
 We have previously shown that during the development of resistance, the mucin 
network is less porous and the overall changes in the environmental niche can be 
detrimental to the worm‟s vitality (Hasnain et al, 2010b). To address whether changes in 
worm viability are affected by the absence of Muc5ac, we measured worm ATP levels. 
Interestingly, the worms extracted from Muc5ac-deficient mice on day 23 pi. had 
significantly higher levels of ATP compared those from the wild-type mice (Figure 4.4D), 
similar to the levels observed in other mice that develop chronic infections (Hasnain et al, 
2010b). Furthermore, we demonstrated that fluorescent beads placed at the top of the 
mucus travelled a greater distance through the mucus barrier in Muc5ac-deficient mice as 
compared to wild-type mice (Figure 4.4E), suggesting that the absence of Muc5ac resulted 
in a more porous network. Whether this is due to the lower mucin content of the mucus or 
different organisation of the barrier due to the lack of Muc5ac remains to be elucidated. 
Nevertheless, these data clearly show that the absence of Muc5ac increases the viability of 
the worm and increases the porosity of the mucus network. We have also previously shown 
that Muc2 plays a significant role in protection against T. muris infection (Hasnain et al, 
2010b). However, Muc2 deficiency delayed worm elimination by 1 week (Hasnain et al, 
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2010b). In contrast, Muc5ac deficiency prevented parasite expulsion, with little to no 
worm expulsion detected as late as 45 days pi., demonstrating a greater requirement for 
Muc5ac. Therefore, these data suggest that Muc2 and Muc5ac act in concert to promote 
worm expulsion, with Muc5ac playing the dominant role in IL-13-driven immunity. 
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 It is well established that a strong TH2-type immune response mediates worm 
expulsion, in particular, IL-13 is critical for resistance to T. muris infection (Artis and 
Grencis, 2008; Cliffe and Grencis, 2004). RT-PCR was used to determine the mRNA 
levels of the TH2-type cytokines, IL-4 and IL-13 and the TH1-type cytokine, IFN-γ in 
mesenteric lymph nodes (mLNs). In contrast to WT mice, a mixed response TH1/TH2-type 
response was observed in the Muc5ac-deficient mice following infection with a 4-fold 
increase in IFN-γ levels on day 14 pi., that further doubled by day 23 pi. (Figure 4.5A) 
accompanied by marked increase in IL-4 and IL-13 expression levels (Figure 4.5B,C). 
Similar cytokine gene expression was observed in the WT mice (Supplementary Figure 
4.3). The increase in IL-4 and IL-13 levels likely explains the increase in goblet cell 
numbers, Muc2 expression, and the increase in epithelial cell turnover observed in the 
Muc5ac-deficient mice.  
 
  
 
 
 
 
 The unimpaired TH2 response seen after infection was surprising given the 
susceptible phenotype of the Muc5ac-deficient mice; however, IFN-γ was also 
significantly elevated in these mice following infection. There was also a slight increase in 
IFN-γ in uninfected Muc5ac-deficient (Supplementary Figure 4.3). Increased levels of 
IFN-γ may skew the immune response towards TH1-dominant environment that is known 
to promote chronic infection. Therefore, we sought to determine whether skewing the 
immune response of the Muc5ac-deficient mice to a more polarised TH2-type immune 
response would return them to a more susceptible phenotype. To this end, mice were 
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treated with anti-IFN-γ antibody or an IgG control antibody, both before and during 
infection (every 2 days starting on 2 days before infection until day 26 pi.). Expression of 
IFN-γ, IL-4, IL-9 and IL-13 was measured after stimulation of mLNs with T. muris 
excretory/secretory (E/S) antigen (Supplementary Figure 4.3). Treatment with anti-IFN-γ 
antibody abolished IFN-γ expression and induced a much stronger TH2-type immune 
response, characterised by increased production of IL-13 and lower IgG2a expression 
(Supplementary Figure 4.3). The Muc5ac-deficient mice treated with anti-IFN-γ 
remained highly susceptible to chronic T. muris infection, despite developing strong TH2-
type immune responses; indeed similar number of worms were observed in both control 
IgG and anti-IFN-γ-treated mice (Figure 4.6). In addition, we investigated whether 
deletion of Muc5ac altered the goblet cell lineage and affected the expression of goblet cell 
bioactive factors that may contribute to the expulsion of T. muris. Immunohistochemical 
and immunofluorescence microscopy were used to determine the expression of intestinal 
trefoil factor (Tff3) and resistin-like molecule-β (Relm-β), respectively. Staining for Tff3 
and Relm- β were similar within the caecum of the WT and Muc5ac-deficient mice on day 
35 after the neutralisation of IFN-γ (Supplementary Figure 4.4). These data clearly 
establish an important and indispensable role for Muc5ac in worm expulsion, even during 
chronic infection. Furthermore, it implies that Muc5ac functions as the key immune 
effector molecule during the development of TH2-dependent immunity.   
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 The question that arises in light of this evidence is how does the absence of Muc5ac 
result in chronic T. muris infection despite an on-going TH2-type immune response? To 
explore whether the Muc5ac present within goblet cells in the caecal crypts during worm 
expulsion has a direct effect on the nematode, we utilised human colonic cell lines 
producing either MUC5AC (HT-29) or MUC2 (LS174T). Worms were extracted from 
highly susceptible athymic nude mice and therefore, the worms extracted from this 
environment are in a low-stress state. Worms were then placed on either MUC2-producing 
LS174T cells or a sub-clone of MUC5AC-producing HT-29 cells (Kirkham et al, 2002) for 
24 hours (Figure 4.7). Interestingly, the data showed that the nematodes placed on MUC2-
producing cells produced significantly higher levels of ATP compared to those placed on 
the MUC5AC-producing cells, suggesting that MUC5AC may have a direct effect on the 
vitality of the nematode. The levels of ATP of worms extracted from a resistant 
environment were significantly lower than those observed in vitro (HT-29 cells) (Figure 
4.7). This may be due to the differences in concentration or chemical composition between 
human and mouse MUC5AC/Muc5ac. In particular, the glycosylation pattern in vivo may 
differ from that in vitro and the protein core structure and assembly differs between the 
two mucins, where MUC2 consists of two cysteine-rich domains MUC5AC consists of 
nine (Hollingsworth and Swanson, 2004; Thornton et al, 2008). Nevertheless, MUC5AC 
had a deleterious effect on the vitality of the nematode. The exact mechanism by which 
this occurs is not yet known. Another interesting possibility by which Muc5ac/MUC5AC 
may exert its effects on the nematodes is via factors that are either produced from the same 
goblet cells and/or are specifically associated with this mucin in mucus. However, since 
Relm-β and Tff3, that are known to be active against nematodes (Herbert et al, 2009), were 
still expressed within the goblet cells of the Muc5ac-deficient mice (Supplementary 
Figure 4.4), our findings suggest that differences in the physical properties of the mucins 
themselves play the major role here.  
 In order to address whether MUC5AC was directly having a detrimental effect on 
the vitality of the nematode, we altered the concentration and structure of polymeric 
MUC5AC produced by HT-29 cells in culture (Figure 4.7B). A dose dependent decrease 
in the nematodes ATP levels was observed when they were treated with increasing 
concentration of MUC5AC. To test whether the intact polymer was required for the direct 
effect on the nematode, the MUC5AC preparation was depolymerised by treatment with 
DTT. Incubation of the nematodes with the monomeric, unfolded mucins did not have a 
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significant effect on the protein function in terms of reducing nematodes vitality (Figure 
4.7C). Subsequently, the monomeric MUC5AC mucins were treated with trypsin which 
degrades the protein-rich N- and C-terminal domains and the internal cys-domains but 
leaves intact the highly-glycosylated tandem repeat domains. Importantly, the digested 
MUC5AC mucin did not reduce the worm vitality, highlighting the specific role of 
MUC5AC as an effector that acts to damage the nematode as part of the co-ordinated 
worm expulsion process.     
 Recently another study has also reported the up-regulation of Muc5ac in intestinal 
epithelial cells in vitro with exposure to the intestinal nematode Nippostrongylus 
brasiliensis (Takeda et al, 2010). Furthermore, Muc5ac mRNA was also shown to be up-
regulated in the intestines during Trichuris suis infection in pigs (Kringel et al, 2006). 
Additionally, we have preliminary data that suggest that Muc5ac is up-regulated during 
Trichinella spiralis infection (data not shown). Therefore, we propose that de novo 
expression of Muc5ac observed as part of the IL-13 mediated immune response serves as a 
“universal protective mechanism” during worm expulsion. This study is the first to address 
the critical role of Muc5ac during an enteric parasitic infection functionally. Moreover, it 
highlights a novel role for Muc5ac not just as a structural component of the mucus barrier 
but as a crucial effector molecule during chronic infections of the intestine.   
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MATERIALS AND METHODS 
Animals 
The wild-type (C57BL/6) mice were commercially bought from Harlan Olac, IL-4 
deficient and their wild-type (BALB/c) littermates were originally obtained from Dr. 
Andrew McKenzie (McKenzie et al, 1998)). IL-4R deficient mice were obtained from 
Prof. F. Brombacher (Mohrs et al, 1999). Muc5ac deficient mice were originally produced 
by gene mutation at the University of Texas (by Dr. C. Evans). The Muc5ac allele was targeted 
by inserting LoxP sites into the 5' flanking region and intron 1.  Neomycin was used for 
selection, and the selection cassette was removed by crossing animals with Rosa-FLPe knock-
in mice (data not shown). Southern blot analysis using a probe located outside of the 5' 
targeting arm (Supplementary Figure 4.1) confirmed homologous insertion of the 5' LoxP 
site.  Long range PCR, restriction endonuclease, and sequence analysis confirmed homologous 
insertion of the 3' LoxP site. EcoRI and BamHI (sites present in the recombinant but not in the 
wild type allele) were used to digest PCR products.  DNA extracted from mouse tail biopsies 
were screened by PCR to identify +/+, +/-, and -/- animals.  Quantitative RT-PCR was used to 
confirm loss of Muc5ac expression in the stomachs of knockout animals using methods 
described previously (Young et al, 2007). All the animals were maintained in the Biological 
Services Unit at the University of Manchester. The protocols employed were in accordance 
with guidelines by the Home Office Scientific Procedures Act (1986). All mice were kept 
in sterilized, filter-topped cages, and fed autoclaved food in the animal facilities. Only 6-
12wk old male mice were used. 
 
Parasitological techniques 
The techniques used for T. muris maintenance and infection were described previously 
(Wakelin, 1967). Mice were orally infected
 
with approximately 100-300 T. muris eggs for 
a high dose infection. Worm burdens were assessed by counting the number of worms 
present in the caecum as described previously (Wakelin, 1967).  
 
Histology, immunohistochemistry and immunofluorescence microscopy 
A 1cm segment or the whole caecum or small intestine (rolled) was fixed in 95% ethanol 
and processed by using standard
 
histological techniques. Sections were treated with 0.1M 
KOH for 30 minutes prior to staining with
 
periodic acid Schiff (PAS) reaction . Slides were 
counterstained with either haematoxylin and eosin or 1% fast-green. Standard 
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immunohistochemical and immunofluorescent staining methods  were used to determine 
the levels of Muc2 and Muc5ac.  
 
Antibodies 
Immunodetection was carried out using a polyclonal antibody raised against a murine 
Muc2 (mMuc2) (Heazlewood et al, 2008). Commercially available 45M1 antibody was 
used for the detection of mouse Muc5ac (Lidell et al, 2008). Detection of BrdU 
incorporated into nuclei was carried out using a monoclonal anti-BrdU antibody (AbD 
Serotec,Oxford, United Kingdom). Commercially available mRelm-β (Abcam, Cambridge, 
UK) and mITF (Santacruz Biotech., USA) antibodies were used to detect Relm-β and Tff3, 
respectively. The rat immunoglobulin G1 monoclonal antibody XMG1.6 and GL113 
antibody (for isotype control) were purified from supernantant by cell culture passage and 
protein G-Sepharose column and concentrated using a Centricon Centriprep tube. 
Antibody was administered at 0.5mg per 200μl of phosphate buffered saline (PBS) by 
intraperitoneal injection. Injections were given every 4 days starting from day -2 to day 26 
post infection.  
 
Analysis of mucus network properties 
Caecal tissue isolated from mice was cut longitudinally, washed with PBS and kept 
hydrated in a 6 well plate. 0.1μm blue fluorescently labelled polymer microspheres (Dukes 
Scientific, UK) were placed on top of the luminal surface of the caecum (set as a reference) 
and their position analysed using the Nikon C1 Upright confocal microscope. 3D optical 
stacks were taken every 5μm and combined to obtain a Z-stack at the time points stated 
(Hasnain et al, 2010b).       
 
Worm isolation for ATP analysis 
The caecum was longitudinally cut and segmented before incubation with 0.1M NaCl for 2 
hours at 37◦C with frequent shaking. Worms were counted after separation from debris and 
epithelial cells using a 0.7μm filter and kept in RPMI-1640 supplemented with 10% FCS. 
Alive worms were subsequently homogenised using the FastPrep
®
 homogeniser (MP 
Biomedicals, Inc.).  
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Energy status of worms 
The CellTiter-Glo
®
 luminescent cell viability assay was carried out according to 
manufacturer‟s instructions (Promega Corp., USA). Relative light units (RLUs) were 
calculated per worm: RLU = (sample light units − blank light units)/number of worms. 
Substrate only was used as a blank control; whereas worms were boiled before 
homogenisation for negative controls. To determine recovery of energy status, worms 
recovered on D19 pi. were washed extensively in DMEM, added to 6 well plates with 
LS174T cells (maintained as previously described by Hayes et al.) for 24 hours prior to 
measuring ATP levels (Hasnain et al, 2010b). MUC5AC was purified as previously 
described (Sheehan et al, 2000).      
 
Rate of epithelial cell turnover  
The rate of intestinal epithelial cell turnover was assessed by visualising BrdU 
incorporated into nuclei after mice were injected with 10mg of BrdU 16hrs before 
sacrifice, as described previously (Cliffe et al, 2005). 
 
In-vitro cytokine analysis 
Mesenteric lymph nodes (mLNs) were removed, cells were isolated and resuspended at 5 x 
10
6
 cells/ml in RPMI 1640 with 10% FBS, 2mM L-glutamine, 100U/ml penicillin and 
100μg/ml streptomycin. Cultures were stimulated with 50μg/ml of ESPs (Excretory 
secretory products) for 24 hours at 37°C and 5% CO2. Cell free supernatants were stored at 
-80°C; cytokine analysis was carried out by cytometric bead assay (BD Biosciences) 
(Hayes et al, 2007). For the analysis of T. muris specific antibodies (IgG2a) was carried 
out by sandwich ELISA using homogenised intestinal tissue.   
 
Quantification of histological staining  
The numbers of goblet cells expressed per crypt were counted in 50 longitudinally 
sectioned crypt units. The area stained (pixel/mm
2
) per 100 crypts was determined by using 
the ImageJ software version 1.39a.  
 
Statistical analysis 
All results are expressed as the mean SEM. Statistical analysis was performed using 
GraphPad PRISM version 3.2 (GraphPad software, Inc.). Statistical significance of 
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different groups was assessed by using parametric tests (ONE-way Analysis of variance 
with post-test following statistical standards or paired Student t test). P<0.05 was 
considered statistically significant.  
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ABSTRACT 
Background & Aims: Mucins are heavily glycosylated proteins that have been shown to 
play an important role in rejection of the nematode, Trichuris muris (T. muris). The 
glycans decorating the mucin protein core can alter the protective properties of the mucus 
barrier. Therefore, we investigated the changes in glycosylation during T. muris infection.   
Methods: Using different infection doses and strains of mice, resistance (high dose 
infection in BALB/c or C57BL/6 mice) or susceptibility (high dose infection in AKR and 
low dose infection in BALB/c mice) to T. muris infection was modelled.  The changes in 
mucin glycosylation, whether these alterations were controlled by the immune system and 
overall the affect of mucin glycosylation on the properties of the mucus barrier were 
investigated.  
Results: During chronicity, within the close vicinity of the T. muris nematode the goblet 
cell thecae contained mainly sialylated mucins. In contrast, mucins were mainly sulphated 
in the goblet cells within the epithelial cell crypts in the resistant models. The mucin 
sulphation was controlled by a TH2-type immune response in particular by IL-13 via the 
up-regulation of sulphotransferases. Moreover, the high sulphomucin content was less 
prone to degradation by T. muris ESPs. However, worm establishment or expulsion was 
unaffected in mice deficient in the Na
+
 sulphate transporter (NaS1) which have depleted 
sulphomucin content. Unexpectedly, T. muris infection resulted in the recovery of 
sulphomucin content of the goblet cells at the time of expulsion via the sulphate anion 
transporter (Sat1).   
Conclusions: This study highlights the complex process by which TH2-mediated alterations 
in glycosylation may contribute in resistance to T. muris.    
 
 
 
 
 
 
 
 
 
 
 
 
ABBREVIATIONS  
NAS, Na
+
 sulphate transporter; PAS, Periodic-Acid Schiff‟s; pi., Post infection; TH, T 
Helper; T. muris, Trichuris muris; LD, Low dose infection; HD, High dose infection; WT, 
Wild-type; HID-AB, High-Iron Diamine-Alcian blue; ESP, Excretory secretory products. 
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INTRODUCTION 
 The intestinal epithelium is lined by a continuous mucus barrier which provides 
physical protection and, by sequestering important host defence factor within its complex 
matrix it chemically protects the epithelial cell layer (Thornton et al, 2008). Gel-forming 
mucins (Muc2 in the intestine) produced by goblet cells, give mucus its gel-like properties 
and play a significant role in protection against nematode infections (Hasnain et al, 2010b). 
Mucins are large heavily glycosylated proteins, predominantly consisting of O-glycans 
which account for at least 70% of their molecular weight (Thornton and Sheehan, 2004). 
The O-linked sugars are assembled progressively by glycosyltransferases on to a serine or 
threonine residue, found in the serine-threonine-proline rich tandem repeats in the mucin 
protein core (Thornton et al, 2008). It is well established that these glycan chains have 
fundamental roles in many biological processes including inflammatory response and 
parasitic infections (Theodoropoulos et al, 2001). 
 Changes in glycosylation have been well described in parasitic infections (Hasnain 
et al, 2010a; Holmen et al, 2002; Karlsson et al, 2000; Soga et al, 2008; Theodoropoulos et 
al, 2005; Tsubokawa et al, 2009; Yamauchi et al, 2006), whether these changes are 
important in the protective function of the mucus barrier however, has not yet been 
established. Several studies have investigated the direct role of glycans as protective 
elements that attach and clear pathogens, in particular bacteria, from the gut (Deplancke 
and Gaskins, 2001; Linden et al, 2004; Linden et al, 2008a; Szymanski and Wren, 2005). 
Most of the evidence for the protective role of the glycans present on mucin comes from 
studies on animal models. Alteration in glycans can lead to inflammation because of the 
alteration in the protective properties of the mucus barrier (Holmen et al, 2002; Hurd et al, 
2005; Theodoropoulos et al, 2005; Yamauchi et al, 2006). For instance, the terminal sugar 
fucose has been shown to be crucial in host-pathogen interaction in the Helicobacter pylori 
infection (Ikehara et al, 2001). Moreover, inducing colitis in mice deficient in the N-
acetylglucosamine-6-O-sulphotransferases-2 (Tobisawa et al, 2010) which is expressed 
highly in the colon, results in leukocyte infiltration and is thought to exacerbate 
inflammation. Furthermore, mice lacking the core 3-derived O-glycan chain have also been 
shown to produce less mucins (An et al, 2007), possibly due to defects in the processing of 
Muc2, which renders the mice more susceptible to colitis.  
 In the intestine, a rich commensal flora is maintained within the mucus layer and it 
is thought that the microflora can influence the level of sulphation on the mucins (Hill et 
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al, 1990). Paradoxically, mucin sulphation can also protect the mucin core from bacterial 
glycosidases (Theodoropoulos et al, 2001). Previous studies have shown that inducing 
sulphation in vivo leads to the reduction in the establishment of the intestinal nematode 
Strongyloides venezuelensis (Ishikawa et al, 1995). Sulphotransferases were also up-
regulated shortly before the rejection of the nematode, Nippostrongylus brasiliensis and are 
thought to play a protective role during worm expulsion (Soga et al, 2008; Tsubokawa et 
al, 2009). In addition, the up-regulation of sialomucins observed in other nematode models 
such as Trichinella spiralis, have been found to be regulated by thymus derived T cells and 
are thought to be protective (Theodoropoulos et al, 2005; Yamauchi et al, 2006). 
Moreover, gastrointestinal disorders such as ulcerative colitis and Crohn‟s disease are 
associated with a loss of mucin sulphation (Corfield et al, 1996; Longman et al, 2006). 
Whether the changes observed in glycosylation occur as a consequence of disease or are an 
active alteration important in resolving the disease has yet to be fully elucidated. Recently 
it was shown that a reduction in mucin sulphation can lead to an increase in susceptibility 
to colitis and subsequently secondary bacterial infections (Dawson et al, 2009). Overall, it 
is thought that the changes in glycosylation can lead to reducing the effectiveness of the 
mucus barrier which in turn may exacerbate inflammation. 
 Trichuris muris (T. muris) infection in mice is used as a model to investigate the 
changes in glycosylation response to Trichuriasis, which affects up to a billion people 
worldwide (Bethony et al, 2006; Cliffe and Grencis, 2004). The T. muris model is useful as 
both resistant (high dose infection in BALB/c and C57BL/6 mice) and susceptible (high 
dose infection in AKR and low dose infection in BALB/c mice) mouse models exist, 
reflecting the situation in humans. It is well-established that the resistant mice 
predominantly exhibit a TH2-type immune response, which is essential for the clearance of 
T. muris; the strains susceptible to chronic infection exhibit a TH1-type immune response 
(Cliffe and Grencis, 2004). Previously we have shown that mucins play a significant role in 
worm expulsion (Hasnain et al, 2010b) and in the caecum, the niche of the parasite, the 
degree of sulphation on mucins is higher than in any other site in the body (Corfield et al, 
1996). Therefore, mucin sulphation could be an important aspect of the protective nature of 
the mucus barrier and affect T. muris establishment and/or expulsion.  
 In this study we investigated the changes in mucin glycosylation (in particular 
sulphation and sialylation) during infection with T. muris. We demonstrated a clear switch 
during chronic infection: from sulphomucins to sialomucins. For the first time to our 
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knowledge, we demonstrate that sulphation on mucins is influenced by IL-13 and mucus 
with high sulphomucin content is more resistant to degradation by the T. muris excretory 
secretory products (ESPs). A reduced state of intestinal mucin sulphation (using NaS1-
deficient mice) did not have an effect on worm establishment. However, we observed that 
T. muris infection was a strong inducer of sulphation of mucins and the sulphomucin 
content within the goblet cells recovered in a Na
+
-independent manner, by the up-
regulation of the sulphate anion transporter (Sat1).  
 
MATERIALS AND METHODS 
Animals 
AKR, BALB/c (Harlan Olac), IL-4-deficient and IL-4R-deficient mice (originally obtained 
from McKenzie et al, 1998) were maintained in the Biological Services Unit at the 
University of Manchester. The protocols employed were in accordance with guidelines by 
the Home Office Scientific Procedures Act (1986). NaS1-deficient mice (4-12 weeks old 
male C57BL/6) and their wild-type littermates originally produced by gene mutation 
(Dawson et al, 2003) were housed at the Mater Medical Research Institute and experiments 
were approved by the University of Queensland Animal Experimentation Ethics 
Committee. All mice were kept in sterilized, filter-topped cages, and fed autoclaved food. 
 
Parasitological technique 
The techniques used for T. muris maintenance and infection were described previously 
(Wakelin, 1967). Mice were orally infected
 
with approximately 100-300 eggs for a high 
dose infection and <15 eggs for a low dose infection. Worm burdens were assessed by 
counting the number of worms present in the caecum as described previously (Wakelin, 
1967).  
 
Histology, Immunohistochemistry and Immunofluorescence microscopy 
A 1cm segment or the whole tissue (rolled) was fixed in 10%
 
neutral buffered formalin or 
95% ethanol and processed using standard
 
histological techniques. Sections were treated 
with 0.1M potassium hydroxide for 30 minutes prior to staining with
 
Periodic Acid 
Schiff‟s reagent (PAS). Slides were counterstained with either haematoxylin and eosin or 
1% fast-green. To assess mucin sulphation, sections were stained with High Iron Diamine-
Alcian Blue (HID-AB) as previously described (Spicer, 1965). Standard 
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immunohistochemical staining methods (Linden et al, 2008b) were used to detect Sat1 
(Sulphate anion transporter 1), using the monoclonal mouse Sat1 antibody (Dawson et al, 
2010).  
 
RT-PCR 
RNA from epithelial cells was isolated using the previously described method (Humphreys 
et al, 2008). cDNA was generated using an IMPROM-RT kit (Promega) or Superscript III 
(Invitrogen). Absolute QPCR SYBR Green (ABgene) was used for quantitative PCR. 
Primer efficiencies was determined using cDNA dilutions and genes of interest 
(Supplementary Table 5.1) were normalised against the housekeeping gene, β-actin, and 
expressed as a fold difference to uninfected naïve message levels. RT-PCR products were 
directly sequenced to verify the identity of the amplified genes. In brief, products were 
digested with Exonuclease I and Calf Intestinal Phosphatase and subsequently sequenced 
using the ABIPRISM Big-Dye Terminator cycle sequencing reaction at the Sequencing 
Facility in the University of Manchester. The data was analysed using Chromas Pro v1.34 
and the sequences obtained were compared against the GenBank database 
(http://www.ncbi.nlm.nih.gov/BLAST).     
 
Mucus extraction and analysis by agarose gel electrophoresis  
Caeca from NAS1-deficient mice and their wild-type littermates were gently flushed with 
PBS to remove the faecal matter. The mucus was lightly scraped and lyophilized and 
subsequently solubilised in 6M urea, reduced using 50mM dithiothreitol (DTT) and 
carboxylmethylated using 0.125M iodoacetamide prior to electrophoresis on a 1% (w/v) 
agarose gel. Mucins were western blotted onto nitrocellulose membrane and detected using 
PAS or HID staining (Thornton et al, 1994).  
 
Treatment with T. muris excretory secretory products 
The excretory secretory products (ESPs) were collected using methods previously 
described (Else and Wakelin, 1989). Aliquots of crude mucus (in equal volumes of PBS) 
were incubated at 37°C with the ESPs at 50μg/ml for various time points (later specified). 
Control samples were not treated with the ESPs, but were incubated at 37°C for the 
maximum time point. 
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Rate zonal centrifugation 
6–8M guanidinium chloride gradients were formed in centrifuge tubes using an MSE 
gradient maker connected to a Gilson Minipuls 2 peristaltic pump. Mucin samples (in 4M 
guanidinium chloride) were loaded onto the gradient and centrifuged in a Beckman 
Optima™ L-90K Ultracentrifuge using a Beckman SW40 rotor at 40,000RPM for 2.45 
hours at 15°C. Fractions were taken from the top of the tubes, analysed by slot blotting and 
PAS-staining (Thornton et al, 1990). The refractive index of each fraction was measured 
using a refractometer to determine the guanidinium chloride concentration; the gradients 
were comparable (data not shown). 
 
Quantification of histological staining  
Sulphomucin containing crypts within the caecum (identified as black goblet cells) were 
quantified and compared to the total number of crypts. The numbers of goblet cells 
expressed per crypt were counted in 20-50 longitudinally sectioned crypt units. The area 
stained (pixel/mm
2
) per 20-50 crypts and the goblet cell staining intensity (arbitrary units) 
were determined by using the ImageJ software version 1.39a.  
 
Statistical analysis 
All results are expressed as the mean  SEM. Statistical analysis was performed using 
SPSS version 16.0. Statistical significance of different groups was assessed by using 
parametric tests (ONE-way Analysis of variance with post-test following statistical 
standards or paired Student t test). P<0.05 was considered statistically significant.  
 
RESULTS 
Reduced sulphation of Muc2 during chronic T. muris infection  
 The degree of sulphation and sialylation were explored during T. muris infection 
using HID-AB staining in resistant (high dose (HD) infection in BALB/c mice) and 
susceptible (HD and low dose (LD) infection in AKR and BALB/c mice, respectively). 
Using HID-AB staining a distinction can be made between sulphomucins (in black) and 
sialomucins (in blue), present in the goblet cell thecae (Spicer, 1965). Normally in the 
caecum, the niche of the parasite, the mucins are majorly sulphated (Figure 5.1A – naïve 
levels). In the resistant mice, as infection progressed, there was an increase in goblet cell 
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numbers in the caecal crypts (Hasnain et al, 2010b), and these goblet cell predominantly 
contained sulphated mucins.  
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 However, in the susceptible models, there was a decrease in goblet cell numbers, 
accompanied by a loss of sulphated goblet cell thecae and an increase in sialomucins 
within the goblet cells. This switch in glycosylation was localised to the caecum; no major 
changes were observed in the colon (Supplementary Figure 5.1). Interestingly, the 
change from goblet cells predominantly containing sulphomucin to containing sialomucin 
was graded in the susceptible mice from the distal end to the proximal end of the caecum 
(Figure 5.1B). On day 21 pi., 20% of the total caecal crypts contained sialomucins which 
were all situated at the distal end of the caecum. However, by day 35pi., 75% of the crypts, 
throughout the caecum, contained sialomucins (Figure 5.1C).  
 
Up-regulation of sulphotransferases in resistance  
 Mucin glycosylation is dependent on glycosyltransferases expressed within the 
goblet cells. Therefore, considering the differences identified, the changes in the 
expression of major sulpho- and sialo- transferases expressed within the caecum were 
determined using RT-PCR (Figure 5.2). Interestingly, mirroring the increase in sulphated 
mucins present in goblet cells, the galactose-O-sulphotransferases Gal3St1, Gal3St2 and 
Gal3St3 (Figure 5.2A) and glucosamine-O-sulphotransferases GlcNAc6ST1, GlcNAc6ST2 
and GlcNAc6ST4 (Figure 5.2B) were up-regulated on day 21 pi. in the resistant mice but 
not in the susceptible mice. Furthermore, an up-regulation of sialyltransferases ST3Gal1, 
ST3Gal2 and ST8GalNAc (Figure 5.2C) was observed, on day 21 and 35 pi., only in the 
susceptible mice.    
 
Inducing resistance in susceptible mice reversed glycosylation from sialylated to 
sulphated 
 We wanted to determine whether the changes in glycosylation were as a direct 
result of infection itself and whether these changes were permanent. Therefore, to address 
these questions, BALB/c mice were infected with a low dose of T. muris eggs (Bancroft et 
al, 2001); this resulted in a chronic infection, as approximately 10-12 adult worms were 
present in the caeca of these mice on day 35 pi. (Figure 5.3A & B). As expected, no 
changes in the goblet cell numbers were observed in these mice (Figure 5.3C) and, by day 
35 pi. goblet cells contained predominantly sialomucins (Figure 5.3D). Subsequently, at 
chronicity (day 35 pi.), these mice were re-challenged with a high dose (~150) of T. muris 
eggs (Figure 5.3A).  
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 The infection established in these mice, as approximately 100 worms were present 
on after 12 days (day 47) of re-infection (Figure 5.3B). However, by day 21 (day 56) pi., 
infection was cleared (Figure 5.3B) and no worms were present in the caecum by day 35 
(day 70) pi. Re-challenge with a high dose infection in the chronically infected mice also 
resulted in inducing goblet cell hyperplasia and elevated expression of IL-13 and IL-4 were 
observed (Supplementary Figure 5.2). Histological analysis with HID-AB staining 
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revealed that the change from goblet cells containing predominantly sulphomucins to 
sialomucins observed in chronic infection, could be reverted in the HD infection (Figure 
5.3D) and the mucins were again predominantly sulphated. Furthermore, the change in 
sulphated mucins correlated with T. muris worm expulsion (Figure 5.3B).   
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Sulphation of mucins occurs under the control of IL-13   
 It is well-established that the mice resistant to T. muris mount a strong TH2-type 
immune response and those susceptible to chronic infections exhibit a TH1-type immune 
(Supplementary Figure 5.2) (Cliffe and Grencis, 2004); high levels of sulphomucins were 
observed in the TH2-type environment, during resistance. Therefore, to assess the role of 
the TH2-type immune response and in particular, IL-4 and IL-13, in mucin sulphation, IL-
4-deficient and IL-4R-deficient mice on the BALB/c background (resistant to high dose 
infection) were infected with a high dose of T. muris eggs (Figure 5.4). The IL-4-deficient 
mice are able to expel worms, however worm expulsion is slightly delayed in these as 
reported previously (Bancroft et al, 2000). On day 18 pi., goblet cell hyperplasia was less 
pronounced in the IL-4-deficient mice when compared to the wild-type mice, although this 
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was not significantly different. However, by day 35 pi. a significant increase in the number 
of goblet cells was observed in the IL-4-deficient mice. Furthermore, HID-AB staining 
showed that goblet cells, in the IL-4-deficient mice, predominantly contained sulphated 
mucins.   
 As IL-4 and IL-13 act through the IL-4R, the IL-4R-deficient mice are unable to 
mount a TH2-type immune response and are susceptible to chronic infection (Bancroft et 
al, 2000). Strikingly, in contrast to the naïve IL-4-deficient mice, the naïve IL-4R-deficient 
mice had significantly lower levels of mucin sulphation (Figure 5.4B & C). As infection 
progressed, a decrease in the number of goblet cells was also observed in the IL-4R-
deficient mice compared to naïve and IL-4-deficient mice. Moreover, the goblet cells lost 
their „goblet like morphology‟, exhibiting very small thecae (Figure 5.4D) which stained 
blue with HID-AB staining, indicative of predominantly containing sialylated mucins 
(Figure 5.4B).  
 
Sulphomucins are less prone to degradation by T. muris products 
 The excretory secretory products (ESPs) released by T. muris, thought to be a 
mixture of enzymes (Drake et al, 1994a; Drake et al, 1994b), have the potential to alter the 
intestinal mucus barrier. To test this mucus from wild-type mice and NaS1-deficient mice 
was treated with 50μg/ml of T. muris ESPs for 2 or 6 hours at 37°C. The intestinal mucins 
from these mice have depleted sulphation, due to the lack of a sulphate transporter (Figure 
5.5A; Dawson et al, 2009). Mucus extracted from the uninfected wild-type and NaS1-
deficient mice was subjected to agarose gel electrophoresis and western blotted before 
staining with PAS to confirm that comparable amounts of mucins were isolated (Figure 
5.5B).  
 Staining with HID clearly showed that lower levels of sulphomucins were present 
in the NaS1-deficient mice compared to wild-type mice (Figure 5.5A, B & C). Treated or 
untreated mucus was subjected to rate zonal centrifugation to assess the change in size 
distribution of the mucins. The sedimentation profiles of mucins from untreated wild-type 
(high sulphomucin content) and NaS1-deficient (lower sulphomucin content) mucus were 
comparable showing a broad polydispersed distribution of mucins (fractions 9-20) (Figure 
5.5C & D). After treatment with ESPs from T. muris, the sedimentation profile of mucins 
from NaS1-deficient mice was altered. The PAS-positive material from the NaS1-deficient 
mice shifted towards the top of the gradient, fractions 4-17 (Figure 5.5D), compared to 
PAS-positive material from the wild-type mice which did not change in sedimentation 
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even after 6 hours of treatment (Figure 5.5C). This suggested that mucins with lower 
sulphation are more susceptible to the degradative effects exerted by the T. muris ESPs.  
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Lower mucin sulphation does not affect worm establishment or expulsion 
 High sulphomucin content that accompanies nematode rejection was partly 
controlled by IL-13 and therefore the sulphation of mucins in the caecum could affect 
T.muris infection in particular worm establishment and rejection. To address this 
possibility, NaS1-deficient and their wild-type littermates (C57BL/6-background) were 
infected with a high dose of T. muris eggs. As stated previously, the mucin sulphation in 
the caecum of the naïve NaS1-deficient mice was lower as compared to the wild-type mice 
(Dawson et al, 2009). This, however, did not have an effect on the establishment of 
infection (Figure 5.6); similar number of worms were present, on day 12 pi., in the NaS1-
deficient and wild-type mice. Moreover, as infection progressed, worm expulsion kinetics 
were similar in the both wild-type and the NaS1-deficient mice (Figure 5.6).  
 
 
 
 
 
 
 
 
 
 
 
 
Recovery of sulphomucins in NaS1-deficient mice after T. muris infection  
 As demonstrated, the NaS1-deficient mice expel T. muris over a similar time course 
as to wild-type mice; RT-PCR was used to determine whether these mice mount a 
concurrent TH2-type immune response to T. muris infection. The levels of IL-4 and IL-13 
were elevated in the caecum after infection in the NaS1-deficient and wild-type mice 
compared to naïve mice (Supplementary Figure 5.3). Interestingly, up-regulation of IL-4 
and IL-13 was significantly lower in the NaS1-deficient mice compared to the wild-type 
mice on day 18 pi. but the levels were similar on day 25 pi. (Supplementary Figure 5.3A 
& B). A 2 to 6-fold increase in IFN-γ levels was also observed across the time course of 
infection (Supplementary Figure 5.3C) in both NaS1-deficient and wild-type mice 
although this did not significantly affect worm expulsion. The effect of the elevated IL-
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4/IL-13 levels was reflected in the histological analysis, as goblet cell hyperplasia was 
observed in the NaS1-deficient mice similarly to the wild-type mice (Supplementary 
Figure 5.4). HID-AB staining intensity showed that mucin sulphation in the caecum of the 
NaS1-deficient naïve mice was significantly depleted as compared to their wild-type 
littermates (Figure 5.7B). However, as the infection advanced, the levels of mucin 
sulphation recovered in the NaS1-deficient mice, and by day 25 of infection no difference 
was observed in the sulphation of the goblet cells in the caecal crypts (Figure 5.7).  
 
 
Up-regulation of Sat1 in the absence of NaS1 after T. muris infection 
 As the T. muris infection progresses in the NaS1-deficient mice, the depletion in 
the sulphomucin content within the goblet cells recovered, suggesting that free sulphates 
were absorbed through another transporter within the caecum. In addition to NaS1, 
sulphate anion transporter 1 (Sat1)  has been shown to be expressed within the caecum 
(Dawson et al, 2010) and may regulate the sulphomucin content within the goblet cells. 
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Therefore, we used RT-PCR (Figure 5.8A) and immunohistochemistry (Figure 5.8B), to 
determine the expression of Sat1 in response to T. muris infection. Sat1 expressed was 
significantly elevated in the NaS1-deficient mice on day 18 pi., however, the up-regulation 
in the wild-type mice was observed on day 25 pi.   
 
 
DISCUSSION 
 Mucins, the major macromolecular component of the mucus barrier, are heavily 
glycosylated proteins; glycosylation of mucins is site specific and is thought to be involved 
in diverse biological processes. Alterations in mucin glycosylation have been reported to 
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coincide with inflammation in several gastrointestinal diseases such as ulcerative colitis 
(Corfield et al, 1992; Theodoropoulos et al, 2001) and during several models of nematode 
infection; N. brasiliensis, T. spiralis and H. polygyrus (Holmen et al, 2002; Karlsson et al, 
2000; Yamauchi et al, 2006). Whether these changes occur as a result of an on-going 
inflammatory response or as a result of an active change in order to resolve infection is not 
yet known. Nonetheless, it is thought that these glycans that decorate the mucin protein 
backbone, contribute to the protective properties of the mucus gel (Thornton et al, 2008). 
Recently we have demonstrated a protective role of mucins, in nematode expulsion (Hasnain et 
al, 2010b); furthermore, we have shown that mucins glycosylation is altered and mucins are 
more highly charged during resistance (Hasnain et al, 2010a).  
 In this study, we described the changes in glycosylation, in particular sulphation 
and sialylation, in mouse models that are resistant or susceptible to chronic T. muris 
infection. The strong TH2 environment, typically seen in resistance, sulphation on the 
mucins was maintained throughout the course of infection. In contrast, majorly sialylated 
mucins were found within the goblet cells during chronic T. muris infection. To our 
knowledge the effect of T. muris ESPs on mucus has not been previously studied; we 
demonstrated for the first time that T. muris ESPs can degrade mucins and, furthermore 
that mucins with high sulphation were less prone to degradation. Despite this, depleted 
mucin sulphation in NaS1-deficient mice did not affect worm establishment. Interestingly 
though, we found that T. muris infection is a strong inducer of mucin sulphation even in 
the absence of the major apical sulphate transporter, NaS1, in the caecum.  
 In total, the data presented here suggests that distinct mechanisms regulate 
glycosyltransferases responsible for mucin sialylation and sulphation, corroborating 
previously published work (Soga et al, 2008). Histological analysis revealed that the 
changes in glycosylation with chronic T. muris infection were gradual and localised within 
the caecum. Interestingly, similar to goblet cell hyperplasia which is restricted to the 
caecum (Hasnain et al, 2010b), no major changes in sulphation/sialylation of mucins were 
observed in the colon post T. muris infection.  This suggested that these changes are a 
result of a local response to or by the nematode itself. Mirroring the histological changes 
observed, an increase in the gene expression of sulphotransferases was observed in 
resistance, and sialotransferases were up-regulated in susceptibility. The loss of sulphation 
was apparent in naïve IL-4R-deficient mice when compared to the IL-4-deficient mice, 
suggesting that maintained sulphation is in part due to IL-13. Along with the down-
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regulation of goblet cell differentiation transcription factors, during chronic infection, 
mucin glycosylation is also perturbed: there is evidence of a general loss of glycosylation 
on mucins in chronic infection (Hasnain et al, 2010a). Thus, these alterations in 
glycosylation could affect the hydration of the mucus gel and consequently affect the 
viscosity of the barrier. Moreover, the particular changes in glycosylation can also lead to 
changing the ability of the mucus barrier to sequester host defence factors. 
 Several studies have shown that parasitic exo-products to have the ability to 
degrade mucins (Lidell et al, 2006). The ESPs of the T. muris nematode have been shown 
to be highly immunogenic (Drake et al, 1994a). Although, the adult T. muris nematode is 
closely associated with the mucus barrier, whether ESPs affect the mucus layer has never 
been investigated before. Therefore, comparable amounts of mucus extracted from naïve 
NaS1-deficient (less sulphated mucins) and wild-type mice (more sulphated mucins) were 
treated with T. muris ESPs. Interestingly, the less sulphated mucins (from NaS1-deficient 
mice) were altered in size within 2 hours and thus highly susceptible to degradation. 
Therefore, this implies that ESPs may be released as part of the nematodes regime to 
promote its own survival (addressed in detail in Chapter 6). The degradation of mucins 
would therefore aid invasion by diminishing the gel-like consistency of the mucus barrier; 
as shown previously the mucus barrier is less porous during susceptibility (Hasnain et al, 
2010b). Furthermore, the data suggests that sulphation plays an important role in 
preventing degradation, and that highly sulphated mucins protect the mucin protein core 
from the degradative effects of the nematodes ESPs. How this is achieved requires further 
investigation, however, a recent study on von Willebrand factor (vWF), a large multimeric 
glycoprotein homologous to gel-forming mucins, revealed that sialylated glycans increase 
susceptibility to proteolysis (McGrath et al, 2010).   
 Increased sulphation on intestinal mucins was also shown to affect the 
establishment of the helminth Strongyloides venezuelensis (Ishikawa et al, 1995). We, 
therefore, hypothesised that specific sulphation/sialylation patterns seen during T. muris 
infection, could potentially influence the establishment and/or expulsion of the parasite. 
The absence of NaS1 results in disturbed sulphate homeostasis leading to depleted 
intestinal mucin sulphation (Dawson et al, 2009). Furthermore, the decrease in mucin 
sulphation has been shown to increase the susceptibility of these mice to colitis and 
systemic bacterial infections (Dawson et al, 2009). Using the NaS1-deficient mouse model, 
we attempted to address the role of sulphated mucins in T. muris infection. In contrast to 
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previous observations with S. venezuelensis infection (Ishikawa et al, 1995), the depleted 
levels of sulphation had no major effect in the establishment of T. muris infection. It is 
possible that although apparent, the depletion in sulphation was not sufficient to have an 
effect on worm establishment. Interestingly, the levels of TH2-type cytokines were lower in 
the NaS1-deficient mice on day 18 pi. This was reflected in the epithelial cell response, as 
fewer goblet cells were present in the caecum of these mice. However, these slight 
differences did not have a significant effect on the rejection of the T. muris nematode. 
Importantly, in addition to the increase in goblet cell numbers, an increase in mucin 
biosynthesis is also observed during worm expulsion (Hasnain et al, 2010a; Hasnain et al, 
2010b). Therefore, it was surprising to observe that the differences in mucin sulphation did 
not become more prominent as infection progressed but converged with the TH2-goblet cell 
expansion and, by day 18 pi., most of the goblet cell thecae in the NaS1-deficient mice had 
similar levels of mucin sulphation as compared to the wild-type mice. In the absence of 
NaS1 (Dawson et al, 2003; Dawson et al, 2009), an up-regulation of the expression of Sat1 
was observed (Dawson et al, 2010). Interestingly, Sat1 is elevated with the increasing 
demand for sulphates during the rejection of T. muris, earlier in the NaS1-deficient mice 
compared to the wild-type mice. Sat1 levels return almost to baseline in the NaS1-deficient 
mice by day 25 pi., which is when the goblet cell hyperplasia seemed to subside. This 
indicates that Sat1 stimulates sulphate transport at a time when sulphate requirement has 
increased.  
 In summary, maintained mucin sulphation, influenced by the TH2-type immune 
response, is clearly a feature of resistance to T. muris infection. This may be at least in part 
a response against T. muris as alterations in glycosylation can change the properties of the 
mucus barrier: highly sulphated mucins (as seen in resistance) are more resistant to 
degradation. With the high demand of cellular sulphate during T. muris infection, Sat1 was 
up-regulated in the hyposulphataemic NaS1-deficient mice and the wild-type mice. We are 
currently investigating the role of Sat1 in T. muris infection, using the Sat1-deficient mice 
(Dawson et al, 2010). Nevertheless, this study highlights the complex process by which 
alterations in sulphation occur following T. muris infection and indicate that increased 
sulphomucin levels are a physiological response against this enteric parasite.  
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ABSTRACT 
The Trichuris nematodes secrete immunogenic excretory secretory products (ESPs), which 
contain proteases. These nematodes survive in the host by tunnelling through the caecal 
epithelium, while their posterior end remains free in the lumen within the mucus layer. We 
investigated the effect of ESPs on the mucin components of the intestinal mucus barrier, in 
particular Muc2 by assessing their effect on the sedimentation behaviour of the mucins on 
6-8M guanidinium chloride gradients. The ESPs isolated from adult T. muris nematode 
markedly decreased the sedimentation rate of mucins isolated from naïve mice indicating 
that they were degraded. Using different doses of infection, susceptibility (low dose) and 
resistance (high dose) to T. muris infection was modelled. During worm expulsion, the 
mucins isolated from resistant mice were less prone to the degradative effects exerted by 
the ESPs. Surprisingly, the main intestinal Muc2 mucin was degraded by the ESPs; 
however ESPs were unable to alter the sedimentation behaviour of the Muc5ac mucin 
which is induced in the intestine during worm expulsion. To further investigate the effects 
of the degradative of ESPs we employed MUC2 produced by the human cell line, LS147T.  
ESPs were shown to have the ability to depolymerise the network formed by the intestinal 
mucin, MUC2. Interestingly, ESPs contained serine proteases that degraded MUC2 and 
potentially affect the uncharacterised „non-reducible‟ MUC2 linkage. We demonstrate for 
the first time that during chronic infection, ESPs released by the T. muris nematode consist 
of serine proteases that have the ability to degrade the mucus gel, which may be part of its 
regime to aid colonisation within the host.   
 
 
 
 
 
 
 
 
 
 
ABBREVIATIONS  
PAS, Periodic-Acid Schiff‟s; pi., Post infection; TH, T Helper; T. muris, Trichuris muris; 
LD, Low dose infection; HD, High dose infection; ESP, Excretory secretory products.  
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INTRODUCTION  
 Trichuriasis is a chronic infection caused by the nematode Trichuris, which is a 
ubiquitous gastrointestinal nematode of vertebrates that affects up to a billion people 
worldwide (Bethony et al, 2006; Cliffe and Grencis, 2004). The adult Trichuris worm 
shares a very intimate relationship with the mucus barrier that blankets the intestinal 
epithelial surface (Artis and Grencis, 2008). Their anterior ends penetrate the intestinal 
crypts by forming syncytical tunnels within the epithelial cells; while their posterior ends 
extend into the intestinal lumen (Else, 2005). The extracellular mucus barrier is an 
essential part of the innate immune system. It provides physical protection and, by 
sequestering host defence factors within its complex matrix provides a „chemical‟ barrier 
to protect the underlying epithelium (Thornton et al, 2008). Goblet cells present in the 
epithelial cell layer are specialised secretory cells responsible for the production of the 
major structural components (gel-forming mucins) that form the mucus barrier (Thornton 
and Sheehan, 2004).  
 Excretory secretory products (ESPs) released from the Trichuris nematode in 
different species are thought to be very well-conserved and similar in terms of their 
antigenicity (Roach et al, 1988). Drake and co-workers have shown that the major protein 
secreted by the Trichuris nematode has the ability to induce ion-conducting pores in a lipid 
bilayer, which in turn may aid nematode invasion (Drake et al, 1994a). Other studies have 
attributed the tunnel formation through the intestinal epithelium, to protease activity (zinc 
metalloproteases, thiol protease and phenol oxidase) detected in the ESPs (Hill et al, 1993; 
Hill and Sakanari, 1997). Although several studies have shown that ESPs released through 
the course of infection are highly immunogenic, their function in vivo remains largely 
unknown. 
 Recently, we have demonstrated that gel-forming mucins are an important 
component of the response involved in the rejection of the Trichuris muris (T. muris) 
nematode (Hasnain et al, 2010a; Hasnain et al, 2010b). In this study, we investigated the 
effect of the ESPs on the mucus gel and demonstrated that ESPs have the ability to alter 
the mucus gel, by affecting the polymerisation of the mucin network. Our findings also 
show that serine proteases within the ESPs degrade Muc2 (the major mucin in the 
intestine) but not Muc5ac (mucin expressed during worm expulsion). These data suggest 
that one of the functions of the nematode secreted ESPs is to alter the gel-like consistency 
of the mucus gel and therefore aid establishment.   
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MATERIALS AND METHODS 
Animals 
BALB/c (Harlan Olac) mice were maintained in the Biological Services Unit at The 
University of Manchester. The protocols employed were in accordance with guidelines by 
the Home Office Scientific Procedures Act (1986). All mice (6-12wk old) were kept in 
sterilized, filter-topped cages, and fed autoclaved food.  
 
Parasitological technique 
The techniques used for T. muris maintenance and infection were described previously 
(Wakelin, 1967). Mice were orally infected
 
with approximately 150 eggs for a high dose 
infection and <15 eggs for a low dose infection. Worm burdens were assessed by counting 
the number of worms present in the caecum. Worms present in the caecum on day 12 
confirmed that infection had established in both groups of mice (high dose and low dose 
infection). Adult worms present in the caecum of the low dose infected group of mice, on 
day 35 post infection, confirmed chronic infection (Supplementary Figure 6.1).  
 
Antibodies 
Immunodetection was carried out using a polyclonal antibody raised against a murine 
Muc2 (mMuc2) (Hasnain et al, 2010b; Heazlewood et al, 2008) or human MU2 (hMUC2) 
(Herrmann et al, 1999). Commercially available 45M1 antibody was used for the detection 
of mouse Muc5ac (Lidell et al, 2008).  
 
Mucus extraction and treatment with T. muris excretory secretory products 
The caecum was gently flushed with PBS to remove the faecal matter, subsequently 
scraped into equal volumes of PBS and kept at -80°C until required. The T. muris ESPs 
were isolated using the method previously described (Else and Wakelin, 1989). Aliquots of 
crude mucus were incubated at 37°C with the ESPs at 50μg/ml for various time points 
(later specified). Control samples were not treated with the ESPs, but were incubated at 
37°C for the maximum time point. ESPs were heat inactivated at 100°C before incubation 
or incubated at 4°C with mucus as negative controls. ESP activity was quenched using the 
protease inhibitors: ethylenediaminetetraacetic acid (EDTA), N-ethylmaleimidide (NEM), 
Lupeptin, Chymostatin and Antipain at 50-150μg/ml concentrations.  
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Agarose gel electrophoresis 
Extracted mucus samples were solubilised in 6M Urea and subsequently reduced using 
50mM dithiothreitol (DTT) and carboxylmethylated using 0.125M iodoacetamide prior to 
electrophoresis on a 1% (w/v) agarose gel for 22 hours. Whole mucus samples were 
separated by agarose gel electrophoresis before reduction in SSC (0.6M NaCl, 60mM 
sodium citrate) containing 0.1M DTT for 30 minutes. The fractions were taken from the 
top of the tubes, analysed by slot blotting or agarose gel electrophoresis followed by 
western blotting on to a nitrocellulose membrane (Thornton et al, 1990). Mucins were 
detected by using PAS staining or mucin-specific antisera.  Staining intensity was 
measured using the GS-800 calibrated densitometer (Bio-Rad Laboratories, U.K). 
 
Rate zonal centrifugation 
6–8M guanidinium chloride (GuCl) gradients were formed in centrifuge tubes using an 
MSE gradient maker connected to a Gilson Minipuls 2 peristaltic pump. Mucin samples (in 
4M GuCl) were loaded onto the tops of the gradients and centrifuged in a Beckman 
Optima™ L-90K Ultracentrifuge (Beckman SW40 rotor) at 40,000RPM for 2.75 hours for 
whole mucus extracts and 3.50 hours for purified mucins (15°C). The refractive index of 
each fraction was measured using a refractometer; all gradients were comparable (data not 
shown). 
 
Purification of mucins 
Mucins were purified using the isopycnic density gradient centrifugation as described by 
Davies and Carlstedt, 2000. In brief, solubilised mucus was purified using caesium 
chloride (CsCl)/4M GuCl density gradient at a starting density of 1.4g/ml, centrifuged in a 
Beckman Optima
TM
 L-90K Ultracentrifuge (Beckman Ti70 rotor) at 40,000RPM for 65 
hours at 15°C. Periodic Acid Schiff‟s (PAS) rich fractions were pooled, dialysed into 0.2M 
GuCl before being subjected to a second CsCl density gradient centrifugation (at a starting 
density of 1.5g/ml) (Davies and Carlstedt, 2000). 
 
Anion-Exchange Chromatography  
The PAS-rich fraction pooled after the second CsCl density gradient was subjected to 
anion exchange chromatography as describe previously (Linden et al, 2002; Thornton et al, 
1996), using a Resource
TM
 Q column. Samples were eluted with the starting buffer (20mM 
Tris-HCl at pH8) for 15 minutes (0.5ml/min), followed by a linear gradient (60 minutes) 
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up to 0.4M Lithium perchlorate-10mM piperazine at pH5 in 6M Urea containing 0.02% 3-
[(chloamidopropyl) dimethylammonio]-1-propanosulphonate (Linden et al, 2002; 
Thornton et al, 1996).  
 
RESULTS  
T. muris secretes products that can degrade the mucus gel 
 ESPs released from the T. muris nematode, thought to be a mixture of enzymes 
were isolated; SDS-PAGE analysis showed that ESPs contained several components 
(Supplementary Figure 6.2) and a major 43kDa protein (Drake et al, 1994a). The mucus 
collected from uninfected BALB/c mice was treated with 50μg/ml of ESPs for 24 hours. 
Treated and untreated (control) mucus was subjected to rate zonal centrifugation to assess 
whether the ESP treatment can alter the size distribution of mucins. Gradients were 
fractionated from the top, transferred to nitrocellulose membrane and stained with PAS and 
mMuc2 antibody (Figure 6.1).  
 The typical size distribution of „whole‟ intestinal mucins from mice is shown in 
Figure 6.1A. The PAS staining showed that the general carbohydrate response was 
comparable to the mMuc2 antibody reactivity; therefore, confirming that the major 
glycoprotein within the whole mucus sample was Muc2. PAS and mMuc2 antibody 
reacted with a component of the whole mucus which sedimented to the bottom of the 
gradient. This may be the „insoluble‟ component of the gel which was characterised 
previously by (Carlstedt et al, 1982). Due to cross-reactivity of mMuc2 with components 
in the ESPs, PAS was used to detect mucins (Muc2) after treatment with ESPs 
(Supplementary Figure 6.2). After 24 hours of treatment with the ESP products, the 
mucins were redistributed to the top of the gradient. The slower sedimentation rate of 
mucins after ESP treatment indicated that the mucus was altered and mucins had a 
decreased size. Importantly, the ESPs were unable to have this affect on the mucus gel if 
heat inactivated or incubated at 4◦C (Figure 6.1B), suggesting that enzyme activity was 
responsible for the degradation of mucins.     
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Mucins are less prone to degradation during resistance 
 Previous studies from our laboratory have shown that the composition of the mucus 
barrier is altered during infection with T. muris (Hasnain et al, 2010b): in resistance, the 
mucus barrier is formed of a less porous network containing a higher ratio of mucins which 
are differentially glycosylated (Hasnain et al, 2010a; Hasnain et al, 2010b). Therefore, we 
sought to determine whether these changes in the mucus barrier during worm rejection 
could hinder the ability of T. muris ESPs to degrade the mucins. To this end, mucus was 
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extracted from resistant (high dose infection in BALB/c mice) and susceptible (low dose 
infection in BALB/c mice) mice on day 14 pi., when infection has established in both 
models, and treated with ESPs (Supplementary Figure 6.3). Untreated and treated 
(50μg/ml of T. muris ESPs for 24 hours) mucins were subjected to rate zonal centrifugation 
prior to fractionation and analysis. The rate zonal profiles of mucins extracted on day 14 
pi. in the resistant and susceptible mice after treatment with T. muris ESPs 
(Supplementary Figure 6.3)  showed that mucins were altered as previously observed 
with mucin extracts from naïve mice (Figure 6.1A).  
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 It is well established that worms are expelled in mice resistant to chronic infection 
by day 21. Interestingly, a difference was observed in the ability of ESPs to alter the 
mucins extracted from resistant and susceptible mice. The sedimentation profile of the 
mucins from resistant mice (extracted on day 21 pi.) was not altered when treated with 
50μg/ml of T. muris ESPs (Figure 6.2A). Moreover, higher concentrations of ESP (up to 
300μg/ml) did not have an effect on the sedimentation profile of the mucins extracted from 
resistance mice on day 21 pi. (data not shown). Furthermore, mucins isolated from resistant 
mice extracted on day 56 pi., 35 days after the expulsion of the nematode were only 
partially degraded with ESP treatment (Supplementary Figure 6.4). It is important to note 
that some of the mucin content of the mucus samples extracted from the susceptible mice 
on day 21 appeared degraded before treatment (Figure 6.2).  In contrast, the main PAS-
peak, of mucus from the susceptible mice (on day 21 pi.) did alter when treated with ESPs 
(Figure 6.2B); suggesting mucins were prone to degradation during susceptibility.  
 
 
 A difference was observed in the ability of ESPs to alter resistant and susceptible 
mucins on day 21 after infection (Figure 6.2). To investigate the effect of ESPs on mucins 
in more detail, the mucus samples were reduced and carboxymethylated. Subsequently, the 
mucins from resistant and susceptible mice on day 21 pi., were purified from the mucus by 
two isopycnic density gradient centrifugation steps: firstly in CsCl/4M GuCl to separate 
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mucins from lower buoyant density proteins (Figure 6.3) (Davies and Carlstedt, 2000). 
Following the second step in CsCl/0.2M GuCl, used to separate mucins from nucleic acid 
(Figure 6.4).   
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 The buoyant density of the mucins purified from resistant and susceptible mouse 
intestinal mucus was similar, however as expected higher amounts of mucins were present 
in the mucus of resistant mice (on day 21) (Hasnain et al, 2010b) as compared to 
susceptible mice as seen by agarose gel electrophoresis and slot blotting (Figure 6.4).   
Subsequently, the mucin-rich fractions were further purified by using anion exchange 
chromatography (Figure 6.5). As previously reported, de novo expression of Muc5ac is 
observed during T. muris infection in the caecum of resistant mice (Hasnain et al, 2010b). 
Therefore, fractions were analysed by PAS, mMuc2 antibody and Muc5ac staining (45M1 
antibody); as expected the PAS-positive material coincided with Muc2 and Muc5ac 
staining (Figure 6.5A). The chromatogram shows that Muc2 was eluted before Muc5ac 
(Figure 6.5); therefore suggesting that within the mucus barrier, Muc5ac is more highly 
charged as compared to Muc2. No Muc5ac was detected in the mucus from susceptible 
mice (data not shown).  
 
T. muris ESPs are unable to degrade Muc5ac  
 The purified mucins from the resistant mice were separated into the Muc2 and 
Muc5ac-rich fractions and treated with 50μg/ml of ESPs for 24 hours. After treatment, 
samples were analysed by rate zonal centrifugation; the gradients were centrifuged for a 
longer period of time as the samples were previously reduced and carboxymethylated. 
Fractions analysed by slot blotting and PAS staining revealed that ESPs degrade Muc2, 
considering a significant amount of Muc2 was present in the fractions at the top of the 
gradient after treatment (Figure 6.6A). This suggests that ESPs can affect the protein core, 
glycosylation of Muc2 and/or polymerisation of mucins. Unexpectedly, the sedimentation 
profile of the Muc5ac-rich fraction was largely unaltered after treatment with ESPs 
(Figure 6.6B). This implied that ESPs specifically act on the intestinal mucin, Muc2 and 
not on the Muc5ac mucin which is only induced in the resistant mice with exposure to 
T.muris infection.  
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ESPs depolymerise the intestinal mucin, Muc2 
 As previously stated, Muc2 isolated from mice was not suitable for analysis after 
ESP treatment with the mMuc2 antibody (Supplementary Figure 6.2). To further explore 
the affect of ESPs on the MUC2 glycoprotein and in particular its polymerisation, LS174T 
cell line was utilised as a source of MUC2 (Figure 6.7). LS174T cells are a goblet-cell 
differentiated human colonic adenocarcinoma cell line that produces MUC2. Whole 
MUC2 isolated from LS174T cells was treated with 50μg/ml of ESPs for 6, 24 or 72 hours, 
subjected to agarose gel electrophoresis (Figure 6.7), transferred onto a nitrocellulose 
membrane and probed with the hMUC2 antibody. The unreduced MUC2 can be seen as at 
least three bands in the control samples which likely represent different multimeric forms 
of MUC2. 
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 Importantly, after ESP treatment the intensity of these bands was markedly 
decreased (Figure 6.7A-D). Whereas the intensity of a slightly faster migrating band was 
increased, with increasing periods of treatment with ESPs, the staining intensity of this 
band was also decreased (Figure 6.7E). Untreated and treated samples from LS174T cells 
were subjected to rate zonal centrifugation, fractionated, transferred to a nitrocellulose 
membrane and probed with the hMUC2 antibody. The rate zonal profiles showed a shift in 
MUC2 content to the top of the gradients gradually with increasing time of treatment 
(Supplementary Figure 6.5). The alteration of MUC2 was apparent just after 6 hours of 
treatment (Supplementary Figure 6.5B). However, the difference was further 
pronounced, after 72 hours of treatment most of the MUC2-positive material was present 
in the top 6 fractions (Supplementary Figure 6.5D). It was noted that along with the shift 
in the MUC2-positive material, the intensity of hMUC2 antibody was lower after treatment 
with ESPs (Figure 6.7E). Moreover, detection of the putative „insoluble‟ mucin content, 
present at the bottom of the tube in the control samples gradually decreased after ESP 
treatment; no „insoluble‟ fraction was observed after the 72 hour treatment.   
 
Trichuris ESPs have serine protease activity that degrades the mucin network 
 ESPs secreted by the T. muris nematode are thought to consist of several different 
proteases such as cysteine, serine and metalloproteases (Drake et al, 1994b). To determine 
whether the ability of ESPs to degrade and alter the polymerisation of MUC2 was due to a 
specific type of protease, ESPs were incubated with protease inhibitors (Supplementary 
Table 1), prior to treatment of mucus extracted from LS174T cells. Note that the control 
samples contained a mixture of all the stated protease inhibitors. With N-ethylmaleimidide 
(NEM), ethylenediaminetetraacetic acid (EDTA) and Aprotinin treatment higher order 
MUC2 polymers were not observed (Figure 6.8). However, it was also noted that after 
incubation with NEM, the lowest band of MUC2 was still intact and a small reactivity of 
the MUC2 with an upper band was also observed, whereas, treatment with aproprotinin 
and EDTA, did not prevent the overall loss of MUC2. Interestingly, after treatment with 
chymostatin and antipain, the ESPs were unable to depolymerise MUC2: the higher order 
multimeric forms of MUC2 were still present after treatment (Figure 6.8A). Overall the 
shift in the MUC2 multimeric forms observed after ESP treatment could not be prevented 
by protease inhibitor treatment. This data implies that proteases secreted by the nematode, 
degrade Muc2/MUC2 during chronic infection.  
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DISCUSSION 
 The Trichuris nematodes are extremely successful within the host, because they not 
only have the ability to evade an immune attack but are thought to actively subvert the 
immune responses generated by the host by exerting its immunomodulatory effects (Cliffe 
and Grencis, 2004). These nematodes have been shown to secrete ESPs, which contain 
proteases and proteins that have immunogenic properties (Drake et al, 1994a; Else et al, 
1990; Hill and Sakanari, 1997). The nematodes moult into adults by day 35 pi., after which 
the infection becomes chronic in the susceptible mouse strains (Cliffe and Grencis, 2004). 
However, in the resistant models of T. muris the worm is rejected before it moults into an 
adult (Day 14-21 pi.). The properties of the mucus barrier have been shown to change to 
facilitate worm expulsion (Hasnain et al, 2010a; Hasnain et al, 2010b) and it is thought 
that during chronicity the immunogenic ESPs may be secreted as part of a co-ordinated 
response to divert the immune response (Cliffe and Grencis, 2004; Grencis and Entwistle, 
1997). However, ESPs may also be released by the nematode to alter the properties of the 
mucus barrier and thus facilitate its own survival and/or improve the conditions within its 
niche. To investigate the effect of ESPs on the mucins, the main components responsible 
for the physical properties of the mucus barrier, we treated intestinal mucus with secretions 
collected from adult T. muris nematodes. Biochemical analysis of the extracted mucins 
showed that the ESPs affect the polymerisation of the mucin network.  
 Mucin polymerisation, which is mediated disulphide bond formation involving the 
cysteine-rich domains at the N and C-termini of the mucin polypeptide, is essential for the 
protective function of the mucus barrier (Thornton et al, 2008). However, there is an added 
level of unique complexity in the assembly of the intestinal MUC2: the uncharacterised 
„non-reducible linkage‟ which results in an „insoluble‟ gel enabling MUC2 to form a 
barrier resistant to the harsh environment of the intestine (Carlstedt et al, 1995). In 
addition, other associated proteins such as Fc Ig binding protein (Fcgbp) was shown to be 
covalently attach to Muc2/MUC2 and could potentially act as a cross-linker (Johansson et 
al, 2009). Interestingly, for the first time we have demonstrated ESPs degrade the 
Muc2/MUC2 polymers into smaller subunits and potentially alter the „non-reducible‟ 
linkage of Muc2/MUC2. The „insoluble‟ mucin content within the mucus sample and the 
Muc2MUC2 was also degraded, when treated with ESPs, supporting the evidence that 
ESPs may be capable of altering the „non-reducible‟ linkage of Muc2/MUC2.  
 During T. muris infection the properties of the mucus barrier change in the resistant 
mice to facilitate worm expulsion (Hasnain et al, 2010a; Hasnain et al, 2010b). 
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Interestingly, the ESPs were unable to degrade the mucins in “whole” mucus collected 
from resistant mice on day 21 after infection. Along with an increase in the amount of 
mucins present in the mucus barrier, during the rejection of the nematode (day 21 pi.), the 
physical properties of the barrier change (Hasnain et al, 2010b). Therefore, the changes to 
the properties and composition of the mucus barrier can hinder ESP activity and in turn 
may affect the vitality of the nematode (Hasnain et al, 2010b). In contrast, in the 
susceptible mice the diminished mucus barrier is formed of mucins that are readily 
degradaded by the nematodes ESPs that results in more porous mucin network than in the 
resistant mice. It is possible, therefore, that the ESPs secreted by the nematode contribute 
the colonisation of the nematode and during chronicity aid movement through the 
epithelial cell layer.  
 Recently, it was demonstrated using von Willebrand factor (vWF), which is a large 
multimeric glycoprotein homologous to gel-forming mucins, that sialylated glycans render 
the protein core more susceptible to proteolysis (McGrath et al, 2010). This supports our 
hypothesis of mucins in susceptibility being more prone to degradation because mucins 
had reduced apparent glycosylation during chronic infection (Hasnain et al, 2010a). 
Therefore, the differences in glycosylation of the mucins in resistance and susceptibility 
could facilitate the “degradative” activity of ESPs. Another possibility for the lack of 
degradation of mucus isolated from resistant mice could be due to the increased 
concentration of mucins and other proteins within the mucus barrier (Hasnain et al, 
2010b). The increased levels of proteins could result in more competition for ESPs to 
cleave sites and therefore make the mucins less susceptible to degradation (Innes et al, 
2009). Data suggests that the mucus barrier and its mucin components remains altered in 
resistance, even after the expulsion of the nematode. We showed that even 21 days after 
the worms have been expelled from the resistant mice the mucins were only partially 
altered by ESPs. This raises an interesting possibility of the mucus barrier remaining 
altered which could, therefore, potentially limit re-infection as reported previously 
(Bancroft et al, 2001). Surprisingly, the ESPs have the ability to degrade mouse and human 
Muc2/MUC2, but not the stomach/airway mucin Muc5ac, suggesting that ESPs are 
relatively specific. This may be because the Trichuris nematodes have evolved in the 
intestine, where Muc2 is the major mucin expressed. Therefore, Muc5ac up-regulated in 
the intestine during worm expulsion could result in the inability of the worm to degrade 
mucins and subsequently be detrimental for the nematode.    
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 Data described in this study revealed that polymeric mucins could be degraded into 
smaller polymers by the ESPs released by the T. muris nematode. This is not the first time 
parasite exoproducts have been shown to degrade mucins, previous studies have shown 
that protozoan parasites such as Entamoeba histolytica (Lidell et al, 2006), Trichomonas 
vaginalis (Lehker and Sweeney, 1999) and Naegleria fowleri (Cervantes-Sandoval et al, 
2008) all release cysteine proteases which have the ability to degrade mucins. However, 
unlike these other studies it is unlikely that a cysteine protease is solely responsible for 
degrading the mucins in the present study. NEM and aprotinin (cysteine protease 
inhibitors) only very partially limited the activity of ESPs to degrade MUC2. Treatment 
with chymostatin and antipain inhibited the depolymerisation of MUC2 implicating trypsin 
and/or serine protease activity. However, since degradation was not inhibited by aprotinin 
(cysteine and trypsin protease inhibitor) it is most likely that serine protease activity is 
responsible for degrading Muc2/MUC2. Interestingly, serine proteases have been reported 
to be isolated with T. muris ESPs previously (Drake et al, 1994b). Data implies that 
cysteine proteases present in the ESPs were in part responsible for the affects observed on 
the insoluble MUC2-gel. Serine and cysteine proteases, therefore, may act in concert to 
disrupt the polymeric mucin network (Corfield and Myerscough, 2000). Adding to the 
complexity, the ESPs had a further affect on the MUC2 protein core as there was a change 
in the electrophorectic migration and gradual loss of MUC2 with treatment. This suggests 
that the ESPs not only depolymerise MUC2, they may also affect the glycosylation, the 
MUC2 protein core or possibly the associated proteins such as the cross-linking Fcgbp 
protein. Therefore, ESPs may be released as part of the nematodes regime, to break down 
the mucin network by depolymerising, deglycosylating and affecting the MUC2 core itself.   
 Overall, the stability and turnover of the ESPs is not known in vivo, however data 
suggests that the proteases present in ESPs may be released within the nematodes 
proximity to open-up the mucus layer to aid its movement through the mucus layer. The 
release of ESPs could result in the altering the viscoelastic properties of the mucus barrier 
(Thornton et al, 2008; Thornton and Sheehan, 2004), which could explain the porous 
mucus network observed during susceptibility (Hasnain et al, 2010b). Furthermore, it 
would improve the niche of the nematode allowing its continuous establishment within the 
caecal crypts of host and therefore result in chronicity. 
 
 
 
T. muris depolymerises mucins | 185 
 
REFERENCES 
 
 
Artis D, Grencis RK (2008). The intestinal epithelium: sensors to effectors in nematode 
infection. Mucosal Immunol 1(4): 252-264. 
 
Bancroft AJ, Else KJ, Humphreys NE, Grencis RK (2001). The effect of challenge and 
trickle Trichuris muris infections on the polarisation of the immune response. Int J 
Parasitol 31(14): 1627-1637. 
 
Bethony J, Brooker S, Albonico M, Geiger SM, Loukas A, Diemert D, Hotez PJ (2006). 
Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 
367(9521): 1521-1532. 
 
Carlstedt I, Herrmann A, Hovenberg H, Lindell G, Nordman H, Wickstrom C, Davies JR 
(1995). 'Soluble' and 'insoluble' mucins--identification of distinct populations. Biochem Soc 
Trans 23(4): 845-851. 
 
Carlstedt I, Karlsson H, Sundler F, Fransson LA (1982). An insoluble mucin complex from 
rat small intestine. Adv Exp Med Biol 144: 155-157. 
 
Cervantes-Sandoval I, Serrano-Luna Jde J, Garcia-Latorre E, Tsutsumi V, Shibayama M 
(2008). Mucins in the host defence against Naegleria fowleri and mucinolytic activity as a 
possible means of evasion. Microbiology 154(Pt 12): 3895-3904. 
 
Cliffe LJ, Grencis RK (2004). The Trichuris muris system: a paradigm of resistance and 
susceptibility to intestinal nematode infection. Adv Parasitol 57: 255-307. 
 
Corfield AP, Myerscough N (2000). Glycosidase activity. Methods Mol Biol 125: 403-416. 
 
Davies JR, Carlstedt I (2000). Isolation of large gel-forming mucins. Methods Mol Biol 
125: 3-13. 
 
Drake L, Korchev Y, Bashford L, Djamgoz M, Wakelin D, Ashall F, Bundy D (1994a). 
The major secreted product of the whipworm, Trichuris, is a pore-forming protein. Proc 
Biol Sci 257(1350): 255-261. 
 
Drake LJ, Bianco AE, Bundy DA, Ashall F (1994b). Characterization of peptidases of 
adult Trichuris muris. Parasitology 109 ( Pt 5): 623-630. 
 
Else K, Wakelin D (1989). Genetic variation in the humoral immune responses of mice to 
the nematode Trichuris muris. Parasite Immunol 11(1): 77-90. 
 
Else KJ (2005). Have gastrointestinal nematodes outwitted the immune system? Parasite 
Immunol 27(10-11): 407-415. 
 
Else KJ, Wakelin D, Wassom DL, Hauda KM (1990). MHC-restricted antibody responses 
to Trichuris muris excretory/secretory (E/S) antigen. Parasite Immunol 12(5): 509-527. 
 
T. muris depolymerises mucins | 186 
 
Grencis RK, Entwistle GM (1997). Production of an interferon-gamma homologue by an 
intestinal nematode: functionally significant or interesting artefact? Parasitology 115 
Suppl: S101-106. 
 
Hasnain SZ, Thornton DJ, Grencis RK (2010a). Changes in the mucosal barrier during 
acute and chronic Trichuris muris infection. Parasite Immunology. In press. 
 
Hasnain SZ, Wang H, Ghia JE, Haq N, Deng Y, Velcich A, Grencis RK, Thornton DJ, 
Khan WI (2010b). Mucin gene deficiency in mice impairs host resistance to an enteric 
parasitic infection. Gastroenterology 138(5): 1763-1771. 
 
Heazlewood CK, Cook MC, Eri R, Price GR, Tauro SB, Taupin D, Thornton DJ, Png CW, 
Crockford TL, Cornall RJ, Adams R, Kato M, Nelms KA, Hong NA, Florin TH, Goodnow 
CC, McGuckin MA (2008). Aberrant mucin assembly in mice causes endoplasmic 
reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med 
5(3): e54. 
 
Herrmann A, Davies JR, Lindell G, Martensson S, Packer NH, Swallow DM, Carlstedt I 
(1999). Studies on the "insoluble" glycoprotein complex from human colon. Identification 
of reduction-insensitive MUC2 oligomers and C-terminal cleavage. J Biol Chem 274(22): 
15828-15836. 
 
Hill DE, Gamble HR, Rhoads ML, Fetterer RH, Urban JF, Jr. (1993). Trichuris suis: a zinc 
metalloprotease from culture fluids of adult parasites. Exp Parasitol 77(2): 170-178. 
 
Hill DE, Sakanari JA (1997). Trichuris suis: thiol protease activity from adult worms. Exp 
Parasitol 85(1): 55-62. 
 
Innes AL, Carrington SD, Thornton DJ, Kirkham S, Rousseau K, Dougherty RH, 
Raymond WW, Caughey GH, Muller SJ, Fahy JV (2009). Ex vivo sputum analysis reveals 
impairment of protease-dependent mucus degradation by plasma proteins in acute asthma. 
Am J Respir Crit Care Med 180(3): 203-210. 
 
Johansson ME, Thomsson KA, Hansson GC (2009). Proteomic analyses of the two mucus 
layers of the colon barrier reveal that their main component, the Muc2 mucin, is strongly 
bound to the Fcgbp protein. J Proteome Res 8(7): 3549-3557. 
 
Lehker MW, Sweeney D (1999). Trichomonad invasion of the mucous layer requires 
adhesins, mucinases, and motility. Sex Transm Infect 75(4): 231-238. 
 
Lidell ME, Bara J, Hansson GC (2008). Mapping of the 45M1 epitope to the C-terminal 
cysteine-rich part of the human MUC5AC mucin. FEBS J 275(3): 481-489. 
 
Lidell ME, Moncada DM, Chadee K, Hansson GC (2006). Entamoeba histolytica cysteine 
proteases cleave the MUC2 mucin in its C-terminal domain and dissolve the protective 
colonic mucus gel. Proc Natl Acad Sci U S A 103(24): 9298-9303. 
 
Linden S, Nordman H, Hedenbro J, Hurtig M, Boren T, Carlstedt I (2002). Strain- and 
blood group-dependent binding of Helicobacter pylori to human gastric MUC5AC 
glycoforms. Gastroenterology 123(6): 1923-1930. 
T. muris depolymerises mucins | 187 
 
 
McGrath RT, McKinnon TA, Byrne B, O'Kennedy R, Terraube V, McRae E, Preston RJ, 
Laffan MA, O'Donnell JS (2010). Expression of terminal alpha2-6-linked sialic acid on 
von Willebrand factor specifically enhances proteolysis by ADAMTS13. Blood 115(13): 
2666-2673. 
 
Roach TI, Wakelin D, Else KJ, Bundy DA (1988). Antigenic cross-reactivity between the 
human whipworm, Trichuris trichiura, and the mouse trichuroids Trichuris muris and 
Trichinella spiralis. Parasite Immunol 10(3): 279-291. 
 
Thornton DJ, Carlstedt I, Howard M, Devine PL, Price MR, Sheehan JK (1996). 
Respiratory mucins: identification of core proteins and glycoforms. Biochem J 316 ( Pt 3): 
967-975. 
 
Thornton DJ, Davies JR, Kraayenbrink M, Richardson PS, Sheehan JK, Carlstedt I (1990). 
Mucus glycoproteins from 'normal' human tracheobronchial secretion. Biochem J 265(1): 
179-186. 
 
Thornton DJ, Rousseau K, McGuckin MA (2008). Structure and function of the polymeric 
mucins in airways mucus. Annu Rev Physiol 70: 459-486. 
 
Thornton DJ, Sheehan JK (2004). From mucins to mucus: toward a more coherent 
understanding of this essential barrier. Proc Am Thorac Soc 1(1): 54-61. 
 
Wakelin D (1967). Acquired immunity to Trichuris muris in the albino laboratory mouse. 
Parasitology 57(3): 515-524. 
 
 
 
 
 
 
 
 
 
 
 
 
 
T. muris depolymerises mucins | 188 
 
SUPPLEMENTARY FIGURES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T. muris depolymerises mucins | 189 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T. muris depolymerises mucins | 190 
 
 
 
 
 
 
 
 
 
 
 
T. muris depolymerises mucins | 191 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T. muris depolymerises mucins | 192 
 
 
 
 
 
 
 
 
T. muris depolymerises mucins | 193 
 
SUPPLEMENTARY TABLE 
 
  
   
 
GENERAL DISCUSSION   
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
General Discussion | 195 
 
 The immune mediated elimination of gastrointestinal nematodes has been the 
subject of considerable investigation (Artis and Grencis, 2008). In general, however, the 
protective effector mechanisms by which worm expulsion is achieved remain poorly 
defined. Interestingly, about 25 years ago, several groups observed that gastrointestinal 
nematodes were contained within globules of mucus when expelled from the host (Bell et 
al, 1984; Miller et al, 1981; Miller and Nawa, 1979). This led to the “Mucus-Trap” 
hypothesis, which suggested that the mucus barrier covering the gastrointestinal 
epithelium, was an active effector component involved in the rejection of nematodes 
(Miller et al, 1981). Despite this, the role of the mucus barrier in this setting had not been 
thoroughly investigated.  
 The goal of my PhD was to investigate the role of the mucus barrier as part of the 
immune defence against gastrointestinal nematodes. I utilised the Trichuris muris (T.muris) 
whipworm which infects mice naturally (Cliffe and Grencis, 2004). It is closely related at 
the morphological, physiological and antigenic levels to the human whipworm Trichuris 
trichiura, the causative agent of Trichuriasis which affects up to a billion people 
worldwide (Bethony et al, 2006). By combining approaches from two specialist fields of 
glycoprotein biochemistry and parasite immunology, I aimed to answer two major 
questions: 
 Is the mucus barrier and its mucin component an integral part of the 
immunomodulated resistance mechanism? 
 During chronicity, does the nematode exert any effects on the mucus gel to 
promote its own survival within the host? 
  
 It has been well-established that during resistance, TH2-type immune response 
results in worm expulsion (Cliffe and Grencis, 2004; Grencis, 2001). The TH2-type 
cytokines have been shown to drive effector mechanisms such as the „epithelial cell 
escalator‟ (Cliffe et al, 2005) and smooth muscle hypercontractility (Khan and Collins, 
2004) which displace the worm out of its niche and therefore facilitate worm expulsion 
(Figure 7.1). Under the control of IL-13 an increase in proliferation of cells is observed 
within the caecal crypts during resistance (Artis et al, 1999). We observed an increase in 
transcription factors involved in goblet cell differentiation, which leads to goblet cell 
hyperplasia and increased mucin secretion into the mucus barrier during worm expulsion 
(Hasnain et al, 2010a) (Chapter 2). In the intestine, the dominant mucin Muc2 produced 
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by goblet cells is proposed to form a barrier composed of two distinct layers; a porous 
outer layer and an adherent inner layer protecting the mucosal surface (Johansson et al, 
2008). At the site of infection, a significant increase in Muc2 containing goblet cells and 
increased Muc2 secretion was observed in immunocompetent mice resistant to chronic 
infection (Chapter 3). Critically, worm expulsion was significantly delayed in Muc2-
deficient mice without an alteration to the goblet cell lineage (Hasnain et al, 2010b).  
 A more startling observation from this work was that Muc5ac, a mucin normally 
exclusively located at other mucosal sites, notably the lung and stomach, was expressed in 
the intestine during worm expulsion (Hasnain et al, 2010b). It is important to note that no 
goblet cell hyperplasia or induction of Muc5ac was observed in uninfected mice and mice 
susceptible to chronic infections that were unable to expel T. muris. Strikingly, in the 
absence of Muc5ac the mice (on a resistant background) were susceptible to chronic 
infection, despite a strong underlying TH2-type cytokine response (Chapter 4). This data 
implies that Muc5ac is acting as an effector. Moreover, changes were not only observed in 
the quantity of the mucins, but also the quality of the mucins: mucins were more highly 
charged and sulphated during worm expulsion (Chapter 5). Overall, these changes within 
the barrier result in altering the rheological properties of the mucus layer; mucus was less 
porous during worm expulsion. The data supported a novel role for mucins which directly 
„damaged‟ the nematodes, reflected by a significant reduction in their ATP levels (Hasnain 
et al, 2010b). Furthermore, during chronicity the nematode itself is capable of 
depolymerising the mucin network possibly to aid its movement in the intestine and/or 
facilitate mating (Chapter 6).  
 Therefore, data generated from my PhD studies has demonstrated a pivotal 
role for the mucin components of the mucus barrier as effectors that facilitate worm 
expulsion and, demonstrated how the worm exerts its effects on the mucin 
environment to promote its own survival within the host.            
  
 Similar to allergic responses, eosinophilia, mastocytosis and a strong peripheral IgE 
antibody response are a prominent feature of nematode infection (Maizels et al, 2009). 
These „classical‟ arms of the immune response, however, have been shown not to be 
critical to T. muris expulsion (Artis and Grencis, 2008; Cliffe and Grencis, 2004). What 
influences the balance between the TH1 –TH2 type immune response to result in chronic or 
acute infection is still undecided. However, it is known that the TH2-type cytokine 
responses are integral to the protective immunity against T. muris infection; multiple 
General Discussion | 197 
 
physiological mechanisms mediated through the TH2-type immune response enforce 
intestinal expulsion of the nematode (Artis and Grencis, 2008). The changes in the mucus 
barrier and mucins during chronic T. muris infection are very similar to those observed 
during inflammatory bowel disease (IBD). For instance, the depleted mucus barrier 
(McGuckin et al, 2009), lower number of goblet cells with smaller thecae (Van der Sluis et 
al, 2006), the loss of mucin sulphation (Corfield et al, 1992) and mature glycosylation 
(Heazlewood et al, 2008) are all a feature of IBD. Corroborating this observation, a recent 
transcriptional profiling study by Pennock and colleagues has highlighted the phenotypic 
and transcriptional similarities of T. muris chronic infection to models of IBD and human 
IBD (Levison et al, 2010). In chronic infection the goblet cells appear depleted, with 
reduced mucin synthesis and storage within the goblet cells; furthermore, the mucins are 
lowly charged and apparent immature glycosylation (Hasnain et al, 2010a; Hasnain et al, 
2010b).  
 The altered mucin glycosylation and down-regulation of goblet cell differentiation 
transcription factors suggests that inflammation during chronic infection induces cell 
stress. Supporting this hypothesis, are a recent set of studies that highlight the overarching 
hypothesis of intestinal secretory cells being susceptible to endoplasmic reticulum (ER) 
stress due to the high rates of biosynthesis of secretory proteins (Heazlewood et al, 2008; 
Podolsky et al, 2009; Zhao et al, 2010). During ulcerative colitis the mucins within the 
goblet cells were shown to have apparent immature glycosylation (similar to that observed 
during chronic T. muris infection) (Heazlewood et al, 2008). Interestingly, these partially 
synthesised mucins accumulate within the goblet cell endoplasmic reticulum (ER) resulting 
in the activation of the ER stress response which consequently leads to a diminished mucus 
barrier and development of intestinal inflammation (Heazlewood et al, 2008). Therefore, 
during chronicity the reduced glycosylation may result in the accumulation of Muc2 within 
the goblet cells, eventually reaching a point where Muc2 production ceases which can, in 
turn, result in the diminished mucus barrier. Therefore, an underlying ER stress response 
within the intestinal epithelia may be the link that ties these molecular changes observed in 
the mucins and the induction of inflammation observed during chronicity.  
   Interestingly, nematodes including Trichuris suis have been used to treat IBD in 
mice and in humans (Summers et al, 2003; Summers et al, 2005a). A caveat to this is the 
fact that in susceptible individuals, nematodes can induce IBD-type symptoms. However, 
T. suis is believed to only transiently infects humans and has been shown to be successful 
in controlling IBD (Summers et al, 2005b). Perhaps as the helminth-induced TH2-type 
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immune response counteracts the TH1-type IBD, this results in the hypersecretion of 
mucins and limits inflammation by replenishing the mucus barrier. The stimulus that 
results in exocytosis of mucins is not known. However, we have for the first time identified 
an intestinal receptor (gamma amino-butyric acid α-3) that may be involved in the 
secretion of mucins during nematode infection. Studies on lung models have shown that 
GABA receptors are directly responsive to IL-13 (Xiang et al, 2007). Therefore, this raises 
the interesting possibility that the receptor could be manipulated to increase the thickness 
of the mucus barrier and potentially reduce inflammation during chronic nematode 
infection or even in IBD.  
 The diminished mucus barrier could result in exacerbating inflammation, not only 
due to increased foreign toxin and antigen exposure but also because of the commensal 
flora coming into contact with epithelium. Commensal flora in the intestine, however, 
plays an important biological role in T. muris infection. It has been shown that commensal 
flora can induce T. muris egg hatching and therefore effect establishment of the nematode 
within the host (Hayes et al, 2010). The loose outer layer of the mucus barrier is the home 
of the commensals and therefore the changes in the mucus barrier could dictate the changes 
in the commensal flora (Johansson et al, 2008). The „breaks‟ in the mucus barrier during 
chronic infection may result in bacterial-epithelial cell contact consequently exacerbating 
inflammation. In fact, recently it was clearly demonstrated that Muc2 protects against 
enteric bacterial infections and its absence makes mice more susceptible to infection 
(Bergstrom et al, 2010). Moreover, commensal flora has been shown to be in direct contact 
with the intestinal mucosa in the Muc2-deficient mice, subsequently resulting in bacterial 
translocation due to the barrier disruption (Johansson et al, 2008). It is clear that secondary 
bacterial infections during T. muris infection result in increased mortality (R. K. Grencis, 
personal communication). Indeed, the survival rates of IL-10-deficient mice infected with 
T. muris, which have a diminished mucus barrier, improve when treated with antibiotics 
(Schopf et al, 2002).  
 The nematode could modulate the decrease in the mucus barrier observed during 
chronicity, by skewing the immune response towards TH1-type response as it secretes an 
IFN-γ like molecule (Grencis and Entwistle, 1997). Moreover, the „breaks‟ in the mucus 
layer maybe as a result of the nematodes ability to disrupt the mucin network by secreting 
serine and cysteine proteases. Excretory secretory products (ESPs) isolated from the adult 
T. muris E isolate (which was used during these studies) specifically degraded Muc2 and 
were unable to degrade Muc5ac. However, it is possible that other isolates of T. muris, in 
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particular the S isolate (D'Elia and Else, 2009) which is able to evade the immune response 
resulting in chronic infection, may be able to secrete proteases capable of degrading 
Muc5ac as well as Muc2. In addition, it is also possible that T. muris at the larval stage 
secretes different molecules that have specialised effects on mucins. Whether the ESPs 
secreted from T. muris larvae are also capable of disrupting the mucus barrier remains to 
be seen; however, considering the nematode is embedded at the base of the intestinal 
crypts during the larval stages and is not directly associated with the mucus barrier it seems 
like an unlikely possibility. Several other parasites have also adopted similar mechanisms 
to survive within the intestine. For instance, Entameoba histolytica secretes cysteine 
proteases that degrade the mucus barrier (Moncada et al, 2003). Helicobacter pylori has 
also been shown to secrete „mucinases‟ which alter the rheological properties of the mucus 
gel (containing Muc5ac and Muc6) and this allows its corkscrew like motion through the 
mucus layer (Celli et al, 2009). Therefore, the difference in the increased porosity of the 
mucus layer during chronic infection may be as a direct result of the ESPs secreted by 
T.muris in vivo. Inhibiting the ability of parasites to secrete proteases may result in 
gradually re-creating a mucin network that can affect the vitality of the nematode or at 
least result in reducing inflammation by repairing the mucus layer.  
 Glycans can influence the extension and expansion of the protein and hydration of 
the mucus barrier. Furthermore, glycans could bind to and aid the T. muris worm expulsion 
process as glycans have been shown to act as decoy receptors that bind and remove 
pathogens (Linden et al, 2008). Another possibility is that mucin glycosylation is involved 
in sequestering factors that have the detrimental effect on the nematode, as seen during 
resistance (Hasnain et al, 2010b). Moreover, the changes in mucin glycosylation that 
occurred during resistance remained after the expulsion of the nematode was complete 
(Hasnain et al, 2010a); in fact, ESPs were unable to completely degrade mucins even after 
21 day post expulsion. This raises an interesting possibility of glycans being important in 
T. muris establishment, considering re-infection results in accelerated expulsion (Bancroft 
et al, 2001). Furthermore, it is important to acknowledge that in endemic areas, people are 
usually infected with low doses of infection repeatedly (Bethony et al, 2006); therefore, the 
gradual change in glycosylation that occurs as a result of infection may eventually 
contribute to „acquired immunity‟. Although, lowered mucin sulphation in the intestine did 
not have an effect on the establishment of T. muris, further studies are required to 
determine whether abolishing mucin sulphation completely would have an effect on 
establishment of infection. Interestingly, an up-regulation in sulphate transporters is 
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observed during resistance, resulting in the active uptake of sulphates (IL-13-mediated), 
which may be directly or indirectly important during T. muris infection. Certainly, reduced 
sulphation and increased sialylation of mucins results in making the mucins more prone to 
degradation, as previously observed with von Willebrand factor (McGrath et al, 2010). 
Muc5ac, present in the mucus barrier during worm expulsion, is more highly charged 
compared to Muc2 which is a property conferred by glycans. More importantly, Muc5ac 
was directly shown to damage the nematode; how this occurs is still unknown. 
Nevertheless, it may be mediated by the Muc5ac protein core or its glycan chains. Recent 
studies have also reported an up-regulation of Muc5ac expression Nippostrongylus 
brasiliensis (Takeda et al, 2010) and T. suis (Kringel et al, 2006) with nematode exposure. 
Furthermore, we examined the expression of Muc5ac in two other murine models of 
nematode infection that inhabit the small intestine: Trichinella spiralis and 
Heligmosomoides bakeri/polygyrus. T.spiralis is expelled from the intestine via a strong 
TH2-type immune response (Lee, 2002), whereas a primary infection with 
H.bakeri/polygyrus results in chronicity (Maizels et al, 2009). Interestingly, we observed 
an up-regulation of Muc5ac mRNA and protein only in the T. spiralis infected mice (data 
not shown). This supports the hypothesis that Muc5ac is a mucin expressed in the 
intestines during protective immunity to intestinal nematodes. Previously, it has been 
demonstrated that specifically targeting an enteric response against one nematode can 
result in promoting concomitant expulsion of unrelated nematodes, via a non-specific 
protective mechanism (Dineen et al, 1977; Miller and Nawa, 1979). Therefore, we suggest 
that Muc5ac may be part of the IL-13 induced „universal response‟ to clear intestinal 
enteric parasitic infections. 
  In conclusion, the findings from this thesis clearly demonstrate that the mucus 
barrier is a critical effector during enteric infection (Hasnain et al, 2010a; Hasnain et al, 
2010b). During susceptibility to T. muris, under a TH1-type immune response no major 
changes in the number of goblet cells are observed. Resulting in a depleted mucus barrier, 
which consists of the mucin (Muc2) that is highly sialylated but more prone to degradation 
by ESPs. The diminished mucus barrier, along with the ability of ESPs released from the 
nematode to disrupt the polymeric mucin network results in a more porous mucus network 
(Hasnain et al, 2010b). Therefore, this in turn could result in damage to the epithelial tissue 
and potential translocation of commensal flora across the epithelium, thus exacerbating 
inflammation during chronicity (Figure 7.2). In contrast, during resistance, under the 
immunological control of a TH2-type immune response, goblet cell hyperplasia is 
General Discussion | 201 
 
observed. This is accompanied by an increase in the synthesis and secretion of Muc2 and 
de novo expression of the Muc5ac mucin in the intestine. The mucins within the mucus 
barrier are highly charged and sulphated, and less prone to degradation by ESPs. These 
changes result in a less porous mucin network which is detrimental to the nematodes 
vitality (Figure 7.2). Overall, the mucin components are critical to worm expulsion and in 
the absence of Muc5ac mice are susceptible to chronic infection. We hypothesise that the 
mucus barrier, therefore, is an integral part of the co-ordinated worm expulsion response. 
The epithelial cell escalator (Cliffe et al, 2005) operating within the intestine can dislodge 
the worm out of its niche. Whereas, changes in the rheological properties of the mucus 
barrier can trap and its bioactive components damage the nematode (Hasnain et al, 2010b). 
This along with smooth muscle hypercontractility (Khan and Collins, 2004) can physically 
facilitate worm expulsion.  
 The work presented here provides compelling evidence showing that mucins play a 
major role in protection against gastrointestinal nematode infection. In addition, we define 
potential mechanisms by which mucins may mediate protection. This will not only have 
application to other types of intestinal pathogens and mucosal protection in general, but 
may open up new avenues for developing anti-parasitic intervention.     
 
FUTURE PROSPECTIVES  
 In these studies we have expanded on the previously described „Mucus-Trap‟ 
hypothesis during worm expulsion and demonstrated that the mucus barrier and its 
components are much more than just a „trap‟. The qualitative and quantitative changes in 
the mucus barrier during worm expulsion can result in directly damaging the nematode. It 
is important to investigate whether inducing mucus secretion and increasing mucus 
turnover specifically in the intestine promote worm expulsion? It is also essential to 
investigate whether the changes that occur during resistance, with regards to mucin 
glycosylation, contribute in the accelerated expulsion that has been reported with 
secondary T. muris infection. Finally, the crucial step would be to dissect the exact 
mechanism by which mucins, in particular Muc5ac protects against nematode infection, 
i.e. directly or via an associated molecule. The potential function of Muc5ac as a 
„universal‟ effector molecule during nematode expulsion should be addressed by using 
different models of different intestinal-dwelling nematodes. It would be interesting to 
investigate whether these changes in the mucus barrier are also observed during human 
Trichuriasis and can these be manipulated to reduce inflammation and limit re-infection.   
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MATERIALS  
All reagents were obtained from Sigma-Aldrich, Poole, U.K unless stated otherwise.  
 
ABgene UK (ThermoScientific), Epsom, UK: Absolute QPCR SYBR green used for 
quantitative PCR.   
 
Axiovision, CarlZeiss Ltd., UK: Images acquired.   
 
BDH Ltd., Poole, Dorset, UK: EDTA-disodium salt, glacial acetic acid, periodic acid, 
sodium chloride, sodium dodecyl sulphate (SDS), Trizma Base, Urea. 
 
Beckman Coulter, High Wycombe, UK: Quick-Seal
®
 and ultracentrifuge tubes.  
 
Dukes Scientific, Brookhaven Instruments Ltd., Worcestershire, UK: Monodisperse 
fluorescent polymer microspheres 
 
Harlan Ltd., Oxon, UK:  Provided the BALB/c, AKR and C57BL/6 mice.  
 
Invitrogen, San Diego, USA: Dulbecco‟s modified eagle media (DMEM) with essential 
amino acids, RPMI-1640 media, foetal calf serum, L-glutamate, penicillin-streptomycin 
solution, sterile phosphate buffered saline without magnesium and calcium and trypsin, 
Superscript III for reverse transcription.  
 
Leica Microsystems, Milton Keynes, UK: Dissecting microscope.  
 
Melford Labs Ltd., Ipswich, UK: Dithiothrethiol (DTT). 
 
Eurofins MWG Operon, Ebersberg, Germany: Primer synthesis.  
 
PerkinElmer, Waltham, USA: Enhanced chemiluminescence (ECL) Western blot 
detection reagent.  
 
Nikon C1 Upright confocal microscope, Melville, USA: Analysis of mucus layer. 
 
Olympus widefield microscopes, Essex, UK: Immunofluorescent images acquired.  
 
Promega Biosciences, Southampton, UK: IMPROM-reverse transcription kit and 
CellTiter-Glo
®
 Luminescent cell viability assay.  
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METHODS 
Animals  
The protocols used at the University of Manchester were in accordance with the guidelines 
set out by the Home Office Scientific Procedures Act (1986). Guidelines by the McMaster 
University Animal Care Committee and the Canadian Council on the Use of Laboratory 
Animals were implemented at the McMaster University for the Muc2-deficient mouse 
studies. NaS1-deficient mouse studies, carried out at the Mater Medical Research Institute, 
were approved by the University of Queensland Animal Experimentation Ethics 
Committee. The mice were kept in sterilised, filter topped cages at all the animal facilities. 
The T. muris strain was maintained at the University of Manchester as previously 
described (Wakelin, 1967). The animals (6-12weeks) were infected with either a high dose 
(approximately 100-300 eggs) or a low dose infection (approximately <15 eggs) by oral 
gavage. At various time points during infection (as shown below), the mice were sacrificed 
using the standard schedule 1 method.  
Naïve mice Uninfected, control mice 
D12-D13 pi. L2 Stage, (worm burden to ensure the establishment of infection) 
D14-D15 pi. L2 Stage 
D18-D21 pi. L3 moults to L4 Stage (expulsion in resistant mice) 
D35-D42 pi. Adult worms 
The worm burden was assessed at various time points, using the method previously 
described (Wakelin, 1967). In brief, the caecum from infected mice was isolated, scraped 
thoroughly, and the number of worms were counted using a Leica dissecting microscope.  
 
Antibodies  
Primary Antibodies 
mMuc2 antibody: The mouse Muc2 (mMuc2) polyclonal antibody was raised in rabbits 
against a murine Muc2 peptide sequence (NGLKPVRVPDADNC) located in the N-
terminus of Muc2 (Heazlewood et al, 2008). The peptide purified antibody was used at a 
dilution of 1:1000 for western blots and 1:200 dilution for immunohistochemistry (IHC).  
 
mITF antibody: The affinity purified goat polyclonal α-ITF antibody, raised against an 
undisclosed peptide mapping to an internal region of mouse ITF, was obtained from 
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SantaCruz Biotechnology, Inc (California, USA) and used according manufacturer‟s 
instructions.  
 
mRelm-β antibody: Rabbit polyclonal to Relm-β, raised against an undisclosed mouse 
Relm-β peptide, was obtained from Abcam, Cambridge, UK (Artis et al, 2004).  
 
mSpdef antibody: Goat polyclonal antibody, against the N-terminus of human PDEF 
(known to have reactivity against mouse Spdef (Noah et al, 2009)) was obtained from 
SantaCruz Biotechnology, Inc (California, USA) and used according manufacturer‟s 
instructions.   
 
45M1 antibody: Commercially available 45M1 antibody (Sigma-aldrich, UK) was used for 
the detection of mouse Muc5ac (Lidell et al, 2008) at a dilution of 1:1000 for western blots 
and 1:200 for IHC. 
 
mMuc5b antibody: The mouse Muc5b-specific antibody was a kind gift from Dr. Camille 
Ehre (University of North Carolina, Chapel Hill, USA). The rabbit polyclonal antibody 
was raised against the repetitive sequence CQPQCQWTKWIDVDY, in the Cys-rich 
domains of Muc5b (Zhu et al, 2008). 
 
α-IFN-γ and α-IgG antibodies: The rat immunoglobulin G1 monoclonal antibody 
XMG1.6 and GL113 antibody (for isotype control) were purified from supernantant by cell 
culture passage and protein G-Sepharose column and concentrated using a Centricon 
Centriprep tube. Antibody was administered at 0.5mg per 200μl of phosphate buffered 
saline (PBS) by intraperitoneal injection. Injections were given every 4 days starting from 
day -2 to day 26 post infection 
 
mSat1 antibody: The mouse specific Sat1antibody was a kind gift from Dr. Paul Dawson 
(Mater Medical Institute, Brisbane, Australia) and Dr. Daniel Markovich (University of 
Queensland, Brisbane, Australia) (Dawson et al, 2010). 
 
BrdU antibody: The rate of intestinal epithelial cell turnover was assessed by visualising 
bromodeoxyuridine (BrdU) incorporated into nuclei after mice were injected with 10mg of 
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BrdU 12-16 hours before sacrifice. The monoclonal anti-BrdU antibody was purchased 
from AbD Serotect, Oxford, UK to detect the BrdU by using IHC (Cliffe et al, 2005).  
 
Biotinylated lectins: Biotinylated lectins (Sambucus nigra, Mackia amuresis, Peanut 
agglutinin, Maclura pomifera, Dolichos biflorus, Triticum vulgaris and Ulex europeaus), 
purchased from Sigma-Aldrich, Poole, UK, were used at 1:500 dilutions for 
immunofluorescent microscopy (Hasnain et al, 2010). 
 
Secondary Antibodies 
Anti-rabbit peroxidase labelled (1:12000) or alkaline phosphatase-conjugated (1:10000) 
secondary antibodies purchased from Jackson Immunoresearch, West Grove, PA were 
used to detect the primary antibodies on nitrocellulose membrane. Anti-rabbit and anti-goat 
biotin conjugated secondary antibodies were used at 1:250 for immunohistochemical 
microscopy. Immunofluorescent detection of primary antibodies was carried out using 
Alexa Fluor
®
 anti-rabbit, anti-mouse and anti-goat dyes (1:800 dilution), obtained from 
Invitrogen, Paisley, UK.   
 
Histochemical analysis 
“Swiss Roll” technique 
The intestine was gently cleaned using PBS, the tissue cut longitudinally, pinned straight 
and fixed in 95% ethanol for 1 hour. The intestine was rolled around tweezers, pinned into 
„rolls‟ and fixed for a further 24 hours in 95% ethanol before being processed. 
 
Tissue processing  
The specimens (intestine rolled or snipped) were transversally processed (Table A.1) using 
the Microm Spin Tissue processor (STP) 120 (Microm UK Ltd.) and subsequently 
embedded in wax (Microm EC 3501). Paraffin cell blocks were stored at room temperature 
until cut to a thickness of 5µm using a Micron Cool Cut HM355S microtome. Sections 
were floated in a warm water bath (37.4°C) before being positioned on microscope slides, 
dried at 37°C overnight and stored at room temperature until used. 
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Table A.1: Tissue processing protocol 
 
Staining 
Prior to staining, wax was removed from all slides using xylene (Genta medical, York, 
U.K). The tissue was placed in industrial methylated spirit (IMS) for 10 minutes, followed 
by a brief wash in ddH2O or PBS.  
 
Alcian blue and Periodic Acid Schiff’s staining: For alcian blue (AB) staining the slides 
were placed in AB (0.6% glacial acetic acid, 19.4% dH2O and 2g of alcian blue at pH 2.5) 
for 5 minutes and washed in ddH2O briefly. For Periodic Acid Schiff‟s (PAS) staining the 
slides were treated with 0.1M potassium hydroxide for 30 minutes, placed in 1% periodic 
acid for 5 minutes and washed in ddH2O. The slides were then placed in Schiff‟s reagent 
for 10 minutes and washed again in ddH2O. All slides were washed under running dH2O 
for 10 minutes and counterstained. Slides were washed in hot ddH2O for 15 to 30 seconds 
and placed in IMS for dehydration, mounted using Crystal Mount™ aqueous mounting 
medium and sealed with cover slips.  
 
High Iron Diamine-Alcian blue staining: Solution was prepared fresh every time as 
follows: 120mg of N, N-dimethly-M-phenylenediamine (HCl)2 and 20mg of N, N-
dimethyl-P-phenylenediamine (HCl) were dissolved in 50ml of ddH2O and 1.4ml of 10% 
FeCl3 added immediately. Slides were stained for 18 hours, washed with ddH2O and 
stained with AB for 30 minutes (Spicer, 1965).  
 
Immunohistochemical staining: Dewaxed tissue was rehydrated for 2 minutes in 100%, 
95% and 70% IMS and washed with PBS (3 x 5 minutes). Antigen was retrieved by 
Treatment Time 
50% Ethanol 2 minutes 
70% Ethanol 7 hours 
90% Ethanol 45 minutes 
95% Ethanol 3 x 30 minutes 
100% Ethanol 3 x 30 minutes 
Xylene 3 x 30 minutes 
Paraffin wax 2 hours 
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incubating the slides in 10mM sodium citrate (pH6) in microwave (at full power) for 5 
minutes. For mucin staining, the slides were reduced at room temperature for 30 minutes 
using 10mM DTT in 0.1M Tris-HCl (pH8) followed by alkylation using 25mM 
iodoacetamide in 0.1M Tris-HCl (pH8) in the dark at room temperature for 30 minutes. All 
the slides were rinsed in PBS again before the endogenous peroxidase activity
 
was blocked 
with 3% H2O2 in methanol. Non-specific binding sites were blocked for 1 hour in 10% 
donkey serum and 1% BSA in PBS. Slides were incubated overnight at 4°C with primary 
antibody in block. Slides were washed with PBS and incubated with secondary antibody in 
block for 1 hour and subsequently washed with PBS once more. The slides were incubated 
with Dako-Strep-avidin Complex Kit horseradish peroxidase (DakoCytomation, Denmark) 
for 1 hour, washed with PBS and incubated for 30 minutes with Dako-DAB (di-
aminobenzadine) detection solution. Slides were washed with PBS as before and 
counterstained with hematoxylin. The slides were dehydrated in 70%, 95% and 100% IMS 
before being mounted. All images were captured using the AxioVision imaging system 
version 4.2 (CarlZeiss Ltd, U.K). 
 
BrdU staining: Slides were incubated in xylene overnight, washed in absolute ethanol and 
peroxidise activity was blocked as described above. Slides were hydrolysed with 1M HCl 
for 8 minutes at 60°C and subsequently neutralised for 6 minutes using boric acid buffer 
(0.2M othoboric acid/0.05M sodium tetraborate solution at pH8.4). Non-specific binding 
was blocked using 5% rabbit serum for 30 minutes at room temperature. Slides were 
washed with PBS and incubated with anti-BrdU antibody for 1 hour. Thereafter, the slides 
were developed as described above (immunohistochemical staining).   
 
Immunofluorescent staining: Dewaxed tissue was rehydrated for 2 minutes in 100%, 95% 
and 70% IMS and washed with PBS (3 x 5 minutes). Antigen was retrieved by incubating 
the slides in 10mM sodium citrate (pH6) in microwave (at full power) for 5 minutes. The 
slides were reduced at room temperature for 30 minutes using 10mM DTT in 0.1M Tris-
HCl (pH8) followed by alkylation using 25mM iodoacetamide in 0.1M Tris-HCl (pH8) in 
the dark at room temperature for 30 minutes. The slides were rinsed in PBS again before 
the endogenous peroxidase activity
 
was blocked with 3% H2O2 in methanol. Non-specific 
binding sites were blocked for 1 hour in 10% goat serum and 1% BSA in PBS. Slides were 
then incubated at room temperature for 2 hours with primary antibody in block. Slides 
were washed with PBS and incubated with the corresponding secondary antibody in PBS 
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for 1 hour, and subsequently washed with PBS once more. Slides were counterstained with 
DAPI and mounted using the Prolong
®
-antifade mounting medium (Invitrogen, Paisley, 
UK). All images were captured using the MetaVue, Olympus imaging system (Olympus, 
Essex, UK). 
 
Counterstaining 
Hematoxylin staining 
Slides were stained with haematoxylin (diluted 1:5) for 1 minute, washed in ddH2O, 
stained with Eosin for 1 minute, washed with ddH2O and subsequently dehydrated 50% to 
100% ethanol. The slides were then mounted and sealed with cover slips. 
 
Fast-green staining  
Slides were stained with 1% fast-green in acetic acid for 1 minute, washed in ddH2O and 
subsequently incubated with 1% acetic acid for 5 minutes. The slides were then dehydrated 
using 50% to 100% IMS, mounted and sealed with cover slips. 
 
Controls 
A tissue section on each slide was incubated with secondary antibody only to measure the 
background staining and autofluorescence. In addition, primary antibody was saturated 
with the immunising peptide, prior to staining to confirm antibody specificity.  
 
Biochemical analysis of mucins and mucus  
Total mucus extraction  
The intestine (caecum and colon kept separate) was gently flushed with PBS to remove the 
faecal matter and then flushed extensively using a 19.5G” needle and syringe with a total 
volume of 7ml of 6M guanidinium chloride (GuCl) reduction buffer (containing 0.1M 
Tris-HCl and 5mM EDTA at pH8). Residual mucus was scraped using a cell scraper and 
the samples were solubilised by rotating at 4°C overnight. For crude mucus analysis, the 
intestine was scraped, lyophilised and stored at -80°C until required.  
 
Secreted mucus extraction 
The intestine was gently flushed with PBS and subsequently flushed 5 times with 3M urea 
to obtain the secreted mucus from the lumen of the intestine. The tissue was processed for 
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histology before and after treatment to ensure that only the secreted mucus was isolated 
and the intestinal crypts remained intact.  
 
Separation of mucins by agarose gel electrophoresis 
Before gel electrophoresis the samples were reduced with 50mM dithiothreitol (DTT) for 2 
hours at 37°C and subsequently carboxymethylated using 0.125M iodoacetamide for 30 
minutes, at room temperature, in the dark to prevent reformation of the disulphide bonds. 
The samples were then dialysed into 6M Urea and 10% (v/v) loading buffer was added 
before electrophoresis (Table A.2).  
Table A.2: Solutions for agarose gel electrophoresis and immunodetection 
 
Samples were electrophoresed on 0.7-1% (w/v) agarose gels in TAE buffer and 0.1% SDS 
at 30 volts for 15 hours (Sheehan et al, 2000). After electrophoresis, mucins were 
transferred to a nitrocellulose membrane by vacuum blotting in 0.6M sodium chloride and 
60mM sodium citrate at a pressure of 45-50 mbar using a Vacugene XL (Pharmacia 
Biotech, Amersham, UK) for 2 hours (Sheehan et al, 2000).  
 
Slot blot Analysis 
Fractions taken from the tubes were blotted onto nitrocellulose membrane using a 72-well 
slot blot manifold (Schleicher & Schuell, Dassel, Germany) attached to a vacuum pump. 
Membranes were then assayed for glycoprotein using PAS reagent or probed with the 
relevant antibody (as described previously). Staining intensity was measured using a Bio-
Rad GS-800 Calibrated densitometer (Thornton et al, 1994).  
 
Glycoprotein detection using PAS staining: Nitrocellulose membrane was washed with 
dH2O, incubated at room temperature for 30 minutes with 1% (v/v) periodic acid and 3% 
Solution Contains 
TAE 40mM Tris acetate and 1mM EDTA, pH8 made up in 1 
litre of dH2O 
10% Loading buffer 50% (v/v) glycerol, 10 x TAE,  bromophenol blue, 1% 
(w/v) SDS 
TBST 10mM Tris-HCl, 150mM NaCl, 0.05% Tween-20, pH8 
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(v/v) acetic acid, washed with dH2O and incubated with 0.1% (w/v) sodium 
metabisulphite/0.01M HCl for 2 x 5 minutes. Schiff‟s reagent was subsequently added to 
the membrane for approximately 10-15 minutes, this was rinsed with sodium 
metabisulphite and dH20 to stop the reaction and dried (Thornton et al, 1994). 
 
HID assay: Nitrocellulose membranes, following a wash with dH2O were incubated with 
HID stain (described previously) for 18 hours at room temperature. The membrane was 
subsequently washed with dH2O and dried.  
 
Immunodetection: Nitrocellulose membrane was briefly washed in TBST and then 
blocked using 1% (w/v) skimmed milk powder in TBST (Table A.2) for at least 30 
minutes, followed by 2 x 15 minute TBST washes and subsequent incubation of the 
primary antibody overnight. The membrane was washed 3 x 5 minutes with TBST, before 
and after the incubation with the appropriate secondary antibody for 30 minutes (refer to 
antibodies section). The membrane was incubated with enhanced chemiluminescence 
western detection reagent (Perkin-Elmer, USA) for approximately 2 minutes and then 
washed to remove excess and subsequently exposed to BIOMAX
TM
BML film (Kodak, 
UK). For the phosphatase conjugated secondary antibody the membrane was washed with 
TBST (2 x 15 minutes) followed by approximately 4-5 minute incubation with Nitro-blue 
tetrazolium/5-bromo-4-chloroindol-3yl phosphate.  
 
Purification of mucins  
Saliva was collected and solubilised in 4M GuCl at 4°C. Purification was performed by 
isopycnic density gradient centrifugation as described by Davies & Carlstedt: caesium 
chloride (CsCl) (Melford, UK) was added to the solubilised mucus to achieve a starting 
density of 1.4g/ml. This suspension was then centrifuged in a Beckman Optima™ L-90K 
Ultracentrifuge (Beckman Ti 70 rotor) at 40,000RPM for 65 hours at 15°C. Following 
centrifugation, fractions were taken from the top of the tubes, densities were determined, 
and fractions were then analysed by slot blotting. The mucin-containing fractions (as 
specified in chapters) were then pooled and dialysed into 0.2 M GuCl before being 
subjected to a second CsCl density gradient centrifugation step at a starting density of 
1.5mg/ml in a Beckman Optima™ L-90K Ultracentrifuge (Beckman Ti 90 rotor) at 
40,000RPM for 65 hours at 15°C. Following centrifugation, fractions were taken from the 
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top of the tubes, densities were determined, and fractions were then analysed by slot 
blotting and by agarose gel electrophoresis followed by western blotting.  
 
Anion Exchange Chromatography 
The PAS-rich fractions were pooled after the second CsCl density gradient and subjected 
to anion exchange chromatography as described previously (Linden et al, 2002; Thornton 
et al, 1996), using a Resource
TM
 Q column. Samples were eluted with the starting buffer 
(10mM piperazine at pH5 in 6M Urea containing 0.02% 3-[(chloamidopropyl) 
dimethylammonio]-1-propanosulphonate) for 15 minnutes (0.5ml/min), followed by a 
linear gradient (60 minutes) up to 0.4M Lithium perchlorate-10mM piperazine at pH 5 in 
6M Urea containing 0.02% 3-[(chloamidopropyl) dimethylammonio]-1-propanosulphonate 
(Linden et al, 2002; Thornton et al, 1996).  
 
Rate Zonal Centrifugation  
6–8M GuCl gradients were formed in centrifuge tubes using an MSE gradient maker 
connected to a Gilson Minipuls-2 peristaltic pump. Mucin samples were adjusted to 4M 
GuCl and loaded onto the tops of the gradients and centrifuged in a Beckman Optima™ L-
90K Ultracentrifuge (Beckman SW40 rotor) at 40,000RPM for 2.75 or 3.50 hours (as 
stated in chapters) at 15°C. Fractions were taken from the top of the tubes, analysed by slot 
blotting and PAS-staining (Thornton et al, 1990). The refractive index of each fraction was 
measured using a refractometer to ensure gradients were comparable. 
 
Analysis of mucus network properties 
Caecal tissue isolated from BALB/c and AKR mice was cut longitudinally, washed with 
PBS and kept hydrated with PBS in a 6 well plate. 0.1μm blue fluorescently labelled 
polymer microspheres (Dukes Scientific, UK) were placed on top of the luminal surface of 
the caecum (set as a reference) and their position analysed using the Nikon C1 Upright 
confocal microscope. 3D optical stacks were taken every 5μm and combined to obtain a Z-
stack at the time points stated. All images were analysed using the EZ-C1 freeviewer 
software (version 3.9).       
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Gene Expression Analysis  
Epithelial cell isolation  
The intestine was flushed with Hank‟s Balanced Salt Solution (HBSS) without Ca2+ and 
Mg
2+
 (Invitrogen, Paisley, UK) using a 19.5G” needle. The intestine was cut longitudinally 
and then cut into 5mm lengths. To remove the mucus the tissue was incubated at 37°C with 
10mM DTT in HBSS for 30 minutes with samples being shaken gently every 10 minutes. 
The supernatant was removed and 0.8M EDTA in HBSS was added to the tissue, which 
was incubated at 37°C for 30 minutes and shaken gently every 10 minutes to detach the 
epithelial cells (Humphreys and Grencis, 2009). The supernatant was filtered through a 
100µm cell strainer to separate the tissue from the epithelial cells and centrifuged at 109.5 
x g for 5 minutes. The supernatant was removed and 1ml of TRIZOL
®
 (Invitrogen) was 
added to the cells (stored at -80°C). 
 
RNA extraction  
RNA was separated from the high molecular weight DNA and cell debris by centrifugation 
at 12470 x g for 10 minutes at 4°C (Biofuge Fresco, Heraeus Instruments). The supernatant 
was recovered and incubated at room temperature for 5 minutes. To separate the phases 
0.2ml of chloroform was added and samples were mixed vigorously for 15 seconds, 
followed by centrifugation at 12470 x g for 10 minutes at 4°C. The upper aqueous layer 
was withdrawn and precipitated using 0.5ml of isopropyl alcohol. The samples were stored 
overnight at -80°C. Samples were centrifuged at 12470 x g at 4°C for 10 minutes; the 
supernatants were withdrawn, the pellet was washed with 1ml of 75% ethanol and 
centrifuged at 12470 x g for 5 minutes at 4°C twice. The supernatant was withdrawn and 
the RNA pellet was air-dried at RT for 15-20 minutes; RNA was resuspended in 50µL of 
DEPC-treated water. The concentration of RNA was determined using a ND-1000 
Spectrophotometer (NanoDrop technology) and ND-1000 version 3.2.1 software. The 
quality of RNA was verified using the Agilent 2100 Bioanalyzer (Agilent Technologies 
Inc., USA).  
 
Reverse Transcription  
1µg of RNA was denatured at 95°C for 5 minutes and subsequently chilled to 4°C for 1 
minute before the addition of 2.5µl of Random primer mix, 1.5µl of 10mM dNTP, 6µl of 
5x buffer, 0.6µL of RNAsin

, 1.5µl of reverse transcriptase, 3.6µl of MgCl2 (from 
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IMPROM-RT or Superscript III kits). Nuclease free water was added to make up the final 
volume to 24µl, the samples were heated to 25°C for 5 minutes followed by incubation at 
38°C for 1 hour to synthesise the cDNA strand. The enzymes were inactivated by heating 
the samples to 70°C for 15 minutes and finally chilling the samples to 4°C. The cDNA was 
stored at -20°C until analysed by polymerase chain reaction (PCR). The negative controls 
lacked either the extracted RNA or the reverse transcriptase as stated in chapters.   
 
Quantitative PCR 
PCR was performed to measure the gene expression of several intestinal genes. Primer 
sequences (specified within chapters) were designed using the Jellyfish programme and 
synthesised by Eurofins MWG Operon, U.K. The housekeeping gene β-actin allowed 
normalisation of the genes of interest. Efficiencies were determined for all the individual 
primer sets by using primer dilutions and cDNA dilutions. PCR amplifications were 
performed in samples consisting of 1µl of cDNA sample, 1pmol of primers (sense and 
antisense), master mix (Absolute qPCR SYBR Green Kit, ABgene, UK) and DEPC-treated 
water to make up the final volume (25µl). The amplification and analysis was carried out 
under the following conditions using DNA Engine OPTICON and OPTICON Monitor 
software v2.03 respectively (Real-Time systems; MJ Research): after denaturation for 10 
minutes at 95°C, 40 cycles of primer annealing for 20 seconds at 60°C, elongation step for 
20 seconds at 72°C, and denaturation at 94°C for 20 seconds. SYBR Green fluorescence 
was monitored after each cycle at 72°C to monitor the melting curves.  
 
Sequencing  
In gel digestion: The amplified PCR product was visualised on a 2% agarose gel using 
2µL ethidium bromide and a UV transluminator and consequently excised from the gel. 
The products were purified using the GENECLEAN
® 
TURBO KIT (Qbiogen, Cambridge, 
U.K) using the following process. 100µL/0.1g of GENECLEAN
®
 turbo salt solution was 
added to the excised gel slice to extract the DNA and incubated at 55°C for 5 minutes to 
melt the gel. The solution was placed in the GENECLEAN
®
 turbo cartridge which binds 
the DNA and centrifuged for 5 seconds to eliminate the unbound liquid. GENECLEAN
®
 
turbo wash solution was used to wash the bound DNA twice before eluting the DNA using 
30µL of GENECLEAN
®
 turbo elution solution.  
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In solution digestion: The PCR products were digested with exonuclease I and calf 
intestinal phosphatise at 37°C for 1 hour. Enzymes were denatured at 75°C for 15 minutes 
and subsequently sequenced.  
 
Sequencing: The sequencing reaction consisted of 3µl Big Dye
®
 terminator (v3.1 Applied 
Biosystems, USA), 2.5% (v/v) DMSO, 5-7µl of isolated DNA and 1pmol of sense and 
anti-sense primers of the gene of interest. Sequencing reaction involved denaturation for 4 
minutes at 96°C, 30 cycles of denaturation at 98°C for 30 seconds, primer annealing for 30 
seconds at 50°C, elongation step for 60°C for 4 minutes and 2:1 (v/v) of 100% ethanol and 
3M sodium acetate was added to the sample to precipitate the DNA, which was incubated 
at -80°C overnight. The sample was centrifuged at 12470 x g for 15 minutes, the 
supernatant was withdrawn, the pellet was washed with 100µl of 70% ethanol and the 
pellet was dried at 60°C for 20 minutes. The samples were subsequently sequenced using 
the ABI sequencing machine by the sequencing Facility, Faculty of Life Sciences, 
University of Manchester. The data was analysed using ChromasPro
®
 v1.34 
(www.technelysium.com.au/ChromasPro.html) and the sequences obtained were compared 
against a database (GenBank at http://www.ncbi.nlm.nih.gov/BLAST). 
 
In vitro analysis 
Worm isolation for ATP analysis 
The caecum was longitudinally cut and segmented before incubation with 0.1M NaCl for 2 
hours at 37°C with frequent shaking. Worms were counted after separation from debris and 
epithelial cells using a 0.7μm filter and kept in RPMI-1640 supplemented with 10% foetal 
bovine serum (FBS). Alive worms were subsequently homogenised using the FastPrep
®
 
homogeniser (MP Biomedicals, Inc.).  
 
Energy status of worms  
The CellTiter-Glo
®
 luminescent cell viability assay was carried out according to 
manufacturer‟s instructions (Promega Corp., USA). Relative light units (RLUs) were 
calculated per worm: RLU = (sample light units − blank light units)/number of worms. 
Substrate only was used as a blank control; worms were boiled before homogenisation for 
negative controls. To determine recovery of energy status, worms were washed extensively 
in DMEM, added to 6 well plates with LS174T cells for 24 hours prior to measuring ATP 
levels.   
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LS174T cells 
LS174T cells (European Collection of Cell Culture, Salisbury, UK) were cultured with 
complete medium containing DMEM, 2mM L-glutamine, 100U/ml penicillin, 100μg/ml 
streptomycin and 10% heat inactivated FBS (all from Invitrogen, Paisley, U.K) at 37°C in 
a humidified incubator (95% air with 5% CO2). When confluent, cells were gently scraped 
until dislodged from the flasks surface and rinsed with approximately 5ml of complete 
media. The suspended cells were dispersed using a 25G” needle, resuspended at 
approximately 1 x 10
6
 cells/ml (Hayes et al, 2007).  
 
Treatment of mucins with T. muris ESPs 
Adult worms were harvested and cultured in vitro, after 24 hours the released excretory 
secretory products (ESPs) were collected (Else and Wakelin, 1989). Aliquots of crude 
mucus (in equal volumes of PBS) were incubated at 37°C with 50-300μg/ml of ESPs for 
various time points (as specified in figure legends). Control samples were not treated with 
the ESPs, but were incubated at 37°C for the maximum time point. All samples were 
analysed by rate zonal centrifugation.  
 
Cytokine analysis 
Mesenteric lymph nodes (mLNs) were removed, cells were isolated and resuspended at 5 x 
10
6
 cells/ml in RPMI 1640 with 10% FBS, 2mM L-glutamine, 100U/ml penicillin and 
100μg/ml streptomycin. Cultures were stimulated with 50μg/ml of ESPs for 24 hours at 
37°C and 5% CO2. Cell free supernatants were stored at -80°C; cytokine analysis was 
carried out by Cytometric Bead Analysis (CBA) provided by BD Biosciences, using the 
manufacturer‟s instructions.  
 
Analysis 
Goblet cell number analysis 
Stained goblet cells (number stated) similar sized crypts were counted per mouse and the 
mean number of goblet cells per 50-100 crypts was determined in three individual mice. 
 
Goblet cell size and staining intensity analysis 
Images taken at x20 magnification were calibrated to the same scale in pixels using the 
Image J software. The area of goblet cells contained in 50-100 crypts was determined as 
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the area/mm
2
 (pixels). The staining intensity was measured using the Image J software, 
data represented as arbitrary units.  
 
Statistical analysis 
Statistical analysis was performed using the one-way ANOVA when comparing more than 
two samples and paired t-tests were used to compare two samples with the GraphPad 
PRISM version 3.2 (GraphPad software, Inc.) or with SPSS Version 16.0 (SPSS Inc, 
Chicago, USA). All results are presented as the mean ± standard error of the mean. P<0.05 
was considered statistically significant.  
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